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Abstract 
A rapid and inexpensive method for the production of protein is crucial for the 
biopharmaceutical industry. The bottleneck in the case of genetically engineered systems 
lies in the recovery of active and properly refolded proteins from inclusion bodies.  The 
correct refolding of a protein from its denatured state is dependent on several parameters 
including the concentration of the protein, the refolding buffers utilized, the approach 
employed and finally the type of refolding additives, if any, used in the process.  
In this study, an emerging class of refolding additives, namely, ionic liquids were 
investigated for the refolding of denatured lysozyme protein. Lysozyme was used as a 
model system due to its rapid refolding kinetics and the fact that enzyme based assay 
could be carried out to measure the refolding yields. The ionic liquids selection was 
hypothesized based on the selection of cation and anion that constitute the ionic liquid. 
The efficacy of Imidazolium based ionic liquids as refolding additives was compared to 
conventional refolding approach that contains urea and redox-couple cysteine/cystine. 
Using response surface methodology (RSM) and central composite design (CCD), an 
empirical model was developed and validated by experimental results. Different refolding 
strategies were also evaluated; dilution refolding, adsorptive on column packed bed 
refolding and adsorptive on column fluidized bed refolding.  
Experimental results indicate that in comparison to the conventional refolding buffer, 
among different ionic liquids examined, ionic liquid 1-ethyl-3-methylimidazolium 
([EMIM]
+
 Cl) has a pronounced effect on the refolding yield and time required to refold 
the denatured lysozyme. The optimal conditions were identified in this study as 150 
μg/ml of denatured lysozyme in presence of 75 mM [EMIM]+ Cl in 50 mM HEPES 
buffer (pH 7.5). On-column refolding studies indicate that in comparison to the packed 
bed system, the fluidized bed ion-exchange system approach, with [EMIM]
+
 Cl as the 
elution-refolding buffer could tolerate higher concentration of denatured lysozyme (up to 
25 mg) with refolding yield ca. 90% and fractional mass recovery ca. 82%.  This was due 
to potentially lower mass transfer limitations in the fluidized bed compared to the packed 
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bed. Thus, the versatility of ionic liquids coupled with on-column adsorptive refolding 
can possibly be the solution to the large scale downstream processing of proteins. 
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Chapter 1  
1 Introduction 
1.1 General Introduction 
The biotechnology industry is estimated to be $93.0 billion industry with a current annual growth 
rate of 5.2% and projected rate of 8.9% in the coming five years (IBIS 2013). Proteins account 
for an important spectrum of products in this industry that have applications in medicine as 
biopharmaceuticals. The production, biochemical engineering and processing of these proteins, 
is thus an important consideration in biotechnology.  
Industrial scale manufacturing of proteins can be categorized as a two-phase process – upstream, 
which is expression and production of recombinant proteins in host cells and downstream, which 
is the recovery and purification of the protein. Often, overexpression of proteins results in the 
production of aggregates or inclusion body proteins that are inactive. Recovery of the active 
protein from genetically expressed proteins is thus limited by several unit operations, starting 
from centrifugation and filtration of the inclusion body proteins to the renaturation of the 
solubilized  
In the early 1980s, the ‘bottleneck’ in the bio-therapeutics industry centered on the large-scale-
production of proteins. Production titers have since sky rocketed from what was considered 
standard, 1g/L, to 10g/L and more recently to 27
+g/L antibody titer by Crucell’s Per.C6® cell 
line (Scott, 2008). Production of intracellular inclusion bodies, even at high titre has shifted the 
aforementioned ‘bottleneck’ to downstream processing and specifically recovery of native 
proteins from solubilized inclusion body proteins. The rate-limiting step in the downstream 
processing of proteins is thus the renaturation of nascent polypeptides to form active, native 
proteins.  
Chow et al (2006) published a database – REFOLD that summarized the literature published 
upto 2006 encompassing the different refolding strategies employed. Of the published articles, 
44% of the articles discussed dilution refolding, 17% dialysis and 16% a combination of dilution 
and dialysis. Approximately 15% of them discussed the use of different on-column refolding 
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strategies such as immobilized metal affinity chromatography, size exclusion, ion exchange, 
and hydrophobic interaction etc.  
Irrespective of the in vitro methodology employed, protein refolding additives have a significant 
impact and critical to the successful downstream processing of proteins. Traditional refolding 
additives such as low concentrations of chaotrope (e.g. 2 M urea), amino acids and amino acid 
derivatives (L-arginine, glycine, arginamide), salts (e.g. ammonium sulfate), polymers (e.g. 
polyethylene glycol PEG, polyvinypyrrolidone PVP) have exhibited limited success. Since their 
first use as protein renaturation agents for denatured lysozyme by Summers and Flowers in 2000, 
the application of ionic liquids as protein refolding additives is being investigated by several 
groups worldwide.  
1.2 Objectives  
The overall objective of this study was to investigate the effect of a new class of protein 
refolding additives, specifically; the imidazolium based ionic liquids as refolding additives for 
on-column adsorptive refolding of denatured lysozyme. Lysozyme was chosen as the 
representative protein due to its relatively fast refolding kinetics and the fact that an enzyme-
based assay can be applied to measure protein refolding yields. 
Specific objectives:  
The overall objective was further divided into the following specific sub objectives: 
[1] First the conventional approaches currently applied for lysozyme protein refolding were 
compared. These included the traditional dilution refolding and comparison with an ion 
exchange based adsorptive refolding technique. Next ionic liquids were applied as 
refolding additives in a conventional dilution-refolding format and the various factors 
that affect refolding yield of lysozyme were investigated. 
[2] The identification of the optimal conditions for refolding denatured lysozyme, with the 
aid of ionic liquid(s) was next attempted using response surface methodology and central 
composite design.  
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[3] Finally, ionic liquids and in particular the ionic liquid [EMIM] Cl was investigated 
for both the elution and refolding of denatured lysozyme in two different ion exchange 
column configurations, i.e. packed bed and fluidized bed ion-exchange systems. 
1.3 Thesis structure 
The thesis is divided into the following chapters: 
 Chapter 2: Literature review.  
An exhaustive, up-to-date review of the published literature is presented in this chapter. Factors 
that affect protein refolding at a molecular level, in-vitro, are discussed. This is used to better 
understand the role of refolding additives, specifically ionic liquids. The potential for 
development of ionic liquids as refolding additives is evaluated and an unbiased, comprehensive 
review of the topic is presented.  
  Chapter 3: Materials and Methods. 
 This chapter provides details of the materials and methods that are common to all the proceeding 
chapters. Details about the fluidized bed ion exchanger and its mode of operation are provided in 
this chapter. Materials and methods pertinent to individual chapters are presented accordingly in 
those chapters.  
 Chapter 4: A comparative study of refolding lysozyme using conventional strategies.  
This chapter begins by validating the requirement of refolding additives and low concentration of 
denatured protein for dilution refolding of denatured lysozyme. Next, it compares the refolding 
yield and fractional mass recovery, as a function of increase in protein concentration, for two 
different on-column modes of operation – packed bed and fluidized bed.  
 Chapter 5: Investigation of dilution refolding of denatured lysozyme using imidazolium 
ionic liquids.  
This chapter identifies the ionic liquid parameters, composition and concentrations of ionic 
liquid, that influence the refolding yield of lysozyme. Refolding yield is presented as function of 
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time, with change in concentration and composition of the ionic liquids tested. Influence of 
chaotropicity and kosmotropicity of the individual ions of the ionic liquid on the refolding yield 
is also discussed.  
 Chapter 6: Application of response surface methodology and central composite design for 
the optimization of lysozyme refolding by [EMIM] Cl  
A quick overview on the theory of response surface methodology and central composite design is 
provided. Experimental design and results thereof that aid and abet in the identification of 
optimal refolding conditions for denatured lysozyme by [EMIM] Cl are discussed in this chapter. 
A validated, empirical model based on the results is provided. 
 Chapter 7: Adsorptive protein refolding with the aid of [EMIM] Cl in a packed 
bed/fluidized bed ion exchanger  
The applicability and influence of [EMIM] Cl as an elution and refolding buffer for adsorptive 
refolding of denatured lysozyme is examined. Refolding yield and fractional mass recovery, due 
to incorporation of [EMIM] Cl in elution buffer, is presented as function of mode of operation 
and increase in concentration of protein load. Comparison on the efficacy of [EMIM] Cl as a 
refolding/elution enhancer to other ionic liquids is also reviewed by means of experimental 
results.  
 Chapter 8: Concluding remarks and recommendations 
Based on the experimental results acquired in this thesis, final concluding remarks and pertinent 
recommendations are provided.  
1.4 Major contributions 
The experimental results in this thesis can be summarized in the form of the major 
contributions, as follows: 
[1] Experimental results obtained demonstrate the use of ionic liquids, specifically 
imidazolium based ionic liquids as refolding additives for denatured lysozyme without 
the support of other refolding agents such urea and cysteine/cystine.  
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[2] For the first time, response surface methodology and central composite design were 
implemented to identify the optimal conditions for refolding denatured lysozyme using 
[EMIM] Cl.  
[3] Refolding of denatured lysozyme on on-column fluidized bed ion exchanger  
i. A novel fluidized bed ion exchange system was proposed and investigated for the 
adsorptive refolding of denatured lysozyme 
ii. For the first time, ionic liquid was incorporated in the elution and refolding 
studies of denatured lysozyme in a packed bed and fluidized bed ion exchanger 
iii. With the aid of [EMIM] Cl in elution buffer, in comparison to packed bed, 
fluidized bed mode of operation tolerates higher concentration of protein load (up 
to 25 mg) without unfavorably affecting the refolding yield and mass recovery 
1.5 Nomenclature 
[EMIM] Cl : 1-ethyl-3-methylimidazolium chloride 
 
1.6 References  
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Chapter 2  
2 Literature Review: Ionic liquids as refolding additives 
An exhaustive, up-to-date review of the published literature is presented in this chapter. Factors 
that affect protein refolding at a molecular level, in-vitro, are discussed. This was used to better 
understand the role of refolding additives, specifically ionic liquids. The potential for 
development of ionic liquids as refolding additives is reviewed.  
2.1 Abstract:  
Globally, purification of proteins is steadily moving towards a single-unit-system that can handle 
higher concentrations of protein while maintaining the productivity and overall cost efficiency of 
the process. The bottleneck of protein production has shifted downstream, specifically, recovery 
of active proteins from inclusion body proteins. In principle, recovery is a two step process; 
solubilization of the inclusion body followed by refolding or renaturation of the unfolded, 
dissolved protein to its active, refolded state. Protein refolding, in-vitro, is a kinetically 
competitive process, which if not executed in the appropriate environment could result in 
formation of aggregates and/or misfolded proteins, thereby substantially reducing productivity. 
Renaturation can be achieved either by use of suitable additives that suppress aggregation and 
enhance structural stability of native protein, and/or chemicals that allow the formation of 
disulfide bridges. Protein refolding aids encompass a variety of chemicals – amino acids (L-
arginine), chaotropic salts at non-denaturing concentrations (urea, guanidine hydrochloride), 
polyols, polymers, amino acid -esters and -amides, molecular chaperones (GroEL, GroES), etc. 
Ionic liquids, ‘green alternatives to organic solvents’, can be designed to serve variety of 
functions ranging from organo-catalysis to active pharmaceutical ingredient. In the past decade, 
reports of their ability to suppress protein aggregation and enhance structural stability against 
thermal denaturation have emerged that make them suitable targets as protein refolding 
additives. A comprehensive review of their mechanism of action has been provided by first 
understanding the fundamentals of protein refolding, need for refolding additives and the 
consequent effect of solutes as protein refolding additives.  
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2.2 Background Information:  
Not more than a decade ago the “capacity bottleneck” in the bio-therapeutics industry centered 
on the large-scale-production of proteins. Production titers have since sky rocketed from what 
was considered standard, 1g/L, to 10g/L, and more recently to more than 27 g/L antibody titer by 
Crucell’s Per.C6® cell line (C. Scott, 2008). In this regard, bacterial expression such as in 
Escherichia coli  (one of the most extensively studied and used prokaryotic organisms) offers 
several advantages including growth on inexpensive carbon sources, rapid biomass 
accumulation, amenability to high cell-density fermentations and simple process scale up 
(Baneyx & Mujacic, 2004; Jungbauer, Kaar, & Schlegl, 2004; Mergili, Eiberle, & Jungbauer, 
2010). However, more often than not, over-expression leads to the accumulation of insoluble 
polypeptide aggregates, often termed as “inclusion body”. Inclusion body proteins are 
amorphous, electron refractile, devoid of biological activity, dense particles of aggregated 
proteins. They can be found in both the cytoplasm and the periplasm of the bacteria, depending 
on if they were engineered to secrete the proteins or not (Clark, Schwarz, & Rudolph, 1999; 
Singh & Panda, 2005; Vallejo & Rinas, 2004; Q. M. Zhang, Wang, Liu, & Wang, 2008). There 
are several advantages associated with expression of proteins as inclusion bodies (Burgess, 2009; 
Clark, 2001; Singh & Panda, 2005; Su, 2011; Vallejo & Rinas, 2004): 
a) The expression levels are often very high, up to 30% of the total cell protein.  
b) The proteins are largely protected from proteolytic degradation by host cell enzymes.   
c) Inclusion body proteins usually have higher density (~1.3 mg/ml) than many cellular 
proteins in vivo. Easy isolation of inclusion bodies from cells due to differences in their size and 
density as compared with cellular contaminants 
d) Homogeneity of protein of interest in inclusion bodies, which helps in reducing the 
number of purification, steps to recover the pure protein. 
Nonetheless, the production of intracellular inclusion bodies (even at high titre) has shifted the 
aforementioned “bottleneck” to downstream processing, specifically recovery of native proteins. 
Protein refolding is a competitive process between folding and aggregation of proteins. As a 
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unimolecular process, protein folding is considered to be a first order reaction. While, on the 
other hand, aggregation is a second- or higher- order reaction, severely influenced by the 
concentration of the denatured protein.  
However, the production of intracellular inclusion bodies even at high titre has shifted the 
aforementioned “bottleneck” to downstream processing and recovery of produced proteins. The 
pressure to develop better separation and purification protocols that combat the new process- and 
product-related impurities and higher titre levels without compromising on the safety, efficacy 
and quality of the product is continually increasing.  The purification of proteins is steadily 
moving from pooling-elution-fractions-of-multiple-runs on a single column towards 
development of columns that can handle higher protein concentrations. In order to do so, it is 
pertinent to develop approaches that incorporate clarification, separation and purification.  
In-vivo, the cell has developed safety mechanisms, in the form of molecular chaperones, to 
combat the issue of misfolding and aggregation that might occur due to premature termination of 
translation of proteins, environmental stress and/or failure for newly synthesized polypeptide to 
reach it’s native conformation. These molecular chaperones can be divided into three functional 
subclasses; folding chaperones (e.g. DnaK, GroEl), holding chaperones (e.g. IbpA/B) and 
aggregating chaperones (e.g. ClpB). Each of the subclasses serves a unique function. Folding 
chaperones, rely on ATP-driven conformational changes to mediate the net refolding/unfolding 
of substrates. Holding chaperones, hold the partially folded state of the proteins until folding 
chaperones are available to execute their activity. And lastly, aggregating chaperones promote 
the solubilization of aggregated proteins. (Hartl, 1996; Hartl, Bracher, & Hayer-Hartl, 2011; 
Kriegenburg, 2012; Obalinsky, 2006; Sinnige, Karagöz, & Rüdiger, 2001; Wittung-Stafshede, 
2011) Some of these molecular chaperones, GroEl, GroEs, DnaK, have recently been examined 
and adopted for in-vitro refolding of denatured protein(Hartl & Hayer-Hartl, 2009). In-vitro, the 
focal point of research for the past several decades has been to develop better refolding additives 
that mimic the action of molecular chaperones in-vivo, while at the same time meet the 
economies of scale and production requirements.  
Ionic liquids are organic salts whose melts are composed of discrete cations (Table 2.1), based 
on methylimidazolium, N-butylpyridinium, N-methyl-N-alkylpyrrolidinium, and anions (Table 
2.2), such as hexafluorophosphate [PF6]
-
, tetrafluoroborate [BF4]
-
, alkylsulfates [R-SO4]
-
, halides 
 9 
 
 
such as chloride [Cl]
-
, nitrate [NO3]
-
 etc,. Some noteworthy characteristics of ionic liquids 
include low to negligible vapor pressure, high thermal stability, non-ionizing, non-flammable 
properties, ability to dissolve wide range of organic, inorganic, organo- metallic compounds and 
polymers, electric conductivity, high electro elasticity, liquid crystal structures, potential to be 
reused and recycled, and immiscibility with either water or organic solvents (Hardacre, Holbrey, 
& Nieuwenhuyzen, 2007; Hough & Rogers, 2007; Turner, 2005; van Rantwijk & Sheldon, 
2007).  Also ionic liquids can be ‘tailored’ such that altering their structure affects its physico-
chemical properties, which further enhances or impairs their functionality. Although, no thumb 
rule has been set to determine the physico-chemical properties of any novel ionic liquid, 
quantitative structure activity relationship (QSAR) is being investigated (Das & Roy, 2013; 
Jastorff et al., 2003). Many applications of ionic liquids have already been reported e.g. use as 
lubricants, additives, in organic and in-organic chemistry, separation technology, and 
biopharmaceuticals (Abbott & McKenzie, 2006; Freire et al., 2012; Greaves & Drummond, 
2008; Han & Row, 2010; H. Lin, de Oliveira, & Veith, 2011; MacFarlane & Seddon, 2007; G. 
W. Meindersma, Maase, & De Haan, 2000; Rodrigues, Prosinecki, Marrucho, Rebelo, & Gomes, 
2011; Zhu et al., 2006). In recent years, their use in refolding of denatured proteins has emerged. 
In order to assess their applicability, we must first understand the downstream processing of 
proteins and factors that influence protein refolding 
.  
 
 
 
 
Table 2.1 List of commonly used cations of an ionic liquid 
Cation Full name Abbreviation 
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1-alkyl-3-methylimidazolium [Cnmim]
+
 
 
1-alkyl-3-methylpyrolidnium [Cnpyim]
+
 
 
N-alkylpyridinium [Cnpy]
+
 
 
Tetraalkyl-ammonium TRA 
 
Tetraalkyl-phosphonium TRP 
 
 
 
 
 
 
Table 2.2 List of commonly used anions in ionic liquids 
Anion Full name 
N N
+
R
CH3
N
+ RCH3
N
+
R
R N
+
R
R
R
RR P
+
R
R
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Cl
−
 Chloride 
Br
−
 Bromide 
BF4
−
 Tetrafluoroborate 
PF6
−
 Hexafluorophosphate 
RSO3
−
 Alkylsulphate 
 
2.3 Downstream processing for protein recovery 
Production of an active refolded protein from a mass of nascent polypeptide chains, often 
aggregated to form inclusion body proteins, involves several stages as elucidated in Figure 1. 
Irrespective of the cellular process used to express proteins, extraction of the protein is the first 
and foremost step. Cell lysis followed by separation using ultra-centrifugation and other such 
techniques are commonly employed to extract the inclusion body proteins. Filtration is ensued by 
solubilization of the inclusion body protein by employing high concentrations of chaotropic salts, 
such as urea and guanidine hydrochloride, detergents such as Triton X 100, deoxycholate and 
sodium-N-lauroyl sarcosine (SLS) (Burgess, 2009; Cabrita & Bottomley, 2004; Singh & Panda, 
2005), and reducing agents such as dithiothrietol (DTT), ß-mercaptoethanol that break the 
disulfide linkages of the protein and completely solubilize and denature the inclusion body 
proteins. 
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Figure 2.1 Purification strategy for recovery of bioactive proteins 
Recovery of folded proteins from denatured, solubilized inclusion bodies is thus dependent on 
multiple unit operations and involves a large number of parameters as shown in Figure 2.2 
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Figure 2.2 Ishikawa diagram eliciting the parameters that affect protein refolding yield and 
protein activity 
Refolding of solubilized proteins involves approaches such as batch dilution, dialysis and pulse 
renaturation. These are traditionally employed methods that can be labor intensive, cost-
ineffective, difficulty to automate and scale-up and often result in higher ratio of aggregates to 
active refolded proteins(Chen, Lin, Wu, & Liu, 2012; Mannall, Titchener-Hooker, Chase, & 
Dalby, 2006; Shiraki, 2010). 
(Jungbauer et al., 2004) review some of the noteworthy contributions in the field of on-column 
protein refolding strategies. It is evident a variety of preparatory modes of on-column refolding 
have been designed and tested for recovery and purification of refolded proteins from IBPs; 
expanded bed (EB), simulated moving bed (SMB), membrane chromatography etc. In 
comparison to packed bed and dilution refolding, EB & SMB offer significant advantages in 
terms of process efficiency, solvent and media utilization, reduced number of post-refolding 
processing steps such as separation, polishing, viral filtration and above all else flexibility to 
work with higher concentrations of protein titre. However, EB systems encounter fouling of 
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resin, protein/lipid build-up, and ligand loss and matrix disintegration rendering them a 
cost-ineffective option for industrial application. Although, SMB addresses some of the EB 
issues, it also suffers limitations owing to cost of construction, operation and maintenance 
(Chase & Draeger, 1992; Ferré et al., 2005; Freydell et al., 2010a; Gu et al., 2002; Lyddiatt, 
2002; B.-J. Park, Lee, Mun, & Koo, 2006). High pressure refolding, although in its embryonic 
stages of development, is also being considered as potential refolding strategy at the industrial 
scale. Notable key advantages of the high pressure refolding method are: (1) performs 
solubilization and refolding/disaggregation of protein simultaneously, (2) requires little or no 
chaotropic agents, (3) is often independent of protein concentration, and (4) can disaggregate and 
refold proteins rapidly (Qoronfleh, Hesterberg, & Seefeldt, 2007). However, so far the published 
literature on the use of high-pressure protein refolding has been under extreme conditions; low 
protein concentration (0.65 mg/ml of growth hormone), high pressure 2000 bar, 65 °C for 24 
hours, creating the element of doubt for scale up at industrial level (St John, 2001). Thus, there is 
a constant need to develop newer refolding strategies that are - economical, robust, cost- and 
process- efficient and generic.  
2.4 Analysis of refolding efficiency 
Irrespective of their final use, it is important that the produced-refolded protein meets the quality 
control and quality assurance standards. Besides high purity, activity of the compound, which is 
closely related to its native structure, is a critical quality control. Activity assays combined with 
circular dichroism (CD) spectroscopy and/or fluorescence spectroscopy are classified as 
adequate means to prove the identity of the product (Bekhouche, Blum, & Doumèche, 2012; 
Diego, Lozano, Gmouh, Vaultier, & Iborra, 2004; Helal & Melzig, 2013; Hennessey & Johnson, 
1981; Kelly, Jess, & Price, 2005; Y. C. Lee & Yang, 2002). Typically, CD and fluorescence 
spectra of unfolded, native and refolded protein are compared and the latter ones have to show 
equal features to meet the activity criteria.  
The correct formation of disulfide bonds can also be determined by chromatography techniques 
such as reverse phase chromatography, hydrophobic interaction chromatography and ion-
exchange chromatography. Analytical size exclusion chromatography is often employed to 
detect and separate the aggregated and misfolded proteins from correctly folded proteins 
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(Freydell, Van Der Wielen, Eppink, & Ottens, 2010b; Gu et al., 2002; Jungbauer et al., 
2004). More recently, progressive proteomic techniques such as atomic force 
spectroscopy(Peterman & Wuite, 2011), light scattering (Gast, Damaschun, Misselwitz, & 
Zirwer, 1992; Peterman & Wuite, 2011), calorimetery (Baldwin & Rose, 2013; Farber, 
Darmawan, Sprules, & Mittermaier, 2010; C. Scott, 2008), ATR-FTIR spectroscopy (Baneyx & 
Mujacic, 2004; jungbauer, Kaar, & Schlegl, 2004; Mergili et al., 2010; Shivu et al., 2013; J. M. 
Walker, 2012) have been suitably adopted to study protein refolding kinetics, protein-protein 
interactions and oblige as a stronger validation protocol.  
2.5 Role of refolding additives on protein refolding 
Proteins are most soluble in aqueous solution when they are in their native, folded state. It is well 
established that protein refolding is a kinetically competitive process between the intermolecular 
hydrophobic interactions resulting in aggregates versus the intra-molecular interactions yielding 
native proteins. As a unimolecular process, protein folding is a first-order reaction with respect to 
protein concentration, while the aggregate formation is a second- or higher- order process caused 
by intermolecular interactions. Competition between the folding and aggregates determines the 
efficiency of the in-vitro refolding step. 
Figure 2.3 depicts a simplified protein refolding kinetic model. In this model, the unfolded 
protein (U) undergoes the early phases of folding to form a transient intermediate (I) with native-
like secondary structure and partial tertiary structure. This model can be further simplified to a 
parallel of reaction of the formations of the native state protein (N) and aggregates (A) from 
transient intermediate. 
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Figure 2.3 Kinetics of protein refolding. Key: U: unfolded and reduced protein; I: 
Intermediate stage; N: Native state 
Aggregation results from non-specific interactions between hydrophobic regions or partially 
refolded structures of different polypeptides, it is usually irreversible, hence it’s critical that this 
step is suppressed so as to achieve high yields of native and active protein (Buswell & 
Middelberg, 2002; X.-Y. Dong, Huang, & Sun, 2004; Ferrone, 1999; Gast et al., 1992; 
Konermann, 2011; Nölting, 2006). 
Competition between folding and aggregation can be expressed by the following equations: 
dI
dt
 -kNI-kAI
n………………………………………………………………………Equation 2.1 
When t= 0, I= U0 and N= 0 
dN
dt
 kNI…………………………………………………………………….Equation 2.2 
where, Uo represents the initial unfolded protein concentration, t - the refolding time (min), kN 
and kA - folding and aggregation kinetic constants, respectively and n - reactor order of aggregate 
formation. 
It is this competition between aggregates and/or misfolded proteins and native proteins that make 
recovery of active proteins from IBPs challenging and also the bottleneck step in downstream 
processing of proteins. 
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 The refolding process is modulated, in vivo, by molecular chaperones (also known as heat 
shock proteins) that ensure the production of native, active protein. Absence or lack of molecular 
chaperones in humans gives rise to neurodegenerative diseases such as Alzheimer’s’ disease, 
Parkinson’s and various other prion diseases (Clark et al., 1999; Goedert, Clavaguera, & Tolnay, 
2010; Jucker & Walker, 2011; Singh & Panda, 2005; T. Zhang & Ye, 2007). For a detailed 
understanding of the protein misfolding and its relationship with human diseases, the reader is 
directed to review by Chiti and Dobson (2003), in addition to other articles cited here (Burgess, 
2009; Chiti & Dobson, 2006; Clark, 2001; F. Li, Dong, & Zhuang, 2009; Singh & Panda, 2005; 
Su, 2011; Vallejo, 2004) 
In vitro the slightest deviation in up-stream process and/or product parameters such as pH, 
concentration of protein, temperature changes, mechanical stress such as shear strain, surface 
adsorption or foaming etc., can alter the structure of the protein and consequently promote 
‘salting out’ and/or misfolding or aggregation (Hamada, Arakawa, & Shiraki, 2009; Ito et al., 
2012; Karuppiah & Sharma, 1995; X. U. T. Lin, 2010; Mergili et al., 2010; Tsumoto, Ejima, 
Kumagai, & Arakawa, 2003; Yamaguchi, Yamamoto, Mannen, Nagamune, & Nagamune, 2012; 
L. Yang, Dong, & Yan, 2008). Often, production of proteins as inclusion body proteins 
(aggregates) is preferred owing to ease of separation, protection from proteolytic degradation and 
higher protein content.  Once solubilized, inclusion bodies are open chain, polypeptides with 
hydrophobic core exposed to the solvent media. Gradual removal of denaturants (solubilization 
agents) generates an environment conducive to protein refolding.  
Essentially during refolding proteins are not properly converted to the native state instead 
assume a partially folded state for a prolonged period of time (Biggar, Dawson, & Storey, 2012). 
Intermediates with hydrophobic regions that are exposed to the solvent play a crucial role in the 
partition between native and aggregated conformations. Folding intermediates are comprised of 
significant elements of the secondary structure but little of the native tertiary structure. Due to 
the expanded volume of these intermediates, the hydrophobic regions, which are usually buried 
in the native state, are exposed to the solvent. When so exposed, hydrophobic regions on separate 
polypeptide chains can be in contact with one another and can interact. This causes the 
intermediates to be diverted from the correct folding pathway, resulting in aggregate formation 
and loss of protein. 
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Thus, it is apparent that in order to achieve high refolding yield the protein structure must 
either be stabilized to minimize deviation and/or the structures that are not in the native state 
must be solubilized to avoid protein-protein interaction (aggregation/misfolding).  This can be 
achieved by addition of solutes/refolding additives. In principle, solution/refolding additives can 
be classified into two categories a) denaturants – indirectly promote refolding by weakening the 
inter- and intra- hydrophobic bonding   b) protein stabilizers- enhance protein refolding by 
modifying the water of hydration and thereby stabilizing the native structure. 
Table 2.3 summarizes refolding aids typically utilized for production of proteins from nascent 
polypeptides and/or inclusion bodies. Chaotropic salts at non-denaturing concentrations (for urea 
below 2.5 M) anion- and non-ionic detergents, amino acids and its derivatives, osmolytes, 
amphiphilic polymers and varying salts have been used as refolding aids in the past.  
Of these, the most popular refolding additives are urea (123 research articles since 2010) and 
arginine (48 research articles since 2010), as per number of research articles published and 
accessed via Scopus on July 23, 13.  For detailed discussions on the mechanism of action of 
commonly used solution additives the reader is referred to what has already been covered by 
other authors (Hamada et al., 2009; Karuppiah & Sharma, 1995; Tsumoto, Ejima, Kita, & 
Arakawa, 2005; Yamaguchi et al., 2012; C. Yang, Yu, Dong, & Sun, 2012; Yasuda, Murakami, 
Sowa, Ogino, & Ishikawa, 1998) 
 
 
 
 
 
 
Table 2.3 Summary of commonly used protein refolding additives 
Sr. 
No. 
Nature Mechanism of action Advantages & 
Limitations 
References 
1 Chaotropic Salt 
 Guanidine 
 Solubilize 
hydrophobic moieties 
exposed to the solvent 
 Urea at concentrations 
below 3M promotes 
refolding 
(Gu et al., 
2002; Hamada 
et al., 2009; 
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Hydrochloride 
 Urea 
 
 
in folding 
intermediates or 
misfolded species. 
 Significantly enhances 
viscosity of the solution 
generating issues in 
chromatographic 
purification of the 
protein 
Hardacre et al., 
2007; Khademi 
and Mostafaie, 
2010; Stumpe 
and 
Grubmüller, 
2009)  
 
2 Detergent 
 SDS (sodium 
dodecyl sulphate) 
 Triton X-100 
 Laroylsarcosin 
 Tween -20 
 CHAPS (3-[(3-
cholamidopropyl)di
methylammonio]-1-
propanesulfonate.) 
 SDS is an anionic 
detergent that imparts 
negative charge to 
entire protein.  
 Above critical micelle 
concentration, SDS 
completely denatures 
protein. Binds to the 
hydrophobic region of 
the polypeptide 
 SDS monomer can bind 
to the protein so tightly 
that dilution or dialysis 
does not completely 
dissociate SDS 
molecules.  
 Development of 
artificial chaperone 
protein refolding; 
solubilization of protein 
using SDS ensued by 
stripping off detergent 
by use of Cyclodextrin.  
 Toxicity of detergent 
imminent threat 
 Method is not versatile 
(Daugherty et 
al., 1998; 
Gautam et al., 
2012; Hendrick 
and Hartl, 
1995; Rozema 
and Gellman, 
1996; 
Yamaguchi et 
al., 2012; 
Yasuda et al., 
1998)  
 
 
 
 
 
3 Amino Acid and 
amino-acid 
derivatives 
 Arginine 
 Arginamide  
 Arginine ethylester 
 Proline  
 Glycine 
 
 Increases solubility of 
aggregation prone 
molecules.  
 Also suppresses heat-
induced aggregation of 
protein (exception 
arginine ethylester) 
 Expensive 
 Moderately toxic  
 Arginine ethylester 
tends to be hydrolyzed 
to alcohols and amino 
acids at high 
temperatures or alkaline 
pH 
(Arakawa et al., 
2003; Hamada 
and Shiraki, 
2007; C. R. R. 
Lange, 2009; 
Meng et al., 
2001; 
Nakakido, 
2009; Samuel 
et al., 2008; 
Tsumoto et al., 
2005) 
 
 
Table 2.3 cont’d 
Sr.
No 
Nature  Mechanism of Action Advantages & 
Limitations 
References 
4 Polymers 
 high 
molecular 
weight 
polyethylene 
 PEG binds to the first 
refolding intermediate to 
perturb self-association 
of aggregate-prone 
intermediates. Also 
decreases thermal 
 Expensive 
 Not – biodegradable 
(Meng et al., 2001; 
Swartz, 2001; 
Yamaguchi et al., 
2012; C. Yang et al., 
 20 
 
 
glycol (PEG) 
 polyvinyl 
pyrrolidone  
(PVP) 
 glycerol 
 sorbitol   
stability 
 PVP binds to early-
molten globule like 
refolding intermediate, 
thus, prevents 
aggregation and 
enhances refolding. 
2012; L. Yang et al., 
2008) 
 
 
 
 
 
 
 
 
5 SALTS 
 Ammonium 
sulphate, 
 Trimethyl 
ammonium 
oxide 
(TMAO) 
 magnesium 
chloride/calci
um chloride, 
 sodium 
citrate/sulfate
. 
 
 Modify the interfacial 
tension between the 
protein surfaces and bulk 
solvent, leading to 
alteration of protein 
solubility 
 Final effect dependant on 
protein concentration and 
salt concentration 
  
(Alibolandi and 
Mirzahoseini, 2011; 
Chen et al., 2012; 
Rajan et al., 2010; 
Wang, 2005) 
 
An emerging class of refolding additives, the sixth category not included in the table above, is 
‘Ionic liquids’. By definition, ionic liquids are ionic salts that are liquid at temperatures below 
100 ˚C. Since the synthesis of ethylammonium nitrate (m.p. 12 ˚C) by Paul Walden in 1914, 
ionic liquids have evolved substantially and found application as lubricants, catalysts, in organic 
and in-organic chemistry, separation technology, and biopharmaceuticals etc. These have been 
reviewed in-depth by others and do not fall under the purview of our discussion.  A brief 
overview on the history and nomenclature is provided in the section below.  
2.6 History and Nomenclature of Ionic liquids 
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‘First-generation’ ionic liquids are mainly composed of N,N’-dialkylimidazolium and N-
alkylpyridinium cations, and metal-halide anions. Due to hygroscopic nature of these anions, 
first-generation ILs have to be handled under inert gas, thus limiting their applications. ‘Second-
generation’ ionic liquids, in comparison, are usually more stable in air and water and can be used 
on bench-top.  This is widely attributed to the replacement of large- and oxygen-reactive anions 
by halides such as chloride, bromide, iodide or anions such as BF4
-
, PF6
-
 and C6H5CO2. The 
activity, kinetic- and thermal- stability of different enzymes such as oxidases, lipases or 
cellulases in the presence of second-generation ILs has been successfully studied, and synthesis 
of various products has been carried out (W. G. W. Meindersma and De Haan, 2012; 
Moniruzzaman et al., 2010; Moon et al., 2006; Turner, 2005; van Rantwijk and Sheldon, 2007) . 
‘Third-generation’ of ionic liquids emerged in the early 2000s; are more task specific, chiral, and 
based on more hydrophobic-, biodegradable- anions and cations(Hough and Rogers, 2007; 
Hough et al., 2007; Turner, 2005). (Hough and Rogers, 2007)review the synthesis and 
application of some of these ILs such as ranitidine docusate (histamine H2-receptor antagonist, 
emollient) and didecyldimethylammonium ibuprofen (antibacterial anti-inflammatory).  
Ionic liquids derived from 1-alkyl -3-methyl imidazolium and 1-alkylpyridinium cation are 
referred to as [Cn mim]+, where the index ‘n’ stands for the number of carbons in one of the 
linear alkyl chains and ‘mim’ stands for N-methylimidazolium. 1-ethyl and 1-butyl derivatives 
are often referred to as [EMIM]+ and [BMIM]+ respectively. C-2 methylation of the 
imidazolium moiety leads to even more possibilities of different cation types. These cations are 
abbreviated [Cndmim]+ for 1-alkyl-2,3-dimethylmethylimidazolium and [Cnpy]+ for 1-
alkylpyridinium cation (Earle and Seddon, 2000; Plechkova and Seddon, 2008; Stark and 
Seddon, 2000). As per IUPAC nomenclature, a square bracket is drawn around polyatomic ions, 
and monoatomic anions are denoted without brackets. Thus [C4 mim]Cl
-
 is correct while [C4 
mim][Cl]- is not; [C4 mim][NTf2] is correct, [C4 mim]NTf2  is not. The cation (if organic) must 
always be enclosed by square brackets.  
While knowledge of ionic liquids that moderate protein refolding is crucial, it cannot be achieved 
without an understanding of the terms ‘water of hydration’, kosmotrope and chaotropes.  
2.7  Water of hydration and structural stability of proteins 
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Proteins are linear macromolecules with a non-repetitive, specific covalent structure capable 
of forming a three-dimensional structure owing to amino-acid sequences that fold to generate 
compact domains. The nature and arrangement of the amino-acid side chains along with the 
protein backbone is responsible for the individual characteristics of the macromolecule (Chase & 
Draeger, 1992; Ferré et al., 2005; Freydell et al., 2010a; Gu et al., 2002; Lyddiatt, 2002; B.-J. 
Park et al., 2006; Vasantha, Attri, Venkatesu, & Devi, 2012). 
In principle, when in solution, water in the vicinity of proteins can be classified into three 
categories(Attri, Venkatesu, & Kumar, 2012; Bekhouche et al., 2012; Collins, Neilson, & 
Enderby, 2007; Degreve et al., 2004; Rand, 2004; Zaccai, 2004):  
(a) Internal water -buried in the bio-molecular structure,  
(b) Water of hydration - at the surface of the biomolecule, and 
(c) Bulk or free water -which, technically, no longer feels the influence of the dissolved 
biomolecule. 
Of these, ‘water of hydration’ is of prime importance when studying protein refolding. During 
the course of any protein reaction the total surface area of the protein in contact with water 
changes. This is accompanied by a change in the number of water molecules with which it 
interacts, i.e., its extent of hydration. The water of hydration ‘Wh’ is the effective number of 
water molecules in a fluctuating cloud that interacts more or less favorably with the protein 
surface. Through Figure 2.4, (Timasheff, 2002), explained the ‘water of hydration’. It 
commences with an ideal situation, where free water molecules in pure water would be in 
equilibrium with the transient cluster (Figure 2.4.A). Next, upon introduction of a protein 
molecule (Figure 2.4.B), based on their associated free energies, the water molecules are either 
attracted to-, repelled from-, or indifferent to-, the surface of the protein. This translates in to the 
corresponding changes in the freedom of motion of the individual molecules, as depicted in 
Figure 2.4.C. For example, molecule ‘a’ (shaded grey) is repelled while molecule ‘b’ (shaded 
black) fluctuates between strong attraction and freedom. In Figure 2.4.D, each arrow on the 
water molecule represents the time average of its net non-random extent of motion in the same 
direction as that of the protein. Molecule ‘a’ being repelled from the surface is not transported. 
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Molecule ‘b’, however, due to its fluctuation between being attracted and repelled, migrates 
at a slow rate. The sum of the contributions of all the water molecules whose motion is 
momentarily (and non-randomly) oriented in the same direction as that of the protein molecule is 
the measured protein hydration, which divided by the molecular weight of the water results in the 
‘number’ of water molecules, Wh, that interact with the protein molecules.  
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Figure 2.4 Illustration elucidating the concept of water of hydration (adapted from 
Timaseff, 2002).   
Figure 2.4.A, ideal state where free water molecules are in equilibrium with transient cluster of 
water molecules. When a protein is introduced, Figure 2.4.B, water molecules interact with it 
with different free energies; represented by the vertical bars- downward pointing bars indicate 
attraction, upward indicate repulsion and absence of bars indicates indifference. In Figure 2.4.C, 
corresponding changes in the freedom of translational and rotational motions of the water 
molecules can be visualized. The consequences are seen in Figure 2.4.D. The large vector 
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(arrow) on the protein indicates its motion induced by the applied field (gravitational in 
sedimentation, electro kinetic in electrophoresis, chemical potential gradient in diffusion). 
Molecules with no vector are neutral thermodynamically and are indifferent to the transport of the 
protein molecule.   
In the absence of hydrating water, proteins lack activity. The cloud of water molecules around 
proteins is affected up to at least a nanometer from its surface or 2 nm between neighboring 
proteins. Some of these water molecules interact with the protein surface, reorienting both 
themselves and the surface groups whereas other water molecules link these to the bulk in an 
ordered manner while continuing to remain in a dynamically active state. Thus, when in solution 
proteins possess a conformational flexibility, which encompasses a wide range of hydration 
states. Equilibrium between these states depends on the activity of the water within its 
microenvironment; that is, the degree of freedom that the water has to hydrate the protein. 
It has been reported chemical solutes, including but not limited to ionic liquids, affect several 
characteristics of protein – stability, folding and aggregation - in a number of different ways 
(Ball, 2013; Record et al., 2013; van der Post et al., 2013). For many decades, several different 
studies have investigated these effects and with the evolution in scientific technology and 
analytical methods resulted in two different perspectives – the historical approach- Hofmeister 
series, and the more recent ‘new’ or evolved approach.  
2.1.1 Effect of chemical solutes on proteins 
The historical approach, which considers the concept ‘order makers’ and ‘order breakers’ as 
Hofmeister effects (chaotropicity, Kosmotropicity), is still considered by several scientists 
(Nostro & Ninham, 2012; Schwierz, Horinek, & Netz, 2013; Szalontai et al., 2013; Tietze et al., 
2013)  and a brief discussion is provided in the following section. A more recent revision 
indicates that this is an oversimplified approach lacking information at the sub-molecular level of 
interaction between hydrated state of individual solutes and proteins. Thereby implying that our 
traditional understanding of the concepts of chaotrope and kosmotrope could in fact be 
misleading.  
Hofmeister (1888) developed the series bearing his name based on the concentrations of various 
salts (cations and anions) needed to ‘salt-in’ or ‘salt-out’ the proteins in solution (López-León, 
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Santander-Ortega, Ortega-Vinuesa, & Bastos-González, 2008; Peterman & Wuite, 2011). In 
principle, the ions in the series were arranged in the order of their ability to change water 
structure.  Kosmotropes or “order makers” were those ions that exhibited strong interactions with 
water molecules and were therefore capable of breaking the water-hydrogen bonds (Gast et al., 
1992; Peterman & Wuite, 2011; Tietze et al., 2013; H. Zhao, 2005). As per Hofmeister series, 
sulphate anion, for example, is a strong kosmotropic anion. Because of its strong interaction with 
water SO4
2−
 competes effectively for the water molecules originally associated with the protein 
molecule. This encourages the protein molecule to minimize its surface area exposed to the 
solvent, thereby favoring the acquirement of its native compact state due to the restored driving 
force of the hydrophobic effect. On the other hand, chaotropes are known as “order-breakers” 
because they exhibit strong interactions with protein vs. water. Chaotropic anion, such as cyanide 
for example, selectively partitions in water allowing the protein a degree of structural freedom 
that subsequently encourages protein extension and denaturation.  
Recently, the ideas of the structure-maker/breaker concept have been revisited . The results 
indicated that the perturbation to water's structure appeared to be confined to the first solvation 
shell of the ion (Baer & Mundy, 2013; Collins et al., 2007). Thus, the revised theories, move 
away from the effect of individual ions or solutes on the bulk-water phase and instead focus on 
the direct interaction of individual ions (cation/anion) with the protein. In general, they are 
thought to affect structural stability of proteins in three main ways (Ball, 2013; Nostro & 
Ninham, 2012; Y. Zhang & Cremer, 2010) : 
 Interaction with the protein backbone and side chains through ion-pairing  
  Alteration of both surface tension and hydrogen-bonding network surrounding 
proteins  
 The hydrophobic interaction of ions with water and proteins  
Of special mention is the study by Collins et al (2007) since it addresses the issues with the 
micro-aqueous environment of the protein (Collins, 1997; Collins et al., 2007). They describe 
three different independent layers of hydration that occur at a protein surface; a) the solvation 
layer in close proximity to the protein surface, b) the transition layer, and c) the bulk layer 
that forms the solution. It is estimated that the solvation layer and bulk layer compete for 
hydrogen bond with the transition layer.  The specific structure, charge and composition of 
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the protein determine the solvation layer, while the composition and properties of the 
bulk solution determine the behavior of the bulk layer. The first and third layers compete for 
hydrogen bonding with the second layer. (Nostro & Ninham, 2012). Thus, addition of ions or 
neutral solutes to the bulk layer affects the capability of the transition layer to solvate the 
protein surface. In particular, a kosmotrope in the bulk layer ‘deflects’ the transition layer 
molecules from participating in the hydration of the protein thereby minimizing the solvent 
exposed area. Whereas, the presence of a chaotropic solute in the bulk layer promotes the 
solvation of the protein by the transition layer; the solution becomes a better solvent for the 
protein, which unfolds, exposing more surface to the solvent. (Collins et al., 2007; Nostro & 
Ninham, 2012).  
Thereafter, Pegram and Record (2008) proposed a solute partitioning model (SPM) that 
interprets chemical effects of nonelectrolyte solutes and Hofmeister salts on all aqueous 
processes (Pegram & Record, 2008). Molecular thermodynamic analysis of surface tension and 
hydrocarbon solubility data using SPM was employed to interpret the solute and salt effects on 
surface tension and on solubility of uncharged molecule quantitatively in terms of surface 
hydration, solute partition coefficient, the ratio of local to bulk solute concentration, and the 
extent to which the solute salt or ion accumulates at the surface. In general, it was observed that 
anions accumulated indifferently in proximity of the amide groups and increased solubility, 
while excluded solutes decreased solubility.  
Similar studies by Mason et al (2009) investigated through molecular dynamic simulations the 
interaction between model peptide and tetrapropylammonium sulfate and guanidium chloride 
(Mason et al., 2009; Nostro & Ninham, 2012). Their results suggests that the Hofmeister series 
could be better understood by assessing the capability of ions to affect hydrogen bonding, salt 
bridges, and hydrophobic interactions in the protein and how these effects are altered by the 
counter- ion. 
Thus, water of hydration of proteins, ion-specific interaction of solute molecules with protein 
surface and backbone have a cumulative effect on the refolding of proteins. A widely adopted 
and accepted policy to characterize these ion-specific effects is by the Jone-Dole viscosity B-
coefficient of individual ions in solution.  
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2.1.2 Characterization of ions based on Jone-Dole viscosity B-
Coefficients 
Jone-Dole realized that some ions make water more viscous (kosmotrope) and some others make 
it more fluid (chaotropes) when compared to the viscosity of pure water at the same temperature 
(Jenkins & Marcus, 1995; Marcus, 1994; Nostro & Ninham, 2012). Please note hereafter for the 
purpose of this review article, kosmotrope is defined as the solute that increases the viscosity of 
solvent and chaotrope as the solute that reduces the viscosity of the solvent.  
For a wide range of concentrations (between 0.005 M and 1 M) the specific viscosity of water 
solution can be fitted to the empirical equation, Equation  2.3, as expressed below. 
Equation 2.3   η/η0 = 1 + Ac
1/2
 + Bc + Dc
2
  … 
where η is the dynamic viscosity of the solution and η0  dynamic viscosity of solvent, c is 
the molar concentration of the electrolyte, A reflects the viscous drag due to the ionic 
atmosphere, which delays the motion of the ion and makes the solution more viscous. B-
coefficient depends on the ion-solvent interactions and is related to the volumes of the ions. The 
ion-specific B-coefficient can be negative (for chaotropes <η0) or positive (for kosmotropes, η 
!η0). The term Dc
2 
is needed only in very concentrated solutions (Jenkins & Marcus, 1995; 
Pusey, Paley, Turner, & Rogers, 2007; Z. Yang, 2009; H. Zhao, 2006).  
Based on their viscosity B-coefficients in water Table 2, characterizes some of the commonly 
used ions in ionic liquids as either chaotrope or kosmotrope. This information could assist in the 
the selection and design of ionic liquids as protein refolding additives. 
. 
 
Table 2.4 Characterization of ions commonly used in ionic liquids based on their viscosity 
B-coefficient 
Ion Viscosity B- Kosmotrope Reference 
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Coefficient 
(Equation 
2.3)  
/Chaotrope 
Acetate (OAc-) 
0.246 Kosmotrope (Jenkins & Marcus, 1995; 
Marcus, 1994) 
Cyanide (CN-) 0.022 Chaotrope (H. Zhao, 2006) 
Fluoride (F-) 0.107 Kosmotrope (H. Zhao, 2006) 
Chloride (Cl-) 
-0.005 Chaotrope/ 
Kosmotrope 
(Jenkins & Marcus, 1995; 
Marcus, 1994; van Rantwijk & 
Sheldon, 2007) 
Sulfate (SO4
2-) 
0.206 Kosmotrope (Jenkins & Marcus, 1995; 
Marcus, 1994; Zeuner et al., 
2011) 
Ammonium  (NH4
+) -0.027 Chaotrope (H. Zhao, 2006) 
Tetramethylammonium (CH3)4 N
+ 
0.123 Chaotrope (Lai, Li, Lü, & Yang, 2011; H. 
Zhao, 2006) 
N-ethylpyridinium [Etpy] 0.482 Chaotrope (H. Zhao, 2006) 
1-ethyl-3-methylimidazolium 
[Emim] 
0.491 Kosmotrope (H. Zhao, 2006) 
Using the Jones-Dole viscosity B-coefficients as scaling factors for the strength of water-water 
interactions, (Collins et al., 2007) demonstrated contact-ion pair formation is actually dominated 
by hydration-dehydration. This was reverberated by Zhao and Marcus as illustrated in Figure 2.4, 
(Marcus, 1994; H. Zhao, 2006). Hinckley noticed that the enzyme activity of laccase C from 
Trametes sp. decreased dramatically with the increase of concentration of 4-methyl-N-
butylpyridinium tetrafluoroborate ([4-MBPy]BF4
-
): 10% IL reduced half of the activity and 20% 
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IL reduced the activity more than 9-fold. It was postulated that the high chaotropicity of 
BF4
-
 ions might be an important factor causing the deactivation (B.-K. Liu, Wu, Xu, & Lin, 
2007). 
2.8 Role of ionic liquids as protein refolding additives 
Addition of any solute to an aqueous protein solution, results in lowering of ‘water of hydration’ 
thereby allowing the water/solute molecules to interact with the protein, consequently affecting 
its stability and solubility (Kohno & Ohno, 2012). Ionic liquids, also known as ‘designer 
solvents’, in general consist of a salt where one or both the ions are large, and the cation has a 
low degree of symmetry which tends to reduce the lattice energy of crystalline form of the salt 
and thereby it’s melting point (Earle & Seddon, 2000). Ionic liquids are known to affect protein 
activity by either a) stripping off the internal water associated with the protein, b) penetrating 
into the micro-aqueous environment to interact with the protein by changing protein dynamics, 
conformational and/or protein’s active site, or c) by interacting with the substrates and products 
either by direct reaction with them or by altering the portioning between the aqueous and non-
aqueous phases.   
 Recent molecular dynamics simulations of biomolecules in ionic liquid/water mixtures or 
‘hydrated ionic liquids’ shed light on the interactions of ionic liquid in aqueous bio-molecular 
solutions (Attri et al., 2012; Haberler, Schröder, & Steinhauser, 2012; Hunt, 2006). One such 
simulation study of 1-ethyl-3-methylimidazolium trifluoromethanesulfonate/water mixture in the 
presence (and absence) of ubiquitin and zinc protein motif (Haberler, Schröder, & Steinhauser, 
2011), demonstrated that the anion and cation of an ionic liquid have individual kosmotropic and 
chaotropic characteristics, respectively, encumbering the characterization of the whole ionic 
liquid as a kosmotropic or chaotropic salt.   
The fact that ionic liquids dissolve and dissociate into individual ions rather than exist as an 
intact molecule is an obvious advantage over molecular organic solvent. Miscibility of the ionic 
liquid or its partition coefficient in water has a considerable effect on aqueous protein solutions. 
Upon dissociation, the individual component ions of ILs interact with water via ion-dipole 
interactions and their hydration state is then dependent on the type of ion and fraction of water 
present in the mixture. Consequently, this determines if the ion is behaving as a kosmotrope or 
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chaotrope. Each ion, cation and anion, in solution will interact with the protein in solution 
and either stabilize or destabilize the protein structure and conformation, as has been illustrated 
in Figure 2.7. So far, studies have shown that anions influence protein stability and activity via 
its hydrogen bonding forming capacity and nucleophilicity properties (Attri & Venkatesu, 2012a; 
Buchfink, Patil, Rudolph, Lange, & Tischer, 2010; Lange, Patil, & Rudolph, 2005; Vidya & 
Chadha, 2009; Weingärtner, Cabrele, & Herrmann, 2011). While changes in the alkyl chain 
length of the cations influence the viscosity, hydrophobicity and polarity of the ionic liquid, all 
of which have an effect on the solubility, stability and activity of targeted protein molecule (Bae, 
Chang, Koo, & Ha, 2012; Lange et al., 2005; Xiao et al., 2009; Yamamoto, Yamaguchi, & 
Nagamune, 2011).  
.  
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Figure 2.5 Flow chart that illustrates the application of ionic liquids as protein refolding 
additives. 
 Ionic liquids when dissolved in aqueous protein solution dissociate into individual ions; either of 
which can behave as a kosmotrope or a chaotrope. For the purpose of enhancing protein-
refolding yield in a downstream process, an ideal ionic liquid would be one that has a 
kosmotropic anion and a chaotropic cation 
2.8.1 Ionic liquid parameters that influence protein refolding  
The first example of an enzyme in an IL was reported in 1984 when Magnuson and co-workers 
demonstrated the activity and stability of alkaline phosphatase in aqueous mixtures of ethyl 
ammonium nitrate (EAN). In 2000, Summers and Flowers reported the effective role of EAN as 
a protein aggregation suppressor which resulted in enhanced recovery and refolding of denatured 
lysozyme (Summers & Flowers, 2000). Since then, ionic liquids have been used to stabilize 
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protein activity, to inhibit or reduce aggregation, and to improve the ‘in vitro’ refolding of 
denatured proteins (Attri et al., 2012; Attri & Venkatesu, 2011; 2012b; 2012a; Attri, Venkatesu, 
& Kumar, 2011a; Attri, Venkatesu, Kumar, & Byrne, 2011b; Bae et al., 2012; Byrne & Angell, 
2009; Byrne, Belieres, & Angell, 2009; Lange et al., 2005; Yamamoto et al., 2011) . There are 
several associated advantages of using proteins specifically enzymes in ionic liquid media; 
enhanced operational and thermal stability, increased solubility of sparingly soluble substances, 
ease of immobilization of enzyme in highly viscous ionic liquids, alteration of substrate 
specificity, ease of enzyme recovery by filtration or centrifugation, ease of substrate and product 
recovery simply by evaporation and/or mixing with non-polar organic solvents and/or 
supercritical carbon-dioxide (Moniruzzaman et al., 2010). For example, many ILs (based on 
BF
4−
, PF
6−
and Tf2N
−
) in comparison to organic solvents have exhibited relatively less 
denaturation, higher enantioselectivity and higher catalytic activity of several enzymes (Naushad, 
ALOthman, Khan, & Ali, 2012; van Rantwijk & Sheldon, 2007). Alterations in the anion 
dramatically affect the chemical behavior and stability of the ionic liquid while the changes in 
cation have a profound effect on the physical properties, such as melting point, viscosity, and 
density (Matthews, 2001; Schwierz et al., 2013).  
2.8.1.1 Effect of anion and cation 
In comparison to anions of same charge density, cations are usually observed to show a less 
dominant effect, because anions are more polarizable and hydrate more strongly (Schwierz et al., 
2013). Additionally, cations seem to present their impact indirectly via interaction with anions, 
and the kosmotropic behavior of anions could be lessened in the presence of kosmotropic 
cations. It was hypothesized that kosmotropic cations, as opposed to the chaotropic ones, have a 
higher tendency of ion-pairing with the kosmotropic anions, thus reducing the abundance of the 
free anions in solution to play their kosmotropic role. This was supported by the “law of 
matching water affinity” which states in aqueous salt solutions, the interactions of ions in the 
order of decreasing strength are as follows: kosmotrope–kosmotrope > kosmotrope–water > 
water– water>chaotrope–water>chaotrope–chaotrope (Degreve et al., 2004; Hess & van der 
Vegt, 2009; Schwierz et al., 2013; Vlachy et al., 2009; Z. Yang, 2009; Zaccai, 2004).  
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In principle, the law of matching water affinity suggests that oppositely charged ions tend to 
form contact ion-pairs in solution if they have equal affinities for water but will separate if their 
water affinities are very different. Thus, in an aqueous solution, a kosmotropic anion and a 
kosmotropic cation will bind together due to the strong interactions between them. A chaotropic 
anion and a chaotropic cation also tend to form an ion-pair because the relatively stronger water–
water interactions will keep the two chaotropes together. Therefore, an optimal stabilization of 
enzymes or other biological macromolecules is usually achieved through the use of salts 
containing kosmotropic anions and chaotropic cations. 
In general, it’s been observed that ILs with highly-fluorinated and charge-delocalized anions are 
highly hydrophobic and immiscible with water, while those with halides, phosphate or 
carboxylate anion are more miscible with water (Kohno & Ohno, 2012). A kosmotropic anion 
strongly interacts with water to stabilize the protein while a chaotropic anion exhibits strong 
interaction with the protein’s chaotropic moieties and results in destabilization. (Bae et al., 2012) 
investigated the refolding of lysozyme with imidazolium based ionic liquids by varying anion 
and alkyl chain length of the cation. They report highest refolding yield in the presence of 
chaotropic cation [EMIM]
+
 or [BMIM]
+
, and kosmotropic anion [MS]. Lange examined the 
effect of N-‘alkyl-N-methylimidazolium chlorides on the denaturation of lysozyme induced by 
heat and guanidinium chloride (GuHCl). All the tested ILs were found to reduce the melting 
temperature of the enzyme, suppress the protein aggregation, and lower the midpoint 
concentration for GuHCl-induced protein unfolding, with a higher tendency corresponding to a 
longer alkyl chain length. While the anion, more often than not, follows the Hofmeister series, 
there are a few exceptions and usually occur in the presence of komstropic cation, such as 
[BMIM]+. The initial reaction rate of lipase-catalyzed enantioselective hydrolysis of d,l-
phenylglycine methyl ester (Moon et al., 2006) in the IL-containing aqueous buffer varied in the 
order of [BMIm][BF4
-
] > [BMIm]Cl
-
> [BMIm]Br
-
 > [BMIm]NO3
-
 >[BMIm]HSO4
-
. The lower 
enzyme activity in the presence of a more kosmotropic IL anion in this situation could possibly 
be explained by the higher tendency of the kosmotropic cation to ion-pair with its kosmotropic 
counter-anion, thus reducing its abundance in the aqueous bulk solution to play its 
stabilizing/activating role, as per the law of matching water affinities.  
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Ionic liquids having long alkyl chains in their cation behave like surfactant in aqueous 
solutions and have a strong impact on the stability and activity of the protein (B.-K. Liu et al., 
2007; Xiao et al., 2009). (Kohno & Ohno, 2012) reviewed the properties of ionic liquids/water 
mixtures and assert long alkyl chain lengths of cation dramatically reduces its miscibility with 
water. (Yamamoto et al., 2011) observed that increase in alkyl chain length of N-alkylpyridinium 
chloride and N-alkyl-N-methylpyrrolidinium chlorides destabilizes’ lysozyme. These results 
were corroborated with results reported by Lange et al., whose study indicated imidazolium 
cation with a longer hydrophobic alkyl chain has a higher preference of destabilizing the enzyme 
due to (1) its strong interaction with the kosmotropic moieties, such as the carboxylic groups, on 
the enzyme surface, and (2) its hydrophobic interaction with the inner hydrophobic moieties of 
the enzyme molecule, leading to the disruption of the enzyme’s native conformation. 
Investigation of the influence of a series of N′-alkyl, and N′-(ω-hydroxyalkyl)-N-
methylimidazolium chlorides on the behavior of hen egg white lysozyme (HEWL) and an 
antibody fragment ScFvOx indicated that in comparison to hydrophobic imidazolium cation 
carrying long alkyl chain, terminal hydroxylation of alkyl chain, made the salt more compatible 
with protein stability (Lange et al., 2005). (Constantinescu, Weingärtner, & Herrmann, 2007) 
used differential scanning calorimetry (DSC) to characterize the thermal denaturation of RNase 
A with addition of ILs holding Br
−
 and Cl
−
 as the common anions. Almost all ILs tested rendered 
the enzyme to have its transition temperature lowered, in the order of K
+
 > Na
+
 > [C1,1,1,1 N]
+
 > 
Li
+
 > [C2,2,2,2 N]
+ ≈ [EMIM]+ > [BMIM]+ > [C3,3,3,3 N]
+
 > [HMIM]
+
 > [C4,4,4,4 N]
+
 , which is 
satisfactorily consistent with the decreasing kosmotropicity order of the cations. 
In summary, although it is safe to say a kosmotropic anion and chaotropic cation are the most 
desirable characteristics in an ionic liquid for protein refolding studies, these are not the sole 
determining factors. Other parameters such as viscosity of the ionic liquid that can be modified 
by addition of water or modulation of the temperature, also plays an instrumental role in 
designing the ionic liquid for biochemical processes . 
 
 
2.8.1.2 Effect of viscosity of ionic liquids on protein refolding 
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The knowledge of the viscosity of ILs is of prime importance from an engineering point of 
view as it plays a major role in stirring, mixing and pumping operations; in addition, it also 
affects other transport properties such as diffusion. ILs are generally viscous liquids with 
viscosities ranging typically from 10 to 500 mPa s at ambient temperature (Y. Zhang & Cremer, 
2006). This is comparable with the values obtained for oils, that is to say two or three orders of 
magnitude higher than viscosities of traditional organic solvents. Viscosity decreases with 
increase in temperature making ILs easier to apply at super ambient conditions. Using a vibrating 
densimeter and rheometer, Jacqueim et al (2006), studied the density and viscosity of six 
different ionic liquids  [BMIM]PF6
-
, [BMIM] BF4
-
, [BMIM]NTf2
-
, [EMIM] NTf2
-
, [EMIM] 
EtSO4
2-
 and butyltrimethylammonium bis(trifluoromethylsulfonyl)imide  as a function of 
temperature. For the ILs studied they observed that the imidazolium-based ionic liquids density 
decreases with increasing alkyl chain length in cation or anion, while the viscosity remains 
constant with increasing shear rates (from 0 to 200 s
-1
)(Jacquemin, Husson, Padua, & Majer, 
2006). This linear relationship between the shear stress and the shear rate corresponds to a 
Newtonian behavior. It is also noteworthy that the alkylammonium-based IL exhibited a higher 
viscosity than the imidazolium-based ILs with the same anion; furthermore, the viscosities of the 
latter ILs increased with the length of the alkyl chain on the imidazolium ring. Amongst the 
anions studied, the NTf2
-
 anion lowered the viscosity while the PF6
2-
 anion significantly 
increased the viscosity.  
Simulations have shown that imidazolium ILs with side chains above butyl (and up to C12) exist 
in the pure liquid phases as micro-structured fluids, in which nonpolar domains are formed by 
the alkyl chains and, at the same time, the charged parts form ionic domains which tend to be 
continuous (channels) (Xiao et al., 2009). This segregation into domains was not observed for 
Emim
+
 based ILs, since the non-polar part is too small, and in structural terms they just showed 
charge ordering like ‘‘simple molten salts’’. The formation of the microstructures is likely to be 
responsible for the increase in viscosity and for the decrease in ion mobility (meaning a decrease 
in conductivity and in diffusion). Therefore, it is not a strong interaction between the non-polar 
parts that is giving rise to a more viscous fluid. In ILs with longer side-chains, the non-polar 
parts are being driven into domains, excluded by the strong electrostatic attraction between the 
anions and charged parts of the cations. 
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(Mannall, Myers, Liddell, Titchener-Hooker, & Dalby, 2009) suggest the addition of high 
viscosity glycerol and polyethylene glycol to the refolding buffer enhances refolding yield by 
inhibiting aggregation process and reducing the diffusivity of proteins in solution. In a similar 
manner, van Rantwijk and Sheldon explain that the high viscosity of ionic liquids slows down 
the conformational changes of proteins, allowing enzymes to maintain their native structure and 
activity. (Zeuner et al., 2011) observed that higher viscosity of [BMIM]PF6
-
 compared to [OH-
MMIM]PF6
-
 is likely to cause lower reaction rates through mass transfer limitations in furuloyl 
esterase from Aspergillus niger. Zhao’s study of the CALB (Candida antarctica Lipase B) 
catalyzed trans-esterification of ethyl butyrate and 1-butanol in more than 20 ILs suggests that IL 
viscosity might affect the reaction rates in some cases. 
2.9 Ionic liquids as protein refolding additives - Examples 
Summers and Flowers paved the way for protein refolding using ionic liquids when they reported 
the successful use of ethyl ammonium nitrate to suppress aggregation of denatured hen-egg 
white lysozyme. Ever since, several groups worldwide have ventured into this emerging 
paradigm. While some have invested their time and effort towards decoding the mystery towards 
the mechanism of action of ionic liquids as refolding additives (Attri & Venkatesu, 2012a; Byrne 
et al., 2009; Esquembre et al., 2013; Fujita, MacFarlane, & Forsyth, 2005; Greaves & 
Drummond, 2008; Mangialardo, Gontrani, Leonelli, Caminiti, & Postorino, 2012; Mann, 
McCluskey, & Atkin, 2009; Stock et al., 2004; Weibels, Syguda, Herrmann, & Weingärtner, 
2012), many others are exploring the vast variety of ionic liquids to find the ideal ‘novel designer 
liquid’ that holds the potential to solve the bottleneck of the downstream process (Buchfink et 
al., 2010; Fujita et al., 2005; Hough & Rogers, 2007; Mester, Wagner, & Rossmanith, 2012; 
Ohno & Fukumoto, 2007; Pusey et al., 2007; RAkita, n.d.; Ranke et al., 2004; Turner, 2005). 
Few of the most recent and relevant, successful refolding studies have been summarized in table 
2.5. As can be seen from the table, a common trend has been to study the effect of the ionic 
liquid as a refolding additive by using it in lieu of urea or guanidine, in the presence of redox-
couple, such as cysteine/cystine or GSSG/GSH and at very low final protein concentration (less 
than 0.5mg ml
-1
) primarily attained by dilution or dialysis several fold into the refolding buffer. 
What is interesting to note is that irrespective of the ionic liquid studied, kosmotropicity of the 
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anions, alkyl chain length of the cation and thereby its hydrophobicity and finally molarity 
of the ionic liquid in the final solution play a critical role in determining the refolding yield or 
efficiency of the system. Thus far, barring a few exceptions (e.g. [HMIM]
+
), the studies indicate 
increasing the concentration (molarity) of the ionic liquid beyond 1M results in a decrease in the 
refolding yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.5 Summary of recent research findings of ionic liquids as refolding additives 
Ionic Liquid Refolding protocol Noteworthy findings Ref 
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Ethylammonium 
nitrate(EAN) 
25 mg/ml of denatured 
lysozyme diluted with 
143mM Tris sulfate buffer, 
pH 8.5 containing 4mM 
GSH and 4mM GSSG 
varying concentration of 
EAN. Final concentration 
of lysozyme : 1.6mg/ml. 
Duration of incubation : 24 
h 
Addition of 5% EAN to 
lysozyme solution in 
buffer appears to stabilize 
enzyme against 
irreversible thermal 
denaturation 
Proposed mechanism: 
Ethyl group of EAN 
interaction with 
hydrophobic parts of 
protein and protects it 
from intermolecular 
association. 
Desalting with centriprep 
centrifugal filters 
(Summers 
and Flowers, 
2000) 
N′-alkyl and N′-(ω-
hydroxy-alkyl)-N-
methylimidazolium 
chlorides 
1:60 dilution with refolding 
buffer (3mM GSH, 0.3mM 
GSSG, 1mM EDTA, 0.1M 
Tris/HCl (pH 8.2) 
containing Ionic liquids. 
 Final concentration of 
lysozyme : 0.28mg/ml 
 Incubation : 18h – 24h 
Refolding Yield increased 
with increasing 
concentrations up to 1M 
{Exception: 0.5M HMIM 
Cl} 
(Lange et 
al., 2005) 
Table 2.5 cont’d 
Ionic Liquid Refolding protocol Noteworthy findings Reference 
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N’-substituted-3-
methylimidazoliu
m 
tetrafluoroborate 
1:100 dilution with refolding 
buffer containing 0.1M 
Tris/HCl pH 8.1, 3mM GSH, 
0.3mM GSSG and varying 
concentrations of ionic liquid 
Chaotropicity of 
imidazolium-based 
cations decreased with 
increase in alkyl chain 
length. Kosmotropicity of 
anions : methylsulfate ~ 
sulfate > Acetate > 
CF3COO
-
>Chloride> 
tetraborofluorate 
(Bae et al., 
2012) 
N-alkyl-N-
methylimidazoliu
m cation based 
ionic liquids 
Lysozyme: 1:60 dilution with 
refolding 3 mM GSH, 0.3 
mM GSSG, 1 mM EDTA, 0.1 
M Tris/HCl, pH 8.2 
containing varying 
concentration ionic liquid. 
Incubate: 18 -24h. Final 
concentration of protein : 
0.28mg ml
-1
. 
rPA: 1:20 dilution with 
refolding buffer 7 mM GSH, 
0.7 mM GSSG, 1 mM EDTA, 
0.1 M Tris/HCl, pH 8.5) 
containing varying 
concentration of ionic liquid. 
Incubation : 8h. 
Variation of the anion 
has a profound effect on 
the renaturation of 
proteins, lysozyme and 
rPA. Strongly 
destabilizing anions with 
higher alkyl substitutions 
were unable to promote 
refolding. The influence 
of the anion as refolding 
enhancers for rPA 
represented by the 
following series: Cl− > 
MDEGSO4 
− > EtSO4 
− 
> acetate > tosylate > 
Et2PO4
− ≈ HexSO4
−. 
Most effective refolding 
additive amongst those 
tested was : [EMIM] Cl
-
 
(Buchfink et 
al., 2010) 
 
 
2.10 Purity and Toxicity concerns of Ionic liquids  
Purity of a raw material is of prime importance in any process. Downstream processing of 
proteins involves removal of product- and process- related contaminants. It is therefore essential 
that raw materials, in this case, ionic liquids being used be of the highest purity. The commonly 
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found contaminants in ionic liquids are halides, water, organic compounds or inorganic 
salts. (Scammells, Scott, & Singer, 2005) provide a comprehensive review of these impurities 
and state that they not only affect the physicochemical properties of the ILs but also pose a threat 
to the success of a reaction. For example, trace quantities of halide anions could deactivate the 
catalyst in transition metal catalyzed reactions (i.e. hydrogenations). An awareness of this issue 
is growing steadfast and methods to measure and remove such impurities from ILs are being 
developed (Austen Angell, Ansari, & Zhao, 2011; Hough & Rogers, 2007; Huddleston et al., 
2001). 
Primarily due to their non-volatile nature and low impact on human health, ionic liquids are 
increasingly being referred to as ‘green alternatives to organic solvents’. Studies on effect of ILs 
on environment have shown that the toxicity profile of ILs varies across trophic levels and 
organisms (Jastorff et al., 2003; Pham, Cho, & Yun, 2010; Ranke et al., 2004; Swatloski et al., 
2004; Zhu et al., 2009). Literature findings indicate toxicity of ILs with eight-carbon-alkyl chains 
attached to imidazolium and pyridinium rings is higher than most organic solvents (acetone, 
acetonitrile, methanol etc.) (Pham et al., 2010; Stepnowski, Skladanowski, Ludwiczak, & 
Laczynska, 2004; Wood & Stephens, 2010). In contrast, study published by (Pernak, 
Sobaszkiewicz, & Mirska, 2002) advocate ILs with ten, eleven, twelve and fourteen carbon 
atoms in an alkoxy group of imidazolium cation exhibits very high antimicrobial property, while 
the anion has very little influence. A plausible explanation for this deviation could be increased 
hydrophobicity of cations, which accentuates permeation into cell membrane & cell death. 
Enhanced hydrophobicity of ionic liquids by virtue of changes in cation is being exploited for the 
synthesis of novel-target-specific third generation of pharmaceutically active ILs. 
 
2.11 Economic feasibility 
Meyer and Werbitzky state the global chemistry market is estimated at $2.92 billion and 
expected to grow to $3.24 billion by 2015 and to $4.012 billion by 2020, with industrial 
biotechnology and pharmaceutical biotechnology representing more than $50 billion and $70 
billion, respectively (Meyer & Werbitzky, 2011). Approximately 6000 companies, globally, are 
active in pharmaceutical sector with an estimated compounded annual growth rate (CAGR) is 
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more than 20%. About 25 % of the industrial biotechnology is fine chemicals, with the need 
to develop ‘green chemicals’ or ‘green process’ being the prime focus. Meyer and Werbitzky 
(2011) rightfully define ‘green chemistry’ as the guiding principle to encourage the development 
of manufacturing processes and products with the lowest possible environmental impact or 
footprint. As discussed earlier, research findings have demonstrated that ionic liquids are 
effective substitutes for common organic solvents where control of volatile organic compound 
emissions is critical (Hough & Rogers, 2007; Meyer & Werbitzky, 2011; RAkita, n.d.; Rogers, 
Seddon, & American Chemical Society Meeting 224th : 2002 : Boston, 2003). It is this 
negligible vapor pressure that permits the removal of products by distillation without further 
contamination by the solvent, thereby facilitating recycling of ionic liquids and reduction in 
operation costs of the process (Tavares, Rodríguez, & Macedo, 2013).  
Due to their specific handling and poor handling production and application of first generation 
ionic liquids has been expensive. In comparison, although second generation ionic liquids are 
more stable, Gorke et al (2010) attribute their high cost to individual building blocks and 
subsequent downstream processing (Gorke, Srienc, & Kazlauskas, 2010). Over the years, 
changes in production strategy by means of ecological and economic optimization (ECO), has 
resulted in the evolution of task-specific ionic liquids. The third-generation of ionic liquids, are 
similar in cost to organic solvents, simple to prepare, biodegradable, and the purity of the starting 
materials determines the purity of the final product while the choice of anion and cation 
determines its toxicity profile (Gorke et al., 2010; Tavares et al., 2013). Reinhardt et al., (2008) 
evaluated the greenness of [C6MIM][BF4], citric acid/N,N’-dimethyl urea, methanol, 
cyclohexane, acetone and methanol/water for Diels-Adler reaction of cyclopentadiene and 
methyl acrylate by means of ECO. In general, conventional solvents are easily available and 
relatively cheap, and in order to be in the same range, Reinhardt estimate the price of ionic 
liquids to be less than or equal to USD 30 kg
-1 
(Reinhardt, Ilgen, Kralisch, König, & Kreisel, 
2008) . 
At present, only a limited type and number of ionic liquids are produced in bulk quantities, most 
of which are used in chemical synthesis. Table 5, lists comparative prices for ionic liquids in use 
today. With increasing demand, and potential for application in biopharmaceutical industry, 
BASF estimates the expects the prices to be below USD 40 kg
-1
, for quantities ranging in metric 
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tons (BASF, 2013). Deep-eutectic solvents, like those manufactured by Scionix, are cheaper 
than imidazolium based ionic-liquids owing to the cost price of its principal component-choline 
chloride, which is manufactured in metric tonnes on a regular basis. 
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Table 2.6 Current market price of ionic liquids and other commonly used protein-
refolding additives 
Sr. 
No. 
Ionic liquid 
Price (USD per 
kg) 
Source 
1 1-ethyl-3-methylimidazolium chloride 110
a
 BASF 
 
 
907
b
 Io-li-tec 
 
 
369
c
 Sigma Aldrich 
2 1-ethyl-3-methylimidazolium acetate 100
a
 BASF 
 
 
459
b
 Io-li-tec 
 
 
1060
c
 Sigma Aldrich 
3 1-butyl-3-methylimidazolium chloride 294
b 
Io-li-tec 
 
 
297
c
 Sigma Aldrich 
4 1-butyl-3-methylimidazolium acetate 964
c
 Sigma Aldrich 
5 1-hexyl-3-methylimidazolium tetrafluoroborate 1972
b
 Io-li-tec 
6 1-methyl-3-propylimidazolium iodide 887
b
 Io-li-tec 
7 Ethylammonium nitrate 899
b
 Io-li-tec 
8 1-butyl-1-methylpyrolidinium trifluoromethane sulfate 2320
b
 Io-li-tec 
9 1-ethyl-3methylimidazolium thiocyanate 870
b
 Io-li-tec 
10 1-ethyl-3-methylimidazolium tetrafluorosulfate 1435
b
 Io-li-tec 
11 Glyceline (choline chloride: glycerol) 57
d
 Scionix, UK 
12 Oxaline (oxalic acid: choline chloride) 57
d
 Scionix, UK 
13 Ethaline (ethylene glycol : choline chloride) 57
d
 Scionix, UK 
14 L-cystine 585
c
 Sigma Aldrich 
15 Cysteine 543
c
 Sigma Aldrich 
16 L-arginine  340
c
 Sigma Aldrich 
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Footnote Table 2.6 .: Price: USD per kilogram. a: Calculated based on quotation received for 1000kg, as of 
September 2013. b: Calculated based on standardized price listed for 5kg in their in-house newsletter, Ionic 
liquids Today, dated December 2012. c: As per price listed on the Sigma-Aldrich website for 1kg of ionic 
liquid, as of September 2013. d: Standardized price listed on their website, based on order quantities greater 
than 50kg but less than 1 metric ton. Greater Britain Pound converted to USD as per foreign exchange on 
20
th
 September 2013. 
When evaluating the economic and process feasibility of a chemical, it is important to 
note that there are lots of ways to look at cost-analysis and purchase price is only one part 
of the equation. Cost related to personal-protective equipment, emission control hardware 
and monitoring equipment, waste disposal and treatment, and the potential to recycle the 
chemical have a cumulative effect on the process feasibility and must not be ignored.  
2.12  Conclusion  
Production and purification of a therapeutic protein is a task that faces many challenges; 
upstream titre, aggregation of protein, membrane fouling, buffer contamination, efficient 
recovery of protein, purification of protein, and protein stability etc. However, the biggest 
challenge and bottleneck today is the cost-effective and process-efficient recovery of 
protein from inclusion body proteins. One or combination of several chromatographic or 
non-chromatographic methods can help achieve this. Irrespective of the methodology 
employed, protein refolding is complicated and dependent on several process- and 
product- related parameters. Hence, the use of a refolding additive is not only imperative 
but also critical to the success of the reaction. In theory, since protein refolding is a 
kinetically competitive process, it may be promoted by stabilizing the native state or 
suppressing the unspecific aggregation of unfolded peptide and/or intermediate-native-
structure formed during the process. 
Since their inception into the scientific community in 1886  ionic liquids have carved a 
niche for themselves in the controversial field of ‘green chemistry’ (Byrne, Wang, 
Belieres, & Angell, 2007). While the characteristics that these ‘designer liquids’ are non-
volatile and that they have low impact on human health classifies them as ‘green 
alternatives to organic solvent’, the fact that most of them are not completely 
biodegradable and highly toxic across several trophic levels tells a cautionary tale. The 
more recent third generation of ionic liquids developed are ‘target-specific’ chemical 
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agents that address the issues of biodegradability and toxicity, and some even serve as 
active pharmaceutical ingredients (Hough et al., 2007; Hough & Rogers, 2007). 
The three dimensional structure of a protein is quintessential for its activity, which is 
maintained by disulfide bonds, hydrogen bonding and hydrophobic (Van der Waals 
contribution) interactions. In general, protein refolding additives function by either 
penetrating the micro-aqueous environment of the protein and stabilizing the protein 
(chaotropic cation) or by competing with the water associated the protein thereby limiting 
its exposure to the solvent and consequently driving the protein to its native state 
(kosmotropic anion). This dichotomy of preferential binding/exclusion originates from 
the Hofmeister series that is explicitly used to justify the effect of ionic liquids and other 
solute molecules on proteins. It is well documented that dependent on their 
physicochemical characteristics such as nucleophilicity, hydrophobicity and viscosity 
ionic liquids affect protein dynamics by their H-bonding and electrostatic and 
hydrophobic interactions with the protein. 
The experimental data obtained thus far on the potential of ionic liquids as refolding 
additives is limited to very low protein concentrations. Of course, with the exception of 
the study by Byrne et al., who report long term stabilization against aggregation and 
hydrolysis of >200mg ml
-1
 of lysozyme in trimethylammonium methane sulfonate (Byrne 
et al., 2007).  As can be seen in Table 3, almost all studies have been based on the 
concept of ‘dilution refolding’, which albeit easy to adapt, is tedious, inefficient and 
difficult to scale up to industrial levels. Lange et al., by reporting the improved refolding 
yield by ionic liquids over traditional refolding additives such as L-arginine has 
demonstrated the potential of ionic liquids for industrial application (Lange et al., 2005). 
However, employing dilution refolding would be counter-productive at that scale. Hence 
a thorough investigation on the applicability of ionic liquids in chromatographic refolding 
strategies such as ion exchange, size exclusion, simulated moving bed and expanded bed 
chromatography is the need of the hour. In addition, the recovery efficiency and 
reusability of the ionic liquid (as a refolding additive) in the process, the bearing of ionic 
liquids on ‘clean-in-place’ protocols for chromatographic downstream processes, 
adaptability of the ionic liquid-assisted protein refolding process to in-house equipment 
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are all parameters that need to be examined and studied exhaustively to facilitate the 
smooth transition of ionic liquids from academic research to industrial application.  
2.13 Nomenclature  
Abbreviation Full form 
IBPs Inclusion body proteins 
QSAR Quantitative structure activity relationship 
DTT Dithiothreitol 
SLS Sodium-N-lauroyl sarcosine 
CD Circular Dichroism 
ATR- FTIR 
Attenuated Total Reflectance- Fourier Transfrom InfraRed 
Spectorscopy 
ATP  Adenosine triphosphate 
4-MBPy]BF4
-
 4-methyl-N-butylpyridinium tetrafluoroborate 
EAN Ethylammonium nitrate 
Ils ionic liquids 
GuHCl guanidinium chloride 
ScFvOx Small chain antibody fragment 
HEWL Hen egg white lysozyme 
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Chapter 3  
3 Materials and Methods 
This chapter describes all the common materials and methodology applied in this thesis. 
Commonly used analytical techniques are also presented.  Subsequent chapters hereafter 
describe relevant materials and methods pertinent for that chapter only. 
3.1 Materials 
Lyophilized lysozyme from chicken-egg-white powder containing more than 90% protein 
(greater than or equal to 40,000 U/mg solid) was purchased from Sigma-Aldrich, 
(Oakville, Canada). Micrococcus lysodeikiticus (ATCC No. 4698), L-cysteine, cystine, 
ethylenediaminetetraacetic acid (EDTA), urea and sodium chloride were purchased from 
Sigma Aldrich (Oakville, Canada). Solutions of N-(2-hydroxyethyl)piperazine-N’-(2-
ethanesulfonic acid) (HEPES) in distilled water (1M) and DL-dithiothrietol (DTT) (1M) 
solution (DTT) (1M) were also purchased from Sigma-Aldrich (Oakville, Canada).  
3.2 Equipment 
Grenier Bio-One 96 well, clear, flat-bottom, UV-Star® microplate was purchased from 
VWR International (Mississauga. Canada.) The detailed specification of which is given 
in Appendix A.  
All packed-bed protein adsorption studies were performed on pre-packed HiTrap cation 
exchange columns connected to an  KTA FPLC equipped with the UNICORN software 
version 5.01 from GE Healthcare (Uppsala, Sweden). Specifications of the HiTrap 
column are provided in Appendix B.  
Pre-packed HiTrap cation exchange columns (1 ml and 5 ml) were purchased from GE 
Life Sciences (Quebec, Canada). The HiTrap columns were pre-packed with Sepharose 
Fast Flow (FF) cation exchange resin media. The Sepharose FF media is made of 
particles with a macroporous gel structure and has neutral hydrophilicity based on chains 
of agarose that are arranged in bundles. Sepharose fast flow (FF) resin particles, with an 
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average particle diameter 90 μm, were used for all fluidized-bed ion-exchange lysozyme 
refolding studies.  
The fluidized bed system used for adsorptive protein refolding was constructed in-house 
from Borosil® glass. A schematic diagram of the fluidized bed system is provided in 
Figure 3.1. The system consisted of a jacketed conical column connected to an air inlet. 
As illustrated in Figure 3.1, air was passed through the column (1); its flow was adjusted 
with a valve (2) and measured by an air flow meter (3). A sintered glass filter of pore size 
40 to 60 μm (4) was at the bottom of the column, and placed 0.5 mm above the air-inlet 
pipe, ensured the resin remains fluidized throughout the duration of the operation. 
Sepharose FF resin beads were placed in the column and fluidized using a gentle airflow 
rate. Water was circulated in the fluidized bed by means of a peristaltic pump (10) for 
temperature control. Ports 6 and 7 served as water in-let and out-let ports for the water 
jacket surrounding the column. Port 5 was the discharge port for clean-in-place (CIP) 
protocols. 
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Figure 3.1 Schematic: Fluidized bed ion-exchanger for the refolding studies of 
denatured lysozyme. 
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3.3 Analytical Methods 
3.3.1 Protein quantification 
The concentration of both native and denatured lysozyme were monitored in 96 well 
micro-plates using UV absorption spectrophotometer (Tecan 200pro, Männedorf 
Switzerland) at A280nm.  The protein concentration was determined using the Beer-
Lambert law with molar extinction coefficients of 2.63 and 2.37 ml mg
-1
 cm
-1
 for native 
and denatured lysozyme, respectively.  
The path-length (cm) of a well in a micro plate was experimentally calculated by the 
method suggested by Greiner Bio-one application note (GmbH, Germany) (Application 
Note, 2008). The sample path length was defined by Equation 3.1 below, and is the ratio 
of the difference in absorption of aqueous sample (path length unknown) measured at 977 
nm and 900 nm to that of water (or reference buffer) with 1cm path-length measured at 
the same wavelengths.   
 Sample path length (cm)  
A977(sample)-A900(sample)
A977(reference)-A900(reference)
……………..… Equation 3.1 
 
3.3.2 Lysozyme activity assay 
Lysozyme enzymatic activity was measured using Microcococcus lysodeikitius (ATCC 
No. 4698) in a microwell plate using Tecan 200pro multimode spectrophotometer 
(Männedorf, Switzerland). A cell suspension of the bacteria was prepared by dispersing 9 
mg of the bacteria in 30 ml of potassium phosphate buffer (0.06M at pH 6.2 units). The 
initial absorbance at 450nm was adjusted between 0.5 – 0.7 unit (Lee & Yang, 2002). An 
aliquot of cell suspension (190 μl) was accurately dispensed into each well of the 
microplate. To this, sample solution (10 μl) containing lysozyme (native, denatured or 
refolded) was added. Using Tecan microplate reader, with intermittent shaking, the initial 
rate of decrease in absorbance at 450 nm was measured every 5 seconds over a period of 
2 min. The activity of lysozyme was calculated from the initial slope of the time course 
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by linear regression of data points. The specific activity of the sample (units min
-1
 ml
-1
)
 
was computed by dividing the initial slope of the lysozyme activity by the concentration 
of lysozyme in reaction mixture. Equation 3.2 represents the specific activity of the 
solution. 
Specific activity (units min-1 ml-1)  
A450nm/min
 concentration of lysozyme(mg)
 …….Equation 3.2 
3.4 Performance indicators:  
Definition of parameters used to determine refolding efficiency and process efficiency   
are given below as follows.  
3.4.1.1 Refolding Yield 
Refolding yield was defined as the percentage of specific activity (units min
-1
 ml
-1 
) of 
sample (or refolded protein) over the specific activity (units min
-1
 ml
-1
) of the native 
lysozyme. It is computed using Equation 3.3 
Refolding ield    
Specific activitysample
Specific Activitynative 
x 100            . Equation 3.3 
3.4.1.2 Fractional mass recovery:  
The ratio of total mass of protein (mg) recovered in elution to the total mass of protein 
(mg) loaded on to the ion-exchanger was defined as fractional mass recovery. It was 
calculated as per Equation 3.4 below. 
Fractional mass recovery   
 eluteCelute
 in ectedCfeed
 ………………………….…..Equation 3.4 
where, Velute and Vinjected represent volume of protein (ml) eluted and injected, 
respectively. Celute and Cfeed indicate the concentration of protein (mg/ml) in the elute and 
feed, respectively.  
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3.5 Nomenclature 
Abbreviation Full form 
ATCC American type culture collection 
EDTA Ethylenediaminetetraaceteic acid 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
DTT Dithiothreitol 
SP FF Sepharose Fast Flow 
CIP Clean-in-place 
Velute Volume of elute (ml) 
Vinjected Volume injected (ml) 
Celute Concentration of protein in elute (mg/ml) 
Cfeed Concentration of protein in feed (mg/ml) 
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Chapter 4  
4 A comparative study of refolding lysozyme using 
conventional strategies.   
This chapter begins by validating the requirement of refolding additives and low 
concentration of denatured protein for dilution refolding of denatured lysozyme. Next, it 
compares the refolding yield and fractional mass recovery, as a function of increase in 
protein concentration, for two different on-column modes of operation – packed bed and 
fluidized bed. 
4.1 Introduction:   
Production of correctly folded and biologically active proteins in Escherichia coli can be 
a challenging process (Fang & Huang, 2001; Su, 2011). Often, proteins are recovered as 
insoluble inclusion bodies and need to be denatured and refolded into the correct 
structure. To address this, various process operations have been developed.  Dilution 
refolding is the simplest and most-commonly used method, and involves refolding 
initiation by reducing the denaturant concentration. By carefully controlling the protein 
concentration at a low level, the formation of protein aggregates can be minimized. In 
large-scale protein refolding this leads to a high cost for reagents and buffers and an 
additional con- centration step is often required for further processing after dilution (Gu 
et al., 2002; Leong & Middelberg, 2005.; Oganesyan, Kim, & Kim, 2004). Developing 
high efficiency and low cost protein refolding methods is a highlighted research focus in 
biotechnology. With speed being a driver for both structural biology and 
biopharmaceutical development, only a limited set of refolding strategies can be tested 
for any given protein. Technology for protein refolding should therefore be: 
 Scale invariant – to ensure that results from screening can be translated to 
preparative systems and manufacture without significant changes in the 
technology used; 
 Easily automated – to address the issue of speed and to enable high-throughput 
processing of samples;  
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 Generic for a broad range of similar proteins – so that the technology does not 
have to be reinvented for each new gene sequence; 
 Economical – to ensure that resources are not being wasted if a large number of 
gene sequences or protein variants is being examined, and possibly to ensure 
streamlined transfer to manufacture. 
These parameters are easily addressed with the use of on-column protein refolding 
processes and thus form the crux of research being conducted in the field of protein 
refolding and purification worldwide. On-column adsorptive refolding of denatured 
proteins is mainly achieved by size exclusion, ion exchange, or affinity processes. Ion 
exchange refolding of proteins permits the selective and controlled adsorption and elution 
of target protein and alleviates the aggregates formed in size-exclusion chromatography 
due to sharp decrease in denaturant concentration.  
Considering the importance and need for the gradual removal of denaturants and gradual 
change in pH, an ion-exchange protein-refolding system was developed to improve the 
refolding recovery at high-protein concentration. This study aims to investigate the 
effectiveness of column refolding of denatured lysozyme under two different modes of 
operation – packed and fluidized bed.  
4.2 Materials and methods: 
All materials and analytical methods, and also equipment design and operation, pertinent 
to the study presented in this chapter, have been discussed and described in Chapter 3. 
The following section describes in detail the experimental methodology utilized.  
4.2.1 Experimental methodology 
4.2.1.1 Preparation of denatured lysozyme  
Native lysozyme was dissolved in 50 mM HEPES, pH 7.0 to prepare a stock solution. 
Denaturation buffer contained 6M urea, 32 mM DTT, 1 mM EDTA in 50 mM HEPES 
buffer pH 8.1. Denatured lysozyme was prepared by diluting an appropriate volume of 
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native lysozyme in denaturation buffer and incubating in a water bath at 37° C for a 
period of 2 hours. The activity of the lysozyme was tested to ensure it was completely 
denatured. 
4.2.1.2 Dilution refolding of denatured lysozyme 
Three different buffers were investigated. Buffer A 50 mM HEPES, pH 8.1, Buffer B      
2 M urea in 50 mM HEPES, pH 8.1 and Buffer C 2 M Urea, 0.03 mM cysteine, 0.3 mM 
cystine in 50 mM HEPES, pH 8.1 were prepared fresh on the day of the study. Denatured 
lysozyme stock solution was diluted with each of the refolding buffers to give a final 
enzyme concentration between 0.1 mg/ml and 2.0 mg/ml. The reaction mixtures were set 
aside, on bench-top shakers at 120 rpm, for a period of 3 hours. At time points, half hour, 
1 hour and 2 hours appropriate volume of sample was aliquoted and analyzed for protein 
concentration and enzyme activity. The experimental results obtained are presented and 
discussed later.  
4.2.1.3 Adsorptive refolding of denatured lysozyme in a packed bed 
ion exchange system  
Figure 4.1 demonstrates the steps discussed below that were followed for the adsorptive 
refolding of denatured lysozyme in an ion-exchange system.
 
Figure 4.1 Schematic representation of adsorptive on-column refolding of denatured 
lysozyme 
  
68 
The pre-packed HiTrap SP FF column (5ml), connected to AKTA FPLC, was 
equilibrated with ten column volumes of equilibration buffer (50 mM HEPES, pH 8.7, 
2M urea). The flow rate throughout the experiment was set at 0.4 ml/min. Denatured 
lysozyme solutions, in the range of 1 mg/ml to 10 mg/ml, were prepared. A protein 
loading of 2.5 ml of denatured lysozyme (at varying concentrations) was applied on to 
the column. After rinsing with five column volumes of equilibration buffer, the column 
was eluted by gradient elution. Elution was started by gradually increasing ratio of 
elution buffer/equilibration buffer from 0:100 to 100:0 at 0.4 ml/min within 12 column 
volumes. The composition of elution buffer was 50 mM HEPES, pH 8.1 containing 2 M 
urea, 0.03 mM cysteine, 0.3 mM cystine and 1M sodium chloride. Fractions were 
collected at every step and analyzed for protein concentration and lysozyme activity. The 
column was washed, cleaned-in-place (CIP) and regenerated for the next cycle. 
4.2.1.4 Adsorptive refolding of denatured lysozyme in fluidized bed 
mode 
A volume of exactly 5 ml of the Sepharose Fast Flow resin slurry, suspended in 50 mM 
HEPES (pH 7.0), was accurately aliquoted and dispensed in the fluidized bed column. 
The resin particles were equilibrated with 50 ml of equilibration buffer (2 M urea in 50 
mM HEPES, pH 8.7) for a period of 30 minutes, by a steady-flow of air at 0.01 LPM 
flow rate. At the end of equilibration, fluidization was halted and the buffer was 
dispensed out of the column with the aid of peristaltic pump. Next, 10 ml of denatured 
lysozyme solution, at varying concentrations 1 mg/ml to 10 mg/ml, was loaded onto the 
re-fluidized resin particles. After 15 minutes of adsorption, the resin was allowed to settle 
and the buffer was dispensed out of the column with the aid of the peristaltic pump. 
Following this, the re-fluidized resin particles were washed with 25 ml of equilibration 
buffer for period of 10 minutes. After separating the washed-resin particles from the 
buffer, the resin particles were re-fluidized. Elution of bound lysozyme was initiated 
when the resin particles were allowed to interact with 100 ml of elution buffer (50 mM 
HEPES, pH 8.1 containing 2 M urea, 0.03 mM cysteine, 0.3 mM cystine and 1 M sodium 
chloride) for duration of 30 minutes. The elution pool was collected and analyzed for 
protein concentration and lysozyme activity. The resins were cleaned-in-place and 
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regenerated before use in the next cycle. Performance indicators, fractional mass 
recovery and refolding yield, were used to assess the efficiency of the process. 
4.3 Results and Discussion  
4.3.1 Refolding of denatured lysozyme by batch-dilution refolding 
In principle, protein refolding was initiated by the gradual removal of denaturant, which 
initiated the collapse of the unfolded molecule and the formation of secondary or tertiary 
structure. This collapse exposed the hydrophobic core of the protein and therefore the 
molecule was susceptible to aggregation. Protein aggregation, often the rate-limiting step, 
is a second or higher order reaction and primarily dependent on the concentration of 
protein and the composition of redox environment. Chaotropic agents such as urea and 
guanidium chloride at non-denaturing concentrations solubilize protein aggregates and in 
effect enhance protein refolding. Addition of redox agents such as cysteine/cystine or 
GSH/GSSG, increase the rate of oxidation and break the non-native disulfide bonds. Thus 
refolding of a denatured protein to its native state is primarily dependent on, the type and 
concentration of refolding additives, the concentration of the protein and the duration of 
incubation. Figure 4.2 shows the experimental results obtained by variation of refolding 
buffer over a period of 2 hours at different concentrations of lysozyme.  
Three different refolding buffers were investigated. Buffer A contained no refolding 
additive, Buffer B contained the chaotropic agent urea, and Buffer C contained both the 
chaotropic agent (urea) and redox couple (cysteine/cystine). Thus, a range of redox 
environments was investigated. The volume of the reaction mixture kept constant (10 ml) 
and the volume of denatured lysozyme was adjusted so appropriately to have varying 
concentrations of lysozyme, from 0.1 mg/ml to 2 mg/ml, in the final reaction mixture.  
Refolding by dilution lowers refolding protein concentration to minimize the propensity 
of inter-molecular interactions of protein refolding intermediates (Basu, Li, & Leong, 
2011). Figure 4.3, shows that increase in concentration of the lysozyme adversely 
affected the refolding yield, irrespective of the refolding buffer used. Also, despite the 
low protein concentration (0.1mg/ml and 0.2mg/ml), refolding buffer composition still 
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plays an important role in influencing protein-refolding kinetics (Figure 4.2).  Highest 
refolding yield was obtained at the lowest concentration of lysozyme (0.1 mg/lm) in the 
presence of both a redox couple and chaotropic agent (Buffer C). This is substantially 
higher refolding yield, than that by Raman et al. (1996), who report ca. 75% renaturation 
yield in 5 h, upon refolding lysozyme at 0.05 mg/ml (Raman, Ramakrishna, & Rao, 
1996). 
 
Figure 4.2 Effect of refolding buffer composition, time (h) and concentration of 
protein (mg/ml) on protein refolding yield (%)  
Three different buffer systems were investigated. Buffer A: 50 mM HEPES, pH 8.1; 
Buffer B: 2 M urea in 50 mM HEPES, pH 8.1; Buffer C: 2 M urea, 0.03 mM Cysteine, 
0.3 mM Cystine in 50 mM HEPES, pH 8.1. Refolding yield obtained at different time 
points (0.5 h, 1 h and 2 h) was presented as a function of change in composition of buffer 
and change in concentration of lysozyme (0.1 mg/ml to 2 mg/ml). The error bars denote 
the standard error of mean between triplicates.  
Diluting a denatured lysozyme by a solution containing 6 M urea and 32 mM DTT into 
refolding buffer containing 2 M urea has an effect on the residual concentration of the 
urea in the final reaction mixture. The concentration of residual urea determines which 
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protein-refolding intermediates proliferate.  For example a 100-fold dilution of denatured 
lysozyme solution in refolding buffer A (no urea) would result in 0.01 M urea, while in 
buffer C (containing 2 M urea) would produce 2.04 M of urea in the final reaction 
mixture. Figure 4.3 shows the effect of residual urea (M) on the refolding yield of 
denatured lysozyme (0.2 mg/ml). Figure 4.3 shows that refolding yield of lysozyme is 
sensitive to the residual amount of urea. 
 
Figure 4.3 Changes in refolding yield due to urea (M) in the reaction mixture at two 
different time points, 0.5 h (Δ) and 2 h (☐ ).  
At concentration above 2.25 M urea, irrespective of the duration of incubation, very little 
activity is regained. This can be explained by the increase in the chaotropic effect of urea. 
A chaotropic solute is one that disrupts the structure of macromolecules by interfering 
with the intramolecular interactions mediated by non-covalent forces such as hydrogen 
bonds, van der Waals forces, and hydrophobic effects. Refolding additives such as urea, 
usually at concentrations greater than 2 M, disrupt the micro aqueous environment of the 
protein resulting in its denaturation, as has been demonstrated by previous research 
findings  (Bian, Liang, Yang, & Liu, 2007; Duan et al., 2009; Hou, Hansen, Staby, & 
Cramer, 2010).  
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4.3.2 Adsorptive refolding of lysozyme in a packed bed ion exchange 
system 
Figure 4.4 is the chromatograph generated by UNICORN when 16 mg of denatured 
lysozyme was passed through the HiTrap SP FF column. Upon injection of the load, as it 
passed through the column changes in UV absorption were recorded. The UV peak 
obtained between 0 and 20 on the x-axis in Figure 4.4 indicates some amount of the 
protein did not bind but instead flowed through. The second UV peak obtained between 
40 and 80 on the x-axis in Figure 4.4 is the elution peak.  
  
 
Figure 4.4 Chromatogram generated by UNICORN upon loading 15 mg of 
denatured lysozyme on a pre packed HiTrap SP FF column (5ml).  
The blue line represents the change in UV absorption (mAU) at 280nm and the green line 
represents the change in concentration of elution buffer from 0:100 to 100:0.  
 adsorption denatured ysozyme sept 22nd001:1_UV  adsorption denatured ysozyme sept 22nd001:1_Conc  adsorption denatured ysozyme sept 22nd001:1_Fractions
 adsorption denatured ysozyme sept 22nd001:1_Inject
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Elution fractions C8 to C12 were pooled and analyzed for protein content and refolding 
yield. Analysis revealed 90% of the bound protein eluted and the refolding yield of the 
eluted peak was 69.34 % with a fractional mass recovery of 0.53 units. Similar 
chromatograms were generated, upon varying the amount of load (mg) and the 
experimental results obtained are presented in the Table 4.1. It shows the experimental 
results obtained by loading varying concentrations of denatured lysozyme on 5 ml HiTrap 
Sepharose Fast Flow column and its corresponding effect on the refolding yield and 
fractional mass recovery of the protein. Table 4.1 also shows that increased in protein 
load resulted in decrease in refolding yield and fractional mass recovery. When the 
protein load (mg) onto the column was kept low (2.5 mg), there were enough adsorption 
sites for the denatured protein to bind and refold. At the same time, the denatured protein 
molecules because of their immobilization at different sites did not interact with each 
other. However, as the protein load increased (15 mg), the number of protein molecules 
exceeded the number of binding sites on the solid support, especially at the top of the 
column. Interaction between the denatured molecules, thus, was inevitable. This 
influenced the correct refolding and thereby decreased the fractional mass recovery and 
refolding yield of lysozyme.  
Table 4.1 Effect of lysozyme load (mg) on the fractional mass recovery and refolding 
yield of lysozyme in a packed bed ion exchanger  
Adsorbent Load : Denatured 
lysozyme (mg) 
 Refolding Yield 
(%) 
Fractional mass 
recovery 
HiTrap SP FF (5ml) 2.5 80.39 0.59 
10 74.23 0.54 
15 69.34 0.53 
Fractional mass recovery of protein is the ratio of concentration of eluted protein (mg) to 
the amount of the protein load (mg).  In comparison to dilution refolding, adsorptive 
refolding of denatured lysozyme was successful at significantly higher protein load (0.2 
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mg in dilution vs 15 mg in packed bed system). This can be explained as follows. During 
an on-column ion-exchange refolding process, protein adsorb to the matrix through the 
interaction of its amino acid residues with the ion-exchange group on the solid support. 
This adsorption minimizes the intermolecular reaction between proteins, thereby 
decreasing the possibility of aggregation at higher concentrations of the protein. During 
gradient elution, as the concentration of the elution buffer increases (from 0:100 to 
100:0), the concentration of the denaturants in the column reduces. This forces the 
partial-folded intermediate to move away from its original binding site and rearrange its 
structure to its correct native conformation.  
In order to meet the economies of scale, and proactively debottleneck the downstream 
process, there is a strong demand in the industry for systems that can support high 
concentration of protein solutions. Packed bed refolding of lysozyme has already 
presented its limitation with regards to protein load (mg); whether this changes favorably 
or not, in a fluidized bed system was investigated in the following section.  
4.3.3 Refolding of denatured lysozyme in a fluidized bed ion 
exchanger 
In the fluidized mode of operation, resin particles are continuously “flowing” inside the 
column by an upward stream generated by gas, buffers or sample solutions. As result, the 
inter-particle porosity increases and mass-transfer between resin media and biological 
component is enhanced. This was supported by the experimental results of Trivedi (2006) 
who demonstrated the successful adaptation of a liquid-solid circulating fluidized bed for 
refolding denatured lysozyme (Trivedi, 2006). Although, 72% refolding yield was 
attained the mass recovery was less than 50%, therefore suggesting an improvement in 
the design of the fluidized bed column. The Glatt-Powder-Coater-Granulator (GPCG) is 
commonly used in the pharmaceutical industry for fluidized bed drying, particle coating, 
pelletizing and wet granulation. The fluidized bed system developed in-house for the 
purpose of this thesis, adopted the underlying principles of the GPCG while tackling the 
design issues raised by Trivedi (2006). Thus, a conical shaped fluidized bed was 
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designed, the construction and operation of which has already been described in Chapter 
3. 
In order to compare the efficiency of the fluidized bed ion-exchange refolding system to 
that of the packed bed, series of experiments were conducted (see Section 4.1.1.4). 
Samples from each step of the ion exchange process (adsorption, wash, elution) was 
collected and analyzed for both protein concentration and enzyme activity. The process 
performance indicators, discussed in analytical methods, were used to assess the 
efficiency of the system in comparison to the packed bed refolding system. Table 4.2 
shows the experimental results obtained. Experimental results obtained by varying the 
amount of denatured lysozyme loaded onto the ion-exchange resin and its’ effect on the 
refolding yield and fractional mass recovery of the process is presented in Table 4.2. In 
comparison to results obtained in Table 4.1, the fractional mass recovery of the eluted 
protein and refolding yield was substantially higher, thereby indicating the superior 
efficacy of the fluidized bed system.  Increasing the protein load to 15 mg of denatured 
lysozyme in the packed bed system reduced the fractional mass recovery to almost 50%.  
Whereas in the fluidized bed system with the same protein load (mg) the fractional mass 
recovery was almost 30% higher (Ferré et al., 2005; Hjorth, 1999). 
Table 4.2 Effect of lysozyme load (mg) on the refolding yield of lysozyme in a 
fluidized bed ion-exchanger  
Sr. No Load : Denatured 
lysozyme (mg) 
Fractional Mass 
Recovery 
Refolding 
Yield (%) 
1 2.5 0.85 86.48 
2 10 0.81 79.98 
3 15 0.80 77.21 
4 25 0.78 75.43 
In the more recent study by, Mazumder et al (2009), with the aid of mathematical 
modeling and simulation supported by experimental results, they showed that rate of 
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protein production and overall recovery increased with the increase in solid circulation 
rate (Mazumder, Zhu, Bassi, & Ray, 2009). Thereby, supporting our theory that increase 
in fluidization of resin particles enhances the mass-transfer and protein elution profile and 
thereby it’s recovery.  
4.4 Conclusion  
This study demonstrated the effectiveness of adsorption-based refolding technology to 
refold a model protein, lysozyme that contains 4 disulfide bonds, at refolding 
concentrations that are not attainable by dilution refolding (> 0.2 mg/ml).  The influence 
of refolding additives, concentration of feed and mode of operation – packed bed vs 
fluidized bed, on lysozyme refolding yield was substantial.  Increase in the amount of 
protein in the feed during packed bed mode of operation, in comparison to fluidized bed, 
resulted in decreased refolding yield and mass recovery.  From this study, a potentially 
feasible process route based on on-column refolding for large-scale manufacture of 
proteins has been identified and demonstrated. The high refolding productivity achieved 
by column refolding compared to dilution refolding will translate into more rapid product 
delivery to market and a cheaper product, upon adequate optimization of the overall 
bioprocess. The ready availability of the chromatographic resin used, coupled with the 
simple and readily scalable on-column refolding process employed, indicates the 
widespread applicability of this technology for simultaneous refolding and purification of 
other protein molecules.  
4.5 Nomenclature 
Abbreviation Full form 
CIP Clean-in-place 
DTT Dithiothreitol 
EDTA ethylene diamine tetraacetic acid 
HEPES 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid  
SP FF Sepharose Fast Flow 
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Chapter 5  
5 Investigation of dilution refolding of lysozyme using imidazolium based ionic 
liquids 
This chapter identifies the ionic liquid parameters, composition and concentrations of 
ionic liquid, that influence the refolding yield of lysozyme. Refolding yield is presented 
as function of time, with change in concentration and composition of the ionic liquids 
tested. Influence of chaotropicity and kosmotropicity of the individual ions of the ionic 
liquid on the refolding yield is also discussed. 
5.1 Introduction 
Proteins are most soluble in aqueous solution when they are in their native, folded state. 
It is well established that protein refolding is a kinetically competitive process between 
the intermolecular hydrophobic interactions resulting in aggregates versus the intra-
molecular interactions yielding native proteins.  In-vitro the slightest deviation in up-
stream process and/or product parameters such as pH, concentration of protein, 
temperature changes, mechanical stress such as shear strain, surface adsorption or 
foaming etc., can alter the structure of the protein and consequently promote ‘salting out’ 
and/or misfolding or aggregation (Hamada, Arakawa, & Shiraki, 2009; Ito et al., 2012; 
Karuppiah & Sharma, 1995; Lin, de Oliveira, & Veith, 2011; Mergili, Eiberle, & 
Jungbauer, 2010; Tsumoto, Ejima, Kumagai, & Arakawa, 2003; Yamaguchi, Yamamoto, 
Mannen, Nagamune, & Nagamune, 2012; Yang, Dong, & Yan, 2008).  
In principle, during refolding, proteins are not promptly converted to the native state; 
instead assume a partially folded state for a prolonged period of time. Folding 
intermediates are comprised of significant elements of the secondary structure but little of 
the native tertiary structure. Due to the expanded volume of these intermediates, the 
hydrophobic regions, which are usually buried in the native state, are exposed to the 
solvent. When so exposed, hydrophobic regions on separate polypeptide chains can be in 
contact with one another and can interact. This causes the intermediates to be diverted 
from the correct folding pathway, resulting in aggregate formation and loss of protein. 
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Thus, it is apparent that in order to achieve high refolding yield the protein structure must 
either be stabilized to minimize deviation and/or the structures that are not in the native 
state must be solubilized to avoid protein-protein interaction (aggregation/misfolding).  
This can be achieved by addition of solutes/refolding additives.  Solution- or refolding- 
additives can be classified into two categories a) denaturants – those that indirectly 
promote refolding by weakening the inter- and intra- hydrophobic bonding  and  b) 
protein stabilizers- those that enhance protein refolding by modifying the water of 
hydration and thereby stabilizing the native structure. 
An emerging category of refolding additives is ‘Ionic liquids’, also known as designer 
liquids due to their tunable nature. By definition, they are ionic salts that are liquid at 
temperatures below 100 °Celsius. Usually, it is the cation in an ionic liquid that has a low 
degree of symmetry which tends to reduce the lattice energy of crystalline form of the 
salt and thereby it’s melting point (Earle & Seddon, 2000). Since the synthesis of 
ethylammonium nitrate (m.p. 12°C) by Paul Walden in 1914, ionic liquids have evolved 
substantially and found application as lubricants, catalysts, in organic and in-organic 
chemistry, separation technology, and biopharmaceuticals etc (Aparicio, Atilhan, & 
Karadas, 2010; Endres et al., 2010; Hough & Rogers, 2007; Ohno & Fukumoto, 2007; 
Pham, Cho, & Yun, 2010).  So far, studies have shown that anions influence protein 
stability and activity via their hydrogen bonding forming capacity and nucleophilicity 
properties (Attri, Venkatesu, Kumar, & Byrne, 2011; Buchfink, Tischer, Patil, Rudolph, 
& Lange, 2010; Lange, Patil, & Rudolph, 2005; Vidya & Chadha, 2009; Weingärtner, 
Cabrele, & Herrmann, 2011).While changes in the alkyl chain length of the cations 
influences the viscosity, hydrophobicity and polarity of the ionic liquid, consequently 
affecting the solubility, stability and activity of targeted protein molecule (Bae, Chang, 
Koo, & Ha, 2012; Baer & Mundy, 2013; Lange et al., 2005; Xiao et al., 2009; 
Yamamoto, Yamaguchi, & Nagamune, 2011). 
A common trend, in some of the recent studies, has been to study the effect of the ionic 
liquid as a refolding additive by using it in lieu of urea or guanidine, in the presence of 
redox-couple, such as cysteine/cystine or GSSG/GSH. This has primarily been achieved 
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by dilution or dialysis several fold into the refolding buffer, reducing the lysozyme 
concentration less than 0.10 mg/ml 
In summary, refolding yield of a protein is dependent on several parameters:  
 Composition of refolding buffer 
 pH of the refolding buffer 
 Type of refolding additive (chaotropic agent, redox couple, ionic liquids, 
detergents) 
 Concentration of refolding additive (mM or %w/w) 
 Concentration of denatured protein (mg/ml) 
 Incubation time (hours) 
 Methodology employed (dilution, dialysis, packed-bed, fluidized-bed, expanded-
bed etc.) 
It has already been established that at low concentrations of protein and in presence of 
redox couple, ionic liquids enhance refolding yield of denatured protein by suppressing 
aggregation of protein and stabilizing the native structure of the protein. However, to the 
best of our knowledge, published literature has not assessed the potential of ionic liquids 
as protein refolding enhancers without redox couple or in a short duration of time. Thus, 
with denatured lysozyme as the target protein, the aim of this study was to investigate the 
effect of imidazolium based ionic liquids on its refolding yield. 
5.2 Materials and Methods: 
5.2.1 Materials  
In addition to the common raw-materials presented in Chapter 3, ionic liquids were 
purchased from purchased from Sigma-Aldrich (Oakville, Canada) and have been 
enlisted in Table 5.1, below. Also, all analytical methods used have been described and 
discussed in Chapter 3. The following section discusses the experimental methodology 
employed for the study presented in this chapter. 
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Table 5.1 List of ionic liquids used in this study 
Sr.No. Chemical Abbreviation Chemical Structure 
1 1-butyl-3-methylimidazolium 
acetate 
[BMIM]Ac 
 
2 1-butyl-3-methylimidazolium 
chloride 
[BMIM]Cl 
 
3 1-butyl-3-methylimidazolium 
methylsulfate 
[BMIM]MS 
 
4 1-ethyl-3-methylimidazolium 
acetate 
[EMIM]Ac 
 
5 1-ethyl-3-methylimidazolium 
chloride 
[EMIM]Cl 
 
6 1-ethyl-3-methylimidazolium 
methylsulfate 
[EMIM] MS 
 
5.2.2 Experimental Methods 
5.2.2.1  Preparation of denatured lysozyme 
Native lysozyme was dissolved in 50 mM HEPES, pH 7.0 to prepare a stock solution. 
Denaturation buffer contained 6 M urea, 32 mM DTT and 1 mM EDTA in 50 mM 
HEPES buffer pH 8.1. Denatured lysozyme was prepared by diluting appropriate volume 
of native lysozyme in denaturation buffer and incubating in water bath at 37 ˚C for period 
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of 2 hours. The activity of the lysozyme was tested examined after this period to ensure it 
is completely denatured.  
5.2.2.2  Preparation of refolding buffer  
Six different ionic liquids were investigated as refolding additives. Stock solution of each 
of the ionic liquids in 50 mM HEPES, pH 8.1 was prepared. This was further diluted with 
50 mM HEPES, pH 8.1 to yield refolding buffers with varying concentration of each of 
the six ionic liquids. Controls, positive and negative, assure us that the experimental 
results obtained are valid, and hence are important in all research-based experiments. A 
positive control, gives the desired outcome of the experiment, provided that all the 
reagents and equipment are functioning properly. While a negative control, does not give 
the desired outcome.  Based on the results presented in Chapter 4, buffer containing 2 M 
urea, 0.03 mM cysteine, 0.3 mM cystine in 50 mM HEPES, pH 8.1 demonstrated it’s 
efficacy in successfully refolding denatured lysozyme. Hence, this was used as positive 
control, and henceforth is referred to as ‘conventional buffer’. While, 50 mM HEPES 
buffer at pH 8.1 units, show negligible refolding yield (not desirable) and hence was used 
as the negative control.  
5.2.2.3  Preparation of refolded lysozyme 
Denatured lysozyme was diluted with equal volumes of appropriate refolding buffer 
(ionic liquid or conventional buffer), in micro-centrifuge tubes (1.5 ml). The tubes were 
incubated at room temperature for a period of 3 hours. Sample aliquots were withdrawn 
at 30 min and then at 1 h interval. These were analyzed for concentration of lysozyme 
and lysozyme activity as described earlier in Chapter 3. 
5.2.2.4  Influence of ionic liquids on the protein quantification assay 
A solution containing, a sample ionic liquid- [BMIM] acetate, at varying concentrations 
from 10 mM to 2.5 M, was prepared in 50 mM HEPES, pH 8.1. It’s absorbance without 
any protein content at 280 nm was recorded. Next, native lysozyme was dissolved in each 
of the ionic liquid containing buffers and the absorbance of the protein solution at 280 nm 
was again recorded. The absorbance of blank (without native lysozyme) was subtracted 
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from the absorbance of ionic liquid solutions containing lysozyme. The corrected (optical 
density) OD was used for calculation of concentration of lysozyme. 
5.2.2.5  Influence of ionic liquids on the lysozyme activity assay 
To examine whether ionic liquids have an effect on micrococcus lysodeikticus, buffers 
containing 2 M [EMIM]Cl in 50 mM HEPES (pH 8.1)  and 2 M [BMIM] Cl in 50 mM 
HEPES (pH 8.1), without any protein were treated as the sample solution in the lysozyme 
activity assay described earlier. Native lysozyme solution served as positive control. 
Change in absorbance at 450 nm representative of the change in turbidity of the cell 
suspension was recorded every 5 seconds for a period of 2 minutes. The experimental 
results are presented and discussed later. 
5.2.2.6  Self-aggregation assay for lysozyme 
The self-aggregation of lysozyme was assayed by measuring the light scattering intensity 
(Yamaguchi, Yamamoto, Tsukiji, & Nagamune, 2008). Three different refolding buffers 
were prepared. Buffer B was conventional buffer containing 2 M urea, 0.03 mM cysteine, 
0.3 mM cystine in 50 mM HEPES buffer pH 8.1. This served as positive control. Buffer 
C was 100 mM [EMIM] Cl in 50 mM HEPES, pH 8.1 and Buffer A was 50 mM HEPES, 
pH 8.1, which served as negative control. The study was conducted in triplicate in micro-
well plates. Equal volumes of denatured lysozyme and each of the refolding buffers was 
mixed and monitored at 450 nm for a period of 2 hours. Absorbance was recorded every 
10 min and the change in turbidity of the solution was noted.  
5.3 Results & Discussion 
5.3.1 Preparation of denatured lysozyme  
Lysozyme is a single chain polypeptide of 129 amino acids cross-linked with four 
disulfide bridges. It hydrolyzes the ß(14) linkages between N-acetlymuramic acid and 
N-acetyl-D-glucosamine residues in the peptidoglycans and between N-acetyl-D-
glucosamine residues in chitodextrin (Gorin, Wang, & Papapavlou, 1971). Thus the 
natural substrate for lysozyme is the peptidoglycan of layer of bacterial cell wall. Of 
these, Micrococcus lysodeikticus is the most popular. An enzyme-substrate reaction is a 
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very target-specific and an accurate reaction. Any change in the enzyme structure would 
make it inaccessible to its specific substrate.  
Lysozyme activity was measured by decrease in turbidity, represented by change in 
absorbance at 450 nm due to lysis of Micrococcus lysodeikticus cells.  Decrease in 
absorbance indicated lysozyme activity and absence thereof implied either the denatured 
state of lysozyme or the presence of a blank (solution without protein).  
 Figure 5.1 illustrates the change in absorbance at 450 nm upon the addition of three 
different solutions, native lysozyme in 50 mM HEPES, pH 7.0, denatured lysozyme 
solution and blank, i.e., 50 mM HEPES, pH 7.0. Upon addition of native lysozyme the 
absorbance of cell suspension decreased linearly, and the initial slope was later used to 
compute the specific activity of lysozyme. Addition of blank (50 mM HEPES, pH7.0) 
and denatured lysozyme did not affect the micrococcus cell suspension and hence no 
change in absorbance was recorded. 
 
Figure 5.1 Graph illustrating the lysis of micrococcus lysodeikticus cell wall as a 
function of time (seconds) upon addition of different solutions; native (o) and 
denatured (Δ) and 50 mM HEPES pH 7.0(✖) 
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5.3.2 Influence of ionic liquid on protein quantification 
The influence of ionic liquid on the measurement of protein concentration was 
investigated. Solutions containing different concentration of native lysozyme (NL), 0.215 
mg/ml, 0.43 mg/ml and 0.86 mg/ml, were prepared in buffers containing increasing 
concentration of [BMIM] acetate in 50 mM HEPES pH 8.1. Absorbance of these 
solutions at 280 nm was noted and a graphical representation of this data is presented in 
Figure 5.2. Increase in concentration of the native lysozyme and ionic liquid in buffer 
resulted in a linear increase in the absorbance at 280 nm, as noted in Figure 5.2. There’s a 
constant shift, corresponding to the increase in concentration of the protein. Hence, in 
order to compensate for ionic liquid, a baseline subtraction was done in all protein 
quantification assays.  
 
Figure 5.2 Change in A280 with corresponding increase in concentration of native 
lysozyme (mg/ml) and [BMIM] Ac. 
Absorption of radiation in the near UV region by proteins depends on the Tyrosine and 
Tryptophan content and to a very small extent on the amount of Phenylalanine and 
disulfide bonds. Recent studies have shown that imidazolium based ionic liquids have 
some absorption in the UV region (Katoh, 2007). It was therefore critical and essential 
when measuring the concentration of protein in buffers with ionic liquids that the 
absorbance of ionic liquid (at 280 nm) be subtracted from that of the solution containing 
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the protein and ionic liquid. Figure 5.3 illustrates the increase in optical density of ionic 
liquids at 280 nm with corresponding increase in concentration (mol/l) of ionic liquid in 
50 mM HEPES pH 7.0.   
 
Figure 5.3 Change in absorbance at 280 nm as function of change in concentration 
of ionic liquid (M). 
It was interesting to note, that different ionic liquids, at same concentration (M) had 
varying optical density at 280 nm. 
5.3.3 Influence of ionic liquids on lysozyme activity assay 
Figure 5.4 represents the change in the turbidity of micrococcus cell suspension over a 
period of 2 minutes upon the addition of three solutions. One of the solutions contains 
active, native lysozyme and hence decreases the optical density of the solution. The other 
two contain ionic liquids at high concentration (2 M). No change in absorbance is seen 
over period of time, which implies that the ionic liquids have no cell lysis ability of their 
own, and hence would not interfere with the assay of lysozyme activity or calculation of 
refolding yield. 
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Figure 5.4 Graph illustrating the lysis of micrococcus lysodeikticus cell wall as a 
function of time (seconds) upon addition of different solutions Native Lysozyme (◊), 
2 M [EMIM]Cl in 50 mM HEPES pH 8.1 (Δ) and 2 M [BMIM] Cl in 50 mM 
HEPES, pH 8.1 (□). 
5.3.4 Effect of ionic liquids as refolding additives for batch dilution 
refolding of denatured lysozyme  
Miscibility of the ionic liquid or its partition in water has a considerable effect on 
aqueous protein solutions. Upon dissociation, the individual component ions of ILs 
interact with water via ion-dipole interactions and their hydration state is then dependent 
on the type of ion and fraction of water present in the mixture. Consequently, this 
determines if the ion is behaving as a kosmotrope or chaotrope. A kosmotropic anion 
strongly interacts with water to stabilize the protein while a chaotropic anion exhibits 
strong interaction with the protein’s chaotropic moieties and results in destabilization. 
The viscosity B-coefficient of Jones-Dole equation measures kosmotropicity of an ion.  
Table 5.2 represents the viscosity B-coefficients of certain anions and cations, as 
presented in literature.  
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Table 5.2 Characterization of ions based on their viscosity B-coefficient values 
Ion 
Viscosity B-
Coefficient 
Kosmotrope/Chaotrope Reference 
Acetate (OAc-) 0.246 Kosmotrope 
(Jenkins & 
Marcus, 1995) 
Chloride (Cl-) -0.005 Chaotrope/kosmotrope 
(Jenkins & 
Marcus, 1995; 
Marcus, 1994) 
Methylsulfate 
(MeSO4
-
) 
0.127 Chaotrope 
(Jenkins & 
Marcus, 1995; 
Marcus, 1994) 
1-ethyl-3-
methylimidazolium 
[Emim] 
0.491 Chaotrope (Zhao, 2006) 
1-butyl-3-
methylimidazolium 
[BMIM] 
0.610  Kosmotrope (Zhao, 2006) 
For the purpose of this study, a selection of imidazolium based ionic liquids based on 
different combination of kosmotropic and chaotropic ions was made. Table 5.3 
summarizes the chaotropicity and kosmotropicity of the cation and anion of the ionic 
liquid used for the purpose of this study. Thus, [EMIM] methylsuflate is a strong 
chaotropic ionic liquid, while [BMIM] acetate is a strong kosmotropic ionic liquid. 
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Table 5.3 Characterization of ionic liquids  
                 Anion 
Cation  
Acetate Chloride Methylsulfate 
[EMIM]
+
 C K C K/C C C 
[BMIM]
+
 K K K K/C K C 
Abbreviations: K- kosmotrope, C: chaotrope, K/C : Borderline kosmotrope/chaotrope  
Efficiency of the ionic liquid as refolding aid was assessed on the basis of changes in 
refolding yield with respect to concentration of ionic liquid and duration of incubation. 
Conventional refolding buffer containing urea and cysteine-cystine as the refolding aids 
was used a positive control and 50 mM HEPES, pH 8.1 as the negative control. Refolding 
yield (mean ± SEM) of independent triplicates is plotted against the concentration of 
ionic liquid. The standard error of the mean (SEM) quantifies the precision of the mean 
and is a measure of how far the sample mean is likely to be from the true population 
mean. It is calculated by the sample standard deviation divided by the square root of the 
sample size.  
Figures 5.5 and 5.6, compare the effect of different anions of 1-alkyl-3-
methylimidaozlium based ionic liquid on the refolding of denatured lysozyme. Figure 5.5 
A, B and C, represent the change in refolding yield (%) of denatured lysozyme as 
function of time (hours) and concentration of [EMIM] based ionic liquid. The maximum 
refolding yield under the employed experimental conditions was 97 % in a period of an 
hour in the presence of 100 mM [EMIM] Cl. [EMIM] acetate proved to be moderately 
effective, with a renaturation yield of about 40% in 3 hours. 
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Figure 5.5 Change in refolding yield (%) of denatured lysozyme as a function of 
time and concentration of A) [EMIM] Cl, B) [EMIM] Acetate C) [EMIM] MS based 
ionic liquids.  
Under similar experimental conditions, with a change in the ionic liquid composition to 
1-butyl-3-methylimidazolium, a substantial change in refolding yield was observed. This 
has been illustrated in Figures 5.6A, B and C. In the presence of 1-butyl-3-
methylimidazolium based ionic liquids, the maximum refolding yield obtained was in the 
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presence of 2.5 M [BMIM]Cl within the first half hour of incubation. Increase in 
incubation time resulted in the decrease of refolding yield. An anomaly was observed in 
the refolding experiment with 500 mM [BMIM] Cl. 
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Figure 5.6 Change in refolding yield (%) of lysozyme as function of time and 
concentration of A) [BMIM] Cl, B) [BMIM] MS, C)[BMIM] Acetate 
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Ionic liquids are known to affect protein activity by either a) stripping off the internal 
water associated with the protein, b) penetrating into the micro-aqueous environment to 
interact with the protein by changing protein dynamics, conformational and/or protein’s 
active site, or c) by interacting with the substrates and products either by direct reaction 
with them or by altering the portioning between the aqueous and non-aqueous phases.  
The fact that ionic liquids dissolve and dissociate into individual ions rather than exist as 
an intact molecule is an obvious advantage over molecular organic solvents. Miscibility 
of the ionic liquid or its partition coefficient in water has a considerable effect on aqueous 
protein solutions. Upon dissociation, the individual component ions of ILs interact with 
water via ion-dipole interactions and their hydration state is then dependent on the type of 
ion and fraction of water present in the mixture. Consequently, this determines if the ion 
is behaving as a kosmotrope or chaotrope. Each ion, cation and anion, in solution then 
interacts with the protein in solution and either stabilizes or destabilizes the protein 
structure and conformation, thereby having an overall effect on the protein stability and 
refolding yield.  
With respect to the influence of alkyl chain length of the cation, refolding yield was 
substantially less with BMIM based ionic liquids as opposed to EMIM based ionic 
liquids. In a similar set up, Lange et al. (2005), examined the effect of N-‘alkyl-N-
methylimidazolium chlorides on the denaturation of lysozyme induced by heat and 
guanidinium chloride (GuHCl). They observed, at higher concentrations of [BMIM] Cl, 
HMIM Cl and OH-[HMIM] Cl, renaturation was effectively suppressed while for 
[EMIM] Cl refolding yield was maximized. They suggest imidazolium cation with a 
longer hydrophobic alkyl chain, such as [BMIM] Cl, has a higher preference of 
destabilizing the enzyme due to (1) its strong interaction with the kosmotropic moieties, 
such as the carboxylic groups, on the enzyme surface, and (2) its hydrophobic interaction 
with the inner hydrophobic moieties of the enzyme molecule, leading to the disruption of 
the enzyme’s native conformation.  
In addition, literature review suggests, in comparison to anions of same charge density, 
cations are usually observed to show a less dominant effect, because anions are more 
polarizable and hydrate more strongly (Schwierz, Horinek, & Netz, 2013). Additionally, 
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cations seem to present their impact indirectly via interaction with anions, and the 
kosmotropic behavior of anions could be lessened in the presence of kosmotropic cations. 
For example, [BMIM] is a kosmotropic cation and acetate a kosmotropic anion. The 
refolding yield observed with [BMIM] acetate is the least in comparison to the other five 
ionic liquids. It was hypothesized that kosmotropic cations (such as [BMIM]), as opposed 
to the chaotropic ones (such as EMIM), have a higher tendency of ion pairing with the 
kosmotropic anions (such as acetate), thus reducing the abundance of the free anions in 
solution to play their kosmotropic role. This is also supported by the “law of matching 
water affinity” which states in aqueous salt solutions, the interactions of ions in the order 
of decreasing strength are as follows: kosmotrope–kosmotrope > kosmotrope–water > 
water– water>chaotrope–water>chaotrope–chaotrope (Degreve et al., 2004; Hess & van 
der Vegt, 2009; Schwierz et al., 2013; Zaccai, 2004).  
Figure 5.7 represents the refolding yield of denatured lysozyme in 1hour as function of 
change in concentration of ionic liquid in refolding buffer. [EMIM] is a chaotropic cation 
and chloride a kosmotropic anion; increase in the concentration of the ionic liquid results 
in the increase of refolding yield. Whereas, BMIM a kosmotropic cation when paired 
with chloride, increase in its concentration results in decrease of refolding yield; as is 
substantiated by the law of matching water affinity. 
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The Jone-Dole empirical equation is commonly used to characterize ions based on their 
ion-specific effect on the viscosity of the solution. Kosmotropes are often classified as 
those that make the solution more viscous and Chaotropes as those that make the water 
more fluid. Equation 5.1 expresses the Jones-Dole empirical equation, where η is the 
viscosity of the solution and η0 is the viscosity of the solvent for most salts at low 
concentrations [(<0.5 M ) or (<0.1 M) for binary strong electrolytes)], the D or higher 
coefficients can be omitted, although they are necessary for higher concentrations. 
 
  
 
               …………………………………………..Equation 5.1 
A plot of refolding yield as a function of the viscosity B-coefficient of anion in 100 mM 
of EMIM and BMIM based ionic liquid is presented in Figure 5.8. It suggests that an 
increase in viscosity-B coefficient of the anion decreases the refolding yield of the 
denatured lysozyme. Increase in B-coefficient is usually associated with increase in 
kosmotropicity of the ion. However, how this pairs with the cation and affects the overall 
refolding yield of the denatured lysozyme, as can been explained the law of matching 
water affinity. 
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Figure 5.8  Graph illustrates the change in refolding yield (%) as a function of 
viscosity B-coefficient of anion with corresponding cations- [EMIM] (dark grey bar) 
and [BMIM] (light grey bar) 
 
The refolding yield of lysozyme under the influence of six different ionic liquids is plotted. The 
X-axis represents the anion with its viscosity B-coefficient quoted in brackets. A positive value of 
B-coefficient for an ion represents the intensity of kosmotropic character for the ion. Thus, 
graphical results indicate effect of ionic liquid on refolding yield as a function of kosmotropicity 
with corresponding changes in cation.  
Urea is a chaotropic salt that at low concentrations (less than 3M) solubilizes protein 
aggregates and enhances refolding of denatured protein. Results have already indicated 
that 100 mM [EMIM]Cl in 50 mM HEPES (pH 8.1) enhances refolding of denatured 
lysozyme. 
A simple, semi quantitative, aggregation assay was conducted to compare the efficiency 
of [EMIM] Cl as an aggregation suppressor in comparison to the conventional refolding 
buffer containing urea and the redox couple, cysteine/cystine. The results of Figure 5.9 
show that in the absence of any refolding additive (Buffer A), the optical density of 
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denatured lysozyme solution increases with time. Thereby implying the denatured 
proteins aggregate and come out of solution. 
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Figure 5.9 Change in optical density of lysozyme solution over a period of time with 
change in composition of buffers. Buffer A (Δ), Buffer B (*) and Buffer C(ο).  
Buffer A: 50 mM HEPES, pH 8.1 containing 2 M urea, 0.03 mM cysteine, 0.3 mM cystine. 
Buffer B: 100 mM [EMIM] Cl in 50 mM HEPES, pH 8.1 Buffer C: 50 mM HEPES, pH 8.1  
In the presence of Buffer B and Buffer C, each of which contains different refolding 
additives, the optical density of the denatured lysozyme solution was almost comparable. 
And in comparison to Buffer B, [EMIM] Cl in Buffer C had a higher impact on 
suppressing the aggregation of denatured protein. These results are corroborated by those 
presented by Yamaguchi et al (2008) which revealed that increase in the hydrophobicity 
of N’-substituent of the cation augmented the suppression of aggregation but adversely 
affected the refolding yield. Hence, a fine balance between the hydrophobicity of the 
cation and the kosmotropicity of anion was desirable in an ionic liquid to function as an 
effective refolding additive(Yamaguchi et al., 2008). 
5.4 Conclusion:  
It is evident that the refolding yield of denatured lysozyme in the presence of ionic 
liquids is influenced by the alkyl chain length of the cation, anion in the ionic liquid, 
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concentration of the ionic liquid as a whole and the duration of incubation.  It now 
remains to be examined if an optimum for maximized refolding yield can be identified. 
To do so, a response surface methodology and central composite design was employed 
and is presented in the next chapter.  
5.5 Nomenclature 
Greek letter  
η viscosity of the solution 
η0 viscosity of the solvent 
Abbreviation Full form 
[BMIM]Ac 1-butyl-3-methylimidazolium acetate 
[BMIM]Cl 1-butyl-3-methylimidazolium chloride 
[BMIM]MS 1-butyl-3-methylimidazolium methylsulfate 
[EMIM] MS 1-ethyl-3-methylimidazolium methylsulfate 
[EMIM]Ac 1-ethyl-3-methylimidazolium acetate 
[EMIM]Cl 1-ethyl-3-methylimidazolium chloride 
OH-HMIM Cl N-(6-Hydroxyhexyl)-N'-methylimidazolium chloride 
C Chaotrope 
DTT Dithiothreitol 
EDTA ethylene diamine tetraacetic acid 
GuHCl) Guanidine hydrochloride 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
K Kosmotrope 
K/C borderline kosmotrope, chaotrope 
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Chapter 6  
6 Application of response surface methodology and central 
composite design for the optimization of lysozyme refolding 
by the ionic liquid [EMIM]Cl 
A quick overview on the theory of response surface methodology and central composite 
design is provided. Experimental design and results thereof that aid and abet in the 
identification of optimal refolding conditions for denatured lysozyme by [EMIM] Cl are 
discussed in this chapter. A validated, empirical model based on the results is provided. 
6.1 Introduction 
Protein refolding, rate limiting step in the downstream processing of bio-therapeutics, is a 
kinetically competitive process between correct folding and unproductive side reactions 
such as aggregation and misfolding (Gautam, Mukherjee, Roy, & Gupta, 2012; Lange, 
Patil, & Rudolph, 2005). Aggregation, considered to be a second- or higher-order 
reaction, at high protein concentrations dominates over folding and leads to significant 
reduction in the refolding yield. Therefore a logical strategy to improve refolding yield is 
to prevent aggregation by adding low molecular weight compounds that interfere with 
unwanted protein–protein interactions (Dechavanne et al., 2011). In principle, protein 
refolding additives function by either penetrating the micro-aqueous environment of the 
protein and stabilizing the protein (chaotropic effect) or by competing with the water 
associated the protein thereby limiting its exposure to the solvent and consequently 
driving the protein to its native state (kosmotropic effect). Numerous additives such as 
chaotropic salts, detergent, polymers and amino acids etc., have been previously shown to 
impede aggregation and enhance refolding yield (Alibolandi & Mirzahoseini, 2011; 
Arakawa, Tsumoto, Kita, Chang, & Ejima, 2007; Hamada, Arakawa, & Shiraki, 2009; 
Meng, Park, & Zhou, 2001; Stumpe & Grubmüller, 2009; West, Guise, & Chaudhuri, 
1997). An emerging class of additives is that of ionic liquids. Ionic liquids are known to 
affect protein activity by either a) stripping off the internal water associated with the 
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protein, b) penetrating into the micro-aqueous environment to interact with the protein by 
changing protein dynamics, conformational and/or protein’s active site, or c) by 
interacting with the substrates and products either by direct reaction with them or by 
altering the portioning between the aqueous and non-aqueous phases. This dichotomy of 
preferential binding/exclusion originates from the Hofmeister series that is explicitly used 
to justify the effect of ionic liquids as protein refolding additives.  
Optimization refers to improving the performance of a system, a process of a product in 
order to obtain the maximum benefit from it (Bezerra, Santelli, Oliveira, Villar, & 
Escaleira, 2008). Traditionally, optimization has been carried out, by monitoring the 
influence of one-factor-at-a-time on an experimental response. The major disadvantage of 
the one-factor-at-a-time approach is that it ignores the interactions among the variables 
studied. As a consequence, this technique does not depict the complete effects of the 
parameters on the response. Another disadvantage of the one-factor optimization is the 
increase in the number of experiments necessary to conduct the research, which leads to 
an increase of time and expenses as well as an increase in the consumption of reagents 
and materials. 
In order to overcome this problem optimization of procedures has been carried out by 
using multivariate statistic techniques. Among the most relevant multivariate techniques 
used is response surface methodology (RSM). Response surface methodology is a 
collection of mathematical and statistical techniques based on the fit of a polynomial 
equation to the experimental data, which must describe the behavior of a data set with the 
objective of making statistical provisions (Aguirre & Bassi, 2013). It can be applied when 
a response or a set of responses of interest are influenced by several variables. The 
objective is to simultaneously optimize the levels of these variables to attain the best 
system performance.  
Protein refolding yield, is affected by several factors. These factors are inherent to the 
system itself (chemical composition of refolding buffer, type of refolding additive, 
concentration of refolding buffer, pH, viscosity etc.), to the protein (molecular mass, 
charge, disulfide bonds) and interactions between the two (Rahimpour, Mamo, Feyzi, 
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Maghsoudi, & Hatti-Kaul, 2007). Hence in this study, RSM design was developed to 
optimize the refolding yield of denatured lysozyme by ionic liquid, specifically [EMIM] 
Cl.  
The simplest model, which can be used in RSM, is based on a linear function. For its 
application, it is necessary that the responses obtained be well fitted to Equation 6.1 given 
below, where k is the number of variables, β0 is the constant term, βi represents the 
coefficients of the linear parameters, xi represents the variables, and ε is the residual 
associated to the experiments. The residual is the difference between the calculated and 
experimental result for a determinate set of conditions. A good mathematical model fitted 
to experimental data must present low residuals values. 
            
 
      ………………………………………………….Equation 6.1 
Interactions among variables are depicted by curvature on the response surface.  To 
evaluate curvature, a second-order model must be used. Two-level factorial designs are 
used in the estimation of first-order effects, but they fail when additional effects, such as 
second-order interaction effects, are significant. Among the more known second- order 
symmetrical designs are the three-level factorial design, Box–Behnken design, central 
composite design, and Doehlert design. These symmetrical designs differ from one 
another with respect to their selection of experimental points, number of levels for 
variables, and number of runs and blocks. Central composite design is the more popular 
and commonly used design for optimization of biological processes (Aguirre & Bassi, 
2013; Akbari, Khajeh, Ghaemi, & Salemi, 2010; Branchu, Forbes, York, & Nyqvist, 
1999; Steinberg & Bursztyn, 2010).  
A central composite design consists of the following parts: (1) a full factorial or fractional 
factorial design; (2) an additional design, often a star design in which experimental points 
are at a distance α from its center; and (3) a central point.  
Figures 6.1 and 6.2 illustrate the full central composite design for the optimization of two 
and three variables 
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Figure 6.1 Central composite design for the optimization of three variables (alpha = 
1.68). Points of Factorial Design (), Axial points () and  Central points (☐ ). 
 
Figure 6.2 Central composite design for the optimization of two variables (alpha = 
1.41). Points of Factorial Design (), Axial points () and  Central points (☐). 
A full uniformly rotatable central composite design is desired in circumstances where the 
experimenter doesn't know the location of the optimum point within the region of interest 
before the experiment is conducted, so it's desirable that all points a given distance (r) 
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from the center point in any direction have the same magnitude of prediction error. Such 
a central composite design presents the following characteristics: 
(1) Requires an experiment number according to N = k
2
 + 2k + cp , where k is the variable 
number and (cp) is the replicate number of the central point; 
(2) α -values depend on the number of variables and can be calculated by  α   2(k − p)/4 . 
For two, three, and four variables, they are, respectively, 1.41, 1.68, and 2.00; 
(3) all factors are studied in five levels (− α ,−1, 0, +1, +  α). 
6.1.1 Definition of key terms  
It is pertinent to introduce and define key terms that are employed in the design of 
experiments.  
Factors or independent variables are experimental variables that can be changed 
independently of each other. Typical independent variables comprise the pH, 
concentration of ionic liquid, concentration of protein, time and temperature, amongst 
others.  
Levels of a variable are different values of a variable at which the experiments must be 
carried out. The variable pH, for example in this study, has been investigated at five 
levels: 6.6, 7, 7.5, 8, and 8.34 units. 
Responses or dependent variables are the measured values of the results from 
experiments. Typical responses are the recovery of an analytes, resolution among 
chromatographic peaks and percentage refolding yield, among others. 
There are several factors that affect the refolding of a protein; protein concentration, time, 
pH of the buffer, temperature, concentration of refolding additive and type of refolding 
additive. For the purpose of this study, two sets of experiments were conducted. First a 
three factor, central composite design was used to assess the significant factors that affect 
protein refolding. Next, two of the previously examined three factors that had significant 
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interaction, were used to optimize the refolding yield of lysozyme using EMIM Cl and 
derive an empirical model. 
6.2 Materials and Methods 
6.2.1 Materials  
The ionic liquid of choice for this study, 1-ethyl-3-methylimidazolium chloride, 
[EMIM]Cl was purchased from Sigma-Aldrich (Oakville Canada).  
UV-Star microplate used for protein quantification and lysozyme activity assay, was 
purchased from VWR International, (Mississauga, Canada). The specifications of plate 
are described in Appendix, Table 1. Micro centrifuge tubes (1.5ml) use for the purpose of 
this study was also purchased from VWR International, (Mississauga, Canada). Tecan 
multimode microplate readers, 200 pro and M1000, (Männedorf, Switzerland) were used 
for the purpose of the study. All other raw materials and analytical techniques used in this 
study have already been discussed in Chapter 3 and hence not reproduced. The follow 
section discusses the design of experiment and experimental methodology employed. 
6.2.2 Design of experiments 
6.2.2.1 Experimental design: RSM 1  
 Response surface methodology was employed to optimize the concentrations of 
denatured lysozyme, concentration of [EMIM]Cl and pH of the refolding buffer that 
produces the highest refolding yield. To fit the experimental data to a mathematical 
model, the central composite design (CCD) 2
3
 + star was used with three factors and five 
levels. The CCD consisted of 17 experiments with three replicates for the central point 
(in parenthesis in Table 6.2) and α   1.68. Table 6.1 represents the range of experimental 
factors, which were investigated. 
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Table 6.1 Range of experimental factors considered for RSM-1 
Name Units Low High 
A: Amount of  Lysozyme  mg 0.25 0.5 
B: Ionic Liquid Concentration mM 75.0 100.0 
C: pH  Units 7.0 8.0 
The data in table 6.2 represents the experimental conditions for the 17 independent runs. 
The experiments appear in the table in the order they were performed. Estimated response 
surface contour graphs were used to study to interactive effect of the variables on the 
refolding yield of lysozyme. The statistical analysis and optimum values for response 
variable was found based on mathematical models using Statgraphics Centurion XVI 
(StatPoint Technologies Inc., Warrenton, USA). 
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Table 6.2 Experimental matrix for three factor central composite design 
Run 
Denatured lysozyme      
(mg) 
Concentration 
of [EMIM] Cl (mM) 
pH (units) 
1 0.37 108.52 7.50 
2 0.16 87.50 7.50 
3 (Replicate 1) 0.37 87.50 7.50 
4 0.37 87.50 6.66 
5 (Replicate 2) 0.37 87.50 7.50 
6 0.25 75.00 7.00 
7 0.50 100.00 7.00 
8 0.50 75.00 8.00 
9 0.59 87.50 7.50 
10 0.38 87.50 8.34 
11 0.38 66.47 7.50 
12 (Replicate 3) 0.37 87.50 7.50 
13 0.50 100.00 8.00 
14 0.50 75.00 7.00 
15 0.25 100.00 8.00 
16 0.25 75.00 8.00 
17 0.25 100.00 7.00 
6.2.2.2 Experimental Design (RSM -2)  
Two significant parameters were identified in Experimental design 1. Response surface 
methodology was employed to optimize those factors, concentrations of denatured 
lysozyme and concentration of [EMIM] Cl, which produces the highest refolding yield. 
To fit the experimental data to a mathematical model, the central composite design 
(CCD) 2
2
 + star was used with two factors and five levels. The CCD consisted of three 
blocks of 10 experiments and two central point replicates (in parenthesis in Table 6.4), 
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per block, and α   1.14. Table 6.3 represents the range of experimental factors, which 
was examined.  
Table 6.3 Range of experimental factors in RSM 2 
Name Units Low High 
A: Amount of lysozyme mg 0.125 0.175 
B: Ionic Liquid Concentration mM 50.0 100.0 
Mathematical model describing the relationship between response variable, percentage 
refolding yield, and manipulated variables, concentration of denatured lysozyme and 
concentration of [EMIM] Cl, was developed by finding the coefficients of a second order 
equation. All the calculations were done using the data obtained at time point 2 hours. 
The accuracy of the model was calculated by the regression coefficients R
2
 and adjusted 
R
2
. Significance of regression coefficients was determined with a confidence level of 
95%. The statistical analysis and the optimum values for the response variable was found 
based on the mathematical model using Statgraphics Centurion XVI (StatPoint 
Technologies Inc., Warrenton, USA). 
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Table 6.4  Experimental design for RSM 2 
Run 
Denatured lysozyme 
(mg) 
Concentration of EMIM 
Cl  
(mM) 
1  (Replicate 1) 0.15 75.00 
2 0.15 110.00 
3 0.13 100.00 
4 0.15 39.60 
5 0.19 75.00 
6 0.18 50.00 
7 0.13 50.00 
8 0.18 100.00 
9 0.12 75.00 
10 (Replicate 2) 0.15 75.00 
11 (Replicate 3) 0.15 75.00 
12 0.15 110.00 
13 0.13 100.00 
14 0.15 39.60 
15 0.19 75.00 
16 0.18 50.00 
17 0.13 50.00 
18 0.18 100.00 
19 0.12 75.00 
20 (Replicate 4) 0.15 75.00 
21 (Replicate 5) 0.15 75.00 
22 0.15 110.00 
23 0.13 100.00 
24 0.15 39.60 
25 0.19 75.00 
26 0.18 50.00 
27 0.13 50.00 
28 0.18 100.00 
29 0.12 75.00 
30 (Replicate 6) 0.15 75.00 
6.2.2.3 Validation of the empirical model  
Amount of lysozyme in the final reaction mixture has a more profound effect on the final 
refolding yield than the concentration of ionic liquid. Hence, experimental validation of 
the model was done under conditions leading to optimal results, by varying the 
concentration of the denatured lysozyme (see Table 6.8). The predicted refolding yield 
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(%) was computed by an input of three different concentrations of denatured lysozyme, 
not previously tested in RSM- 2. Comparing to the observed refolding yield validated the 
accuracy of the model.  
6.2.3 Experimental methodology 
Preparation of native and denatured lysozyme:  
Native lysozyme was prepared by dissolving lysozyme in 50 mM HEPES, pH 7.0. 
Composition of the denaturation buffer was 6 M urea, 32 mM DTT and 1 mM EDTA in 
50 mM HEPES, pH 8.7. Denatured lysozyme was prepared by diluting appropriate 
volume of native lysozyme solution in denaturation buffer and incubating in hot-water 
bath at 37 °C for a period of 2 hours. Final concentration of the stock denatured lysozyme 
was 1 mg/ml.  
Preparation of refolding buffers:  
A concentration stock solution of [EMIM] Cl in 50mM HEPES was prepared. Refolding 
buffer, at its required concentration (mM), was prepared by diluting the stock solution of 
with 50 mM HEPES. The final pH (units) of the refolding buffer was adjusted per the 
design of experiments previously discussed. Either hydrochloric acid or sodium 
hydroxide was used to attain the desired pH value.   
Refolding methodology: 
Refolding of the denatured lysozyme was studied as per design of experiments (DOE), 
previously discussed. The experiments were conducted in micro centrifuge tubes (1.5ml) 
at ambient room temperature.  The final volume of the reaction mixture was 1ml. Based 
on the requirement of DOE and calculations; denatured lysozyme solution (1 mg/ml) was 
diluted to a final volume of 1 ml with its corresponding refolding buffer (mM). Once the 
reaction mixture was prepared, the micro centrifuge tubes were placed on a shaker at 125 
rpm for a period of 2 hours. Sample was carefully aliquoted and analyzed for protein 
concentration and refolding yield. 
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6.3 Results and Discussion 
6.3.1 Refolding yield as a function of composition of refolding 
buffer and concentration of lysozyme 
Results of the experimental set up, described in RSM-1, are presented in Table 6.5. It is 
evident that increase in the amount of denatured lysozyme (mg) adversely affected the 
refolding yield. Maximum refolding yield was obtained at the lowest concentration 
(0.165 mg) of denatured lysozyme, which was consistent with the results presented in 
Chapter 5 
Table 6.5 Experimental results of RSM -1 
Run 
Denatured 
lysozyme      
(mg) 
Concentration 
of [EMIM] Cl 
(mM) 
pH 
(units) 
Refolding 
Yield 
(%) 
1 0.37 108.52 7.50 3.83 
2 0.16 87.50 7.50 56.00 
3  (Replicate 1) 0.37 87.50 7.50 33.50 
4 0.37 87.50 6.66 22.70 
5  (Replicate 2) 0.37 87.50 7.50 33.30 
6 0.25 75.00 7.00 44.00 
7 0.50 100.00 7.00 17.30 
8 0.50 75.00 8.00 4.00 
9 0.59 87.50 7.50 18.70 
10 0.38 87.50 8.34 6.67 
11 0.38 66.47 7.50 17.30 
12 (Replicate 3) 0.37 87.50 7.50 33.20 
13 0.50 100.00 8.00 10.70 
14 0.50 75.00 7.00 12.00 
15 0.25 100.00 8.00 10.40 
16 0.25 75.00 8.00 24.70 
17 0.25 100.00 7.00 20.00 
The visualization of the predicted model equation can be obtained by surface response 
plot. Based on the results obtained in Table 6.5, Figures 6.3, 6.4 and 6.5 illustrate the 
quadratic response surface plot obtained in this study.  
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Figure 6.3 Estimated response surface contour graph illustrating the refolding yield 
as a function denatured lysozyme (mg) and [EMIM] Cl ( mM) at pH 7.5 units 
 
Figure 6.4 Estimated response surface contour graph of refolding yield as a function 
of concentration of [EMIM] Cl (mM) and change in pH (units) at 0.165  mg 
lysozyme.  
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Figure 6.5 Estimated response surface contour graph of refolding yield as a function 
of change in amount of lysozyme (mg) and pH (units) at fixed concentration of 
[EMIM] Cl = 75 mM 
Maximum refolding yield (56%) was obtained when the concentration of lysozyme was 
0.165 mg using refolding buffer 87.5 mM [EMIM]Cl in 50 mM HEPES, pH 7.5.  At 
constant pH, 7.5 units, increase in the concentration of denatured lysozyme results in a 
decrease in the refolding yield from 53 % to 3 %, Figure 6.3. In figure 6.4, change in 
refolding yield was presented as function of pH units and concentration of [EMIM] Cl 
(mM), at lysozyme concentration, 0.18 mg. A similar response surface contour graph was 
obtained when the lysozyme concentration was varied along with pH of the refolding 
buffer, but the concentration of [EMIM] Cl was kept constant at 75 mM. 
6.3.2 Refolding yield as a function of lysozyme concentration (mg) 
and concentration of [EMIM] Cl (mM) 
The response surface graphs obtained Figures 6.3, 6.4, and 6.5, show that the maximum 
(refolding yield) point was outside the experimental region and hence it was necessary to 
displace, if possible, the initial design to test it. Consequently, the RSM-2 design 
maintained the pH of the refolding buffer constant at pH 7.5 units but narrowed the range 
of denatured lysozyme and [EMIM] Cl. Table 6.6 presents the experimental results of the 
RSM-2 design described earlier. The repetition of central runs was carried out to provide 
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information on the variation of the responses about the average, the residual variance, and 
eventually estimate the pure experimental uncertainty. 
Table 6.6 Experimental results of RSM- 2 
Run 
Denatured lysozyme 
(mg) 
Concentration of 
EMIM Cl (mM) 
Refolding Yield 
(%) 
1 0.15 75 80.0 
2 0.15 110 13.7 
3 0.125 100 20.8 
4 0.15 39.6 4.77 
5 0.185 75 6.79 
6 0.175 50 3.03 
7 0.125 50 9.41 
8 0.175 100 8.27 
9 0.115 75 17.6 
10 0.15 75 76.5 
11 0.15 75 82.7 
12 0.15 110 12.8 
13 0.125 100 22.1 
14 0.15 39.6 5.51 
15 0.185 75 6.92 
16 0.175 50 2.84 
17 0.125 50 9.74 
18 0.175 100 8.69 
19 0.115 75 14.8 
20 0.15 75 78.0 
21 0.15 75 79.5 
22 0.15 110 14.0 
23 0.125 100 20.7 
24 0.15 39.6 5.21 
25 0.185 75 7.05 
26 0.175 50 2.88 
27 0.125 50 9.83 
28 0.175 100 8.9 
29 0.115 75 15.1 
30 0.15 75 85.6 
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(Bezerra et al., 2008), state in order to find a critical point (maximum, minimum or 
saddle), it is necessary for the polynomial function to contain quadratic terms according 
to Equation 6.2, where     represents the coefficients of the quadratic parameter. 
y  β
0
+  β
i
xi
k
i 1 + βii  
 + β
i 
  
   +
k
1 i  ε
k
i 1 ………………………Equation 6.2 
Based on the results presented in Table 6.5, Equation 6.3 is the equation of the fitted 
model, where : Y = refolding yield (%), X1 =  Amount of denatured lysozyme (mg), X2 = 
Concentration of [EMIM]Cl (mM), X1X2 = interaction effect of amount of lysozyme 
(mg) and [EMIM]Cl (mM).  
   - .          .               -  .     
    
 -  .         -  .       
 ……
…..Equation 6.3 
The quality of the fitted model was evaluated by the application of analysis of variance 
(ANOVA). The central idea of ANOVA is to compare the variation due to the treatment 
(change in the combination of variable levels) with the variation due to random errors 
inherent to the measurements of the generated responses (Bezerra et al., 2008; Hanrahan 
and Lu, 2006; Steinberg and Bursztyn, 2010).  
The ANOVA table (Table 6.7) partitions the variability in refolding yield into separate 
pieces for each of the effects. As replicates of the central point were made, it was possible 
to estimate the pure error associated with repetitions. The statistical significance of each 
effect by comparing the mean square against an estimate of the experimental error was 
evaluated. In this study, 5 effects have P-values less than 0.05, indicating that they are 
significantly different from zero at the 95.0% confidence level.  As per ANOVA, all 
parameters, including the interacting parameters X1X2 are significant 
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Table 6.7 Analysis of variance for the response surface quadratic model of refoldind 
yield of lysozyme 
Source 
Sum of 
Squares 
Degrees 
of 
freedom 
Mean 
Square 
F-value P-Value 
X1 384 1 384 85.08 0 
X2 269 1 269 59.56 0 
X1
2 16185 1 16185 3596.68 0 
X1X2 25.3 1 25.3 5.62 0.0261 
X2
2
 17102 1 17102 3800.51 0 
Total error 108 24 4.51   
Total (corr.) 2.43E+04 29    
R-squared = 99.6 % , R-squared (adjusted for d.f.) = 99.4 %, Standard Error of Est. = 
2.12, Mean absolute error = 1.47, Durbin-Watson statistic = 2.36 (P=0.7300) and Lag 1 
residual autocorrelation = -0.307. 
The goodness of the model for yield of refolding can be checked by several standards. 
The regression coefficient, R
2
 = 99.6%, table 6.7, indicated that only 0.4% of the 
variability of the response was not explained by the model. The adjusted R
2
 , which was 
used to compared model, was 99.4%. These results indicated good accuracy of the model 
in the conditions investigated. 
Further, Figure 6.6 represented the plot of experimental refolding yield versus the 
predicted, based on the model (Equation 6.3). The points cluster around the diagonal line 
indicating there was no significant deviation between the corresponding values 
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Figure 6.6 Plot of refolding yield: observed vs. predicted based on empirical model 
Figure 6.7 shows the response surface and contour graph for refolding yield (%). 
Maximum refolding yield was obtained when the concentration of denatured lysozyme 
was 0.15mg and the concentration of EMIM Cl was 75 mM.  It is also interesting to note 
that, when the amount of lysozyme is set at high value (0.19 mg), the refolding yield (Y) 
increases with increase in [EMIM]Cl concentration (from 35 mM to around 70 mM) and 
then decreases ([EMIM]Cl concentration from 80 mM to 110 mM). 
 
Figure 6.7 Estimated RSM contour plot of refolding yield (%) as a function of 
concentration of [EMIM] Cl  (mM) (ionic liquid) and  lysozyme (mg) 
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The response surface model was validated with a random set of experiments to confirm 
the accuracy of the empirical model, equation 6.3. Experimental points, previously not 
tested, were examined. The predicted refolding yield was calculated by substituting the 
values of the experimental factors in Equation 6.3.  Details of the experiment and 
obtained results along with predicted results are presented in Table 6.8.  
Table 6.8 Validation of empirical model. Experimental conditions, predicted 
response calculated from Eq. 6.6 and observed experimental resutls 
Denatured 
lysozyme (mg) 
EMIM Cl 
conc. (mM) 
Predicted 
Refolding Yield (%) 
Experimental 
Refolding yield (%) 
0.13 75 63.76 59.23 
0.15 75 83.79 86.89 
0.17 75 58.11 49.13 
0.19 75 -10.84 0 
The optimum concentration of [EMIM]Cl was kept constant and the refolding yield as 
function of change in amount of denatured lysozyme was observed, and also predicted 
using Equation 6.3. The calculated refolding yield was in close proximity of the predicted 
values; thus, validating the model. 
Further, aggregation assay was used as means to evaluate the effect of [EMIM] Cl on the 
refolding of denatured lysozyme. The parameters were set as described in RSM-2. The 
experimental results obtained are presented in Table 6.9. 
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Table 6.9 Influence of [EMIM] Cl as protein aggregation suppressor 
Lysozyme (mg) Concentration of [EMIM] Cl (mM) %Refolding % Turbidity 
0.13 100.00 12.79 28.65 
0.15 110.00 13.68 29.81 
0.12 75.00 17.62 32.69 
0.18 100.00 28.27 32.31 
0.17 87.50 42.00   
0.15 75.00 88.27 21.15 
0.19 75.00 36.79 40.00 
0.25 75.00 34.00 49.38 
0.38 87.50 15.72 11.89 
Based on the results obtained in Table 6.9 and optimal conditions obtained earlier, Figure 
6.8 is a graphical representation of the effect of 75 mM [EMIM] Cl in 50 mM HEPES as 
a refolding buffer for varying amount of denatured lysozyme (mg). 
 
Figure 6.8 Graphical representation of the effect of 75 mM  [EMIM] Cl in 50 mM 
HEPEs ,pH 7.5 on lysozyme refolding and aggregation. 
Refolding yield (%) (black bar) and aggregation represented by turbidity (%) (grey bar) is 
presented a change in amount of lysozyme (mg) in final reaction mixture. 
The results of Table 6.9 and Figure 6.8 support the empirical model and elucidate the 
effect of [EMIM] Cl on increasing concentration of lysozyme. It was, thus, evident that 
increase in the concentration of lysozyme increases the aggregation (%) hence poor 
refolding yield.  
0 
20 
40 
60 
80 
100 
120 
0.115 0.15 0.19 0.25 
P
er
ce
n
ta
g
e,
  
R
ef
o
ld
in
g
 y
ie
ld
, 
T
u
rb
id
it
y
 
Amount of lysozyme (mg) 
Refolding Yield Turbidity 
  
120 
6.4 Conclusion  
Refolding of denatured lysozyme, evidently, was grossly dependent on the amount of 
lysozyme in the final reaction mixture along with the concentration and type of refolding 
additive. Table 6.10 summarizes the published research findings of Lange et al (2005, 
2010), Bae et al (2012), Buchfink et al (2010) and the results obtained in this thesis 
(chapter 4 and 6).   
Table 6.10 Summary of experimental results obtained and data published by other 
scientists 
Protein Refolding Buffer Refolding 
duration 
(h) 
Conc. of 
denatured 
protein 
(µg/ml) 
Max. 
Refolding 
Yield (%) 
Ref. 
Lysozyme 0.3 mM GSH, 0.03 
mM GSSG, 1 mM 
EDTA, 0.1 M 
[EMIM] Cl, 0.1 M 
Tris/HCl (pH 8.2) 
1:60 
dilution for 
24 hours 
280 80 Lange et 
al (2005) 
rPA 
(recombinant 
plasminogen 
activator) 
0.3 mM GSH, 0.03 
mM GSSG, 1 mM 
EDTA, 3 M 
[EMIM] Cl, 0.1 M 
Tris/HCl (pH 8.2) 
1:60 
dilution for 
24 hours  
280 16 Buchfink 
et al 
(2010) 
Lysozyme 0.3 mM GSH, 0.03 
mM GSSG, 1 mM 
EDTA, 1 M 
[EMIM] BF4, 0.1 
M Tris/HCl (pH 
8.2) 
1:100 
dilution for 
24 hours 
100 80 Bae et al 
(2012) 
Lysozyme 0.3 mM GSH, 0.03 
mM GSSG, 1 mM 
EDTA, 1 M 
[EMIM] MS, 0.1 M 
Tris/HCl (pH 8.2) 
1:100 
dilution for 
8 hours 
100 90 Bae et al 
(2012) 
Lysozyme 2 M urea, 0.03 mM 
cysteine, 0.3 mM 
cystine 50 mM 
HEPES (pH 8.1) 
1:100 
dilution for 
2 hours 
100 90 Chapter 
4, Kaur 
2013 
Lysozyme 75 mM [EMIM] Cl 
50 mM HEPES pH 
7.5 
1:6 dilution 
for 2 hours 
180 84 Chapter 
6, Kaur 
2013 
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Thus far, only three research groups have published data on the refolding of denatured 
proteins using imidazolium based ionic liquids. The maximum refolding yield obtained in 
each of the studies is summarized in Table 6.10. None of the studies, by either research 
group, reports the exclusive use of ionic liquid as a refolding additive in lieu of 
cysteine/cystine. They however, do investigate the impact of ionic liquid as protein 
aggregation suppression agents. Also, the duration of the refolding process is almost 
always 24 hours, with results of the refolding yield at intermittent time intervals missing. 
Whether this yield was achieved within the initial few hours is not clear. The table also 
shows results obtained by the author in this thesis and serves as a comparison to 
published data.  
As is evident from the Table 6.10, to the best of our knowledge, the results presented in 
this chapter, is the first report of using imidazolium based ionic liquids without any 
additional redox couple (cysteine/cystine) to refold any protein and in particular 
denatured lysozyme. This is also the first report of study using response surface 
methodology and central composite design to find the conditions that yield optimum 
refolding yield for denatured lysozyme using imidazolium based ionic liquids. 
6.5 Nomenclature  
Greek symbol  
xi  Variables in a central composite design 
βi   Represents the coefficients of the quadratic parameter 
cp Replicate number of the central points 
k Number of variables 
β0 Constant term 
βi  Coefficients of linear parameters 
ε Residual associate to the experiments 
Abbreviation Full Form 
[EMIM] Cl 1-ehtyl-3-methyl imidazolium chloride 
ANOVA Analysis of variance 
CCD Central composite design 
DTT Dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
R
2
 Regression coefficient 
RSM Response surface methodology 
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X1 Concentration of denatured lysozyme (mg) 
X1X2  Interaction effect of concentrations of lysozyme (mg) and [EMIM] Cl (mM) 
X2 Concentration of [EMIM] Cl (mM) 
Y Refolding yield (%) 
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Chapter 7  
7 Adsorptive protein refolding with the aid of [EMIM] Cl in a 
packed bed/fluidized bed ion –exchanger 
The applicability and influence of [EMIM] Cl as an elution and refolding buffer for 
adsorptive refolding of denatured lysozyme is examined. Refolding yield and fractional 
mass recovery, due to incorporation of [EMIM] Cl in elution buffer, is presented as 
function of mode of operation and increase in concentration of protein load. Comparison 
on the efficacy of [EMIM] Cl as a refolding/elution enhancer to other ionic liquids is also 
reviewed by means of experimental results. 
7.1 Introduction  
The bottleneck in biotechnology, in the last decade, has shifted from upstream to 
downstream processing of biomolecules. The pressure to develop better separation and 
purification protocols that combat the new process- and product-related impurities and 
higher titre levels without compromising on the safety, efficacy and quality of the product 
is continually increasing.  The purification of proteins is steadily moving from pooling-
elution-fractions-of-multiple-runs on a single column towards development of columns 
that can handle higher protein concentrations. In order to do so, it is pertinent to develop 
integrated approaches that incorporate clarification, separation, recovery and purification.  
The recovery of active protein from inclusion bodies, to date, is the biggest challenge in 
downstream processing of proteins.  Protein refolding is a kinetically competitive 
process. Aggregation caused by the hydrophobic interaction between folding 
intermediates competes with the on-pathway renaturation process, leading to low 
refolding yields.  A potentially efficient strategy to minimize aggregation is to decrease 
this risk of intermolecular interaction by adsorbing the denatured protein molecules to a 
solid support, thus, effectively separating the individual protein molecules from each 
other during refolding.  
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Usually, adsorbent particles are packed in fixed beds which require pre-clarified feed ,  in 
order to avoid plugging particulate material in the packed bed, which can lead to 
increased pressure drop and operating failure (Thömmes, 1997). Fluidization of the 
protein adsorption media, increases the inter-particle distance of the resin particles , 
thereby allowing the feed to pass freely in the interstitial volume of the matrix. A 
significant advantage of this process is the integration of clarification, separation and 
recovery of the purified biomolecule in one unit operation. 
Refolding additives, enhance refolding yield of a protein, by either suppressing 
aggregation or by stabilizing the native structure of the protein. Chaotropic salts at non-
denaturing concentrations (for urea below 3 M), anion- and non-ionic detergents, amino 
acids and its derivatives, osmolytes, amphiphilic polymers and varying salts have been 
used as refolding aids in the past (Arakawa, Tsumoto, Kita, Chang, & Ejima, 2007; 
Daugherty, Rozema, Hanson, & Gellman, 1998; Hamada & Shiraki, 2007; Wang, Nema, 
& Teagarden, 2010; Yamaguchi, Yamamoto, Mannen, Nagamune, & Nagamune, 2012; 
Yasuda, Murakami, Sowa, Ogino, & Ishikawa, 1998). An evolving class of refolding 
additives is the “designer liquids” or ionic liquids.  Ionic liquids, by definition are salts 
that are liquid at temperatures below 100 °C and consist entirely of ionic species. As they 
are made up of two components (the anion and cation), which can be varied, the solvents 
can be designed with a particular end use in mind, or to possess a particular set of 
properties. The effect of ionic liquids in biocatalysis has been previously reviewed by 
(van Rantwijk & Sheldon, 2007). In addition to experimental results presented and 
discussed in chapters 5 and 6 of this thesis, several other scientist have demonstrated the 
efficacy of ionic liquids as refolding additives via dilution refolding of denatured protein 
(Bae, Chang, Koo, & Ha, 2012; Buchfink, Tischer, Patil, Rudolph, & Lange, 2010; 
Lange, Patil, & Rudolph, 2005; Yamamoto, Yamaguchi, & Nagamune, 2011). The 
general consensus, so far, has been to use ionic liquids with a kosmotropic anion and 
chaotropic cation to achieve enhanced refolding yields.  
The purpose of this work was to investigate the influence of one such imidazolium based 
ionic liquid [EMIM] Cl, on the refolding yield of denatured lysozyme in a packed 
bed/fluidized mode of operation. Process performance indicators such as refolding yield 
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and fractional mass recovery were used to compare and evaluate the efficiency of the 
different adsorptive refolding processes. 
7.2 Materials and Methods 
7.2.1 Materials 
All materials and equipment used in this study have already been described in Chapter 3, 
with the exception of the ionic liquids 1-ethyl-3-methylimidazolium chloride, 1-butyl-3-
methylimidazolium chloride and methylimidazolium chloride, which were purchased 
from Sigma-Aldrich (Oakville, Canada). The following section discusses the 
experimental methodology employed. The reader is requested to refer Chapter 3 for 
discussion on the analytical techniques employed.  
7.2.2 Experimental methodology 
7.2.2.1 Preparation of denatured lysozyme  
Native lysozyme was dissolved in 50 mM HEPES, pH 7.0 to prepare a stock solution. 
Denaturation buffer contained 6 M urea, 32 mM DTT, 1 mM EDTA in 50 mM HEPES 
buffer pH 8.7. Denatured lysozyme was prepared by diluting an appropriate volume of 
native lysozyme in denaturation buffer and incubating in a water bath at 37° C for a 
period of 2 hours. The activity of the lysozyme was tested to ensure it was completely 
denatured. 
7.2.2.2 Investigation of adsorption of ionic liquid ([EMIM]Cl) on ion-
exchange resin 
A 5 ml pre-packed HiTrap SP FF column was connected to the AKTA FPLC system 
equipped with UV flow cell, conductivity cell and UNICORN version 5.01. The column 
was equilibrated with 10 column volumes of 50 mM HEPES, pH 8.7. Two column 
volumes of [EMIM] Cl in 50mM HEPES, pH 7.5 at varying concentrations, ranging from 
10 mM to 150 mM, were applied to the column. The flow rate was kept constant at 0.4 
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ml/min. The load cycle was followed by wash cycle of 5 column volumes with 
equilibration buffer. Elution was started by gradually increasing the ratio of elution 
buffer/equilibration buffer from 0:100 to 100:00 within 12 column volumes. Composition 
of the elution buffer was 50 mM HEPES at pH 8.1. Changes in conductivity and 
absorbance were recorded to assess the adsorption-desorption of [EMIM] Cl on the ion-
exchanger.  
7.2.2.3 Investigation of the efficiency of [EMIM] Cl as an 
elution/refolding buffer   
The pre-packed HiTrap SP FF column (5 ml), connected to AKTA FPLC, was 
equilibrated with ten column volumes of equilibration buffer (50 mM HEPES, pH 8.7, 2 
M urea). A 1ml aliquot of denatured protein (2.5 mg/ml) was loaded on to the column. 
After rinsing with five column volumes of equilibration buffer above, the column was 
eluted by gradient elution. Elution was started by gradually increasing ratio of elution 
buffer/equilibration buffer from 0:100 to 100:0 at 0.4 ml/min within 12 column volumes. 
Four different elution buffers were examined. Composition of each elution buffer varied 
as follows;  
Buffer A: 50 mM HEPES, pH 8.1 (negative control) 
Buffer B: 50 mM HEPES, pH 8.1 containing 1M sodium chloride  
Buffer C: 50 mM HEPES, pH 7.5 containing 75mM [EMIM] Cl,  
Buffer D: 50 mM HEPES, pH 7.5 containing 75mM [EMIM] Cl 1M sodium chloride.  
Buffer E: 50 mM HEPES, pH 8.1 containing 2M urea, 0.03mM cysteine, 0.3mM cystine 
and 1M sodium chloride 
The entire study was conducted at a steady flow rate of 0.4 ml/min. Fractions were 
collected and analyzed for both protein concentration and lysozyme activity. The column 
was washed, cleaned-in-place (CIP) and regenerated for the next cycle. The study was 
conducted in triplicates and average results (mean ± SEM) are presented. The standard 
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error of the mean (SEM) quantifies the precision of the mean. It is a measure of how far 
the sample mean is likely to be from the true population mean. SEM is computed by 
feeding the data to GraphPad Prism Software Inc. (LaJolla CA, USA). It is calculated by 
dividing the sample standard deviation by the square root of the sample size.  
7.2.2.4 Adsorptive refolding of denatured lysozyme in a packed bed 
mode 
The pre-packed HiTrap SP FF column (5 ml), connected to AKTA FPLC, was 
equilibrated with ten column volumes of equilibration buffer (50 mM HEPES, pH 8.7, 2 
M urea).  The flow rate throughout the experiment was set at 0.4 ml/min. Denatured 
lysozyme solutions, in the range of 1 mg/ml to 10 mg/ml, were prepared. A protein 
loading of 2.5 ml of denatured lysozyme (at varying concentrations) was applied on to 
the column. After rinsing with five column volumes of equilibration buffer, the column 
was eluted by gradient elution. Elution was started by gradually increasing ratio of 
elution buffer/equilibration buffer from 0:100 to 100:0 at 0.4ml/min within 12 column 
volumes. Composition of elution buffer was 50 mM HEPES, pH 7.5 containing 75 mM 
[EMIM] Cl and 1 M sodium chloride. Fractions were collected at every step and analyzed 
for protein concentration and lysozyme activity. The column was washed, cleaned-in-
place (CIP) and regenerated for the next cycle.
 
7.2.2.5 Adsorptive refolding of denatured lysozyme in fluidized bed 
mode 
A volume of exactly 5 ml of the Sepharose Fast Flow resin slurry, suspended in 50 mM 
HEPES (pH 7.0), was accurately aliquoted and dispensed in the fluidized bed column. 
The resin particles were equilibrated with 50 ml of equilibration buffer (2 M urea in 50 
mM HEPES, pH 8.7) for a period of 30 minutes, by a steady-flow of air at 0.01 LPM 
flow rate. At the end of equilibration, fluidization was halted and the buffer was 
dispensed out of the column with the aid of peristaltic pump. Next, 10 ml of denatured 
lysozyme solution, at varying concentrations 1 mg/ml to 10 mg/ml, was loaded onto the 
re-fluidized resin particles. After 15 minutes of adsorption, the resin was allowed to settle 
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and the buffer was dispensed out of the column with the aid of the peristaltic pump. 
Following this, the re-fluidized resin particles were washed with 25 ml of equilibration 
buffer for period of 10 minutes. After separating the washed-resin particles from the 
buffer, the resin particles were re-fluidized. Elution of bound lysozyme initiated when the 
resin particles were allowed to interact with 100 ml of elution buffer (50 mM HEPES, pH 
7.5 containing 75 mM [EMIM]Cl and 1M sodium chloride) for duration of 30 minutes. 
The elution pool was collected and analyzed for protein concentration and lysozyme 
activity. The resins were cleaned-in-place and regenerated before use in the next cycle. 
7.2.2.6 Investigation of [EMIM] Cl as a refolding additive in the elution 
buffer in a fluidized bed mode 
 A 5ml slurry of the Sepharose FF resin, re-suspended in 50 mM HEPES (pH 7.0) was 
accurately aliquoted and dispensed in the fluidized bed column. The resin particles were 
equilibrated with 50 ml of equilibration buffer (2 M urea in 50 mM HEPES, pH 8.7) for a 
period of 30 minutes, by a steady-flow at 0.01 LPM air flow rate. At the end of 
equilibration, fluidization was halted and the buffer was dispensed out of the column with 
the aid of peristaltic pump. Next, 10 ml of denatured lysozyme solution, at varying 
concentrations 1 mg/ml to 10 mg/ml respectively, was loaded onto the re-fluidized resin 
particles. After 15 minutes of adsorption, the resin was allowed to settle and the buffer 
was dispensed out of the column with the aid of the peristaltic pump. Following this, the 
re-fluidized resin particles were washed with 25 ml of equilibration buffer for period of 
10 minutes. After separating the washed-resin particles from the buffer, the resin particles 
were re-fluidized using the same airflow rate. Elution of bound lysozyme commenced 
when the resin particles were allowed to interact with 100 ml of each of the elution 
buffers for duration of 30 minutes.  
The composition of various elution/refolding buffers examined was as follows:  
Buffer D: 50 mM HEPES, pH 7.5 containing 75 mM [EMIM] Cl and 1M sodium 
chloride  
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Buffer E 50 mM HEPES, pH 8.1 containing 2 M urea, 0.03 mM cysteine, 0.3 mM 
cystine and 1M sodium chloride.  
Buffer F: 50 mM HEPES, pH 7.5 containing 75 mM [MIM] Cl and 1M sodium chloride  
Buffer G: 50 mM HEPES, pH 7.5 containing 75 mM [BMIM] Cl and 1M sodium 
chloride. 
The elution pool was collected and analyzed for both protein concentration and enzyme 
activity. The refolding efficiency and performance parameters were used to assess the 
efficiency of the process. The resins were cleaned-in-place and regenerated before next 
cycle 
7.3 Results and Discussion 
The effect of ionic liquids via the on-column adsorptive refolding of denatured lysozyme 
is yet, to the best of our knowledge, unexplored. The purpose of this study was to 
evaluate investigate the application of ionic liquids, specifically [EMIM] Cl, as a 
refolding additive in the adsorptive refolding of denatured lysozyme in both a packed bed 
ion exchange system and fluidized bed ion exchange system.  
7.3.1 Investigation of adsorption of [EMIM] Cl on ion-exchanger  
It has already been established in chapters 5 & 6 that dilution refolding of denatured 
lysozyme with the ionic liquid, 1-ethyl-3-methylimidazolium chloride, ([EMIM] Cl) gave 
the high refolding yields (ca. 95%) in a short duration of time (1 hour). Imidazolium 
based ionic liquids are usually miscible in water. Upon dissolution they dissociate into 
individual ions. Therefore, it was essential to assess if [EMIM] Cl bound to the ion-
exchange resin or not. Different concentrations of [EMIM] Cl were loaded onto the 
packed bed column as discussed previously. 
Figure 7.1 is the chromatogram generated by UNICORN when 150mM of [EMIM] Cl 
was passed through the HiTrap SP FF column. Upon injection of the ionic liquid, as it 
flowed through the column, changes in UV (at 280 nm) and conductivity were recorded. 
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The UV peak observed between 0 and 5 on the x-axis in Figure 7.1 indicates that none of 
the ionic liquid bound to the column but instead flowed through. There is significant 
difference in the conductivity of the load (EMIM]Cl in 50 mM HEPES pH 8.1) and 
elution buffer (50 mM HEPES, pH 8.1) and was evident in the Figure 7.1. It was thus 
noteworthy that [EMIM] Cl increases the conductivity of the buffer. This property was 
harnessed and utilized by incorporating [EMIM] Cl in the elution buffer.  
 
 
Figure 7.1 Chromatograph generated by UNICORN upon loading 150 mM [EMIM] 
Cl on to a Hi Trap SP FF column.  
The pink line at point 0ml indicates the injection of [EMIM]Cl. The blue line represents 
the change in UV absorption at 280 nm, the brown line represents the change in 
conductivity and the green line represents the change in concentration of elution buffer. 
 
Ionic liquids tend to be viscous solutions. A real concern when working with packed bed 
systems is the column pressure that is generated due to use of viscous solutions or 
buffers. However, ionic liquids at concentration below 60 mM act as salts and thus do not 
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generate high back pressure in the system. It was therefore interesting to note that at high 
concentration of 150 mM [EMIM] Cl, no pressure issues were noted by UNICORN. This 
could be attributed to the low flow rate, of 0.4ml/min, at which all the steps of packed 
bed ion-exchange system were operated. Hence for all further experimental studies on 
packed bed system with ionic liquids, the flow rate was fixed at 0.4 ml/min for a 5 ml pre 
packed column. 
7.3.2 Examination of [EMIM] Cl as an elution/refolding buffer for 
lysozyme 
Based on results from previous section (7.3.1), it would be safe to conclude that buffer 
containing [EMIM] Cl (up to 150 mM), when run through a 5 ml HiTrap SP FF (or 
Sepharose based) ion exchange system at 0.4 ml/min does not bind to the column but 
instead flowed through. Thus making it suitable for use with an ion exchange system. It 
was now important to investigate its efficacy as a refolding/elution buffer. Figure 7.2 
represents the results of the study carried out as described in section 7.8.2. The 
concentration of [EMIM] Cl in the buffer was set at 75 mM. This was based on its 
efficacy in refolding denatured lysozyme via dilution refolding, as demonstrated earlier in 
Chapter 6. The efficiency of [EMIM] Cl as a refolding additive (in dilution refolding) has 
been reported in Chapters 5 and 6 of this thesis. The present study, evaluated its efficacy 
in packed bed refolding system.  
Figure 7.3, shows that the percentage- elution and refolding yield was the least, 2.25% 
and 2.14% respectively, with Buffer A, which also served as the negative control in this 
experiment. Buffer E, (conventional buffer) containing 2M urea, 0.03mM cysteine, 
0.3mM cystine and 1M sodium chloride in 50mM HEPES, pH 8.1 served as the positive 
control. In ion exchange based systems, increase in ionic strength of the buffer, the ions 
(usually sodium and chloride) compete with the bound protein for charges on the surface 
of the ion-exchange medium. This causes bound species to elute. Thus, addition of 1M 
sodium chloride to the Buffer A, increased the ionic strength (salt concentration) of the 
buffer and its subsequent effect on percentage elution (86.34% elution) was apparent in 
Figure 7.3. Sodium chloride is a salt that does not have any direct effect on the denatured 
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protein. However, as Buffer B flowed through the column diluting the concentration of 
denaturant and simultaneously eluting the protein, it created an environment for some of 
the protein to refold. Hence, a slight increase in refolding yield (10.27%) in comparison 
to Buffer A was recorded. In comparison to Buffer B, Buffer C containing 75mM 
[EMIM]Cl, yielded substantially better refolding (50.22 ), although it’s efficiency as 
elution buffer was not as high as in comparison to buffer B. Thus, a combination of 
Buffer B and C - Buffer D - was evaluated. A combination of the two salts (sodium 
chloride and [EMIM] Cl), considerably improved the elution and had much more 
pronounced effect on the refolding yield. Buffer D, containing 75mM [EMIM] Cl, 
enhanced the refolding yield of the denatured lysozyme by 62 % in comparison to Buffer 
B and improved by 5% in comparison to the positive control (Buffer E). These results are 
substantiated by experimental results, as reported by Lange et al (2005).  
 
 
Figure 7.2 Effect of buffer composition on elution (%) and refolding yield (%) of 
adsorbed protein on HiTrap SP FF column.  
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Five different buffers are presented. Buffer A (Negative control): 50 mM HEPES, pH 8.1 
Buffer B: 50mM HEPES (pH 8.1) containing 1 M sodium chloride Buffer C: 50mM 
HEPES (pH 7.5) containing 75mM [EMIM]Cl, Buffer D: 50mM HEPES (pH 7.5) 
containing 75mM [EMIM] Cl and 1 M sodium chloride. Buffer E (positive control): 
50mM HEPES, pH 8.1 containing 2M urea, 0.03mM cysteine, 0.3mM cystine, 1M 
sodium chloride. Protein load : 2.5mg 
Lange et al. (2005) examined a series of N-alkyl and N-hydroxyalkyl- N-
methylimidazolium based ionic liquids as refolding additives for two different model 
proteins, lysozyme and ScFvOx. They compared the efficacy and efficiency of the ionic 
liquids as refolding additives to one of the more popular refolding additives, L-arginine 
hydrochloride. And found the results (refolding yield, stability of the protein and 
aggregation suppression) were comparable to, and in some instances better than, that 
obtained by L-arginine hydrochloride. The enhanced refolding yield was attributed to, 
suppression of aggregation coupled with stabilization of native structure of the protein, 
by ionic liquids. They also report, increase in the hydrophobicity of the cation and 
concentration of ionic liquid (M) adversely affected the refolding yield and aggregation 
of the target proteins (Lange et al., 2005). 
In summary, elution buffer D, containing 75 mM [EMIM] Cl and 1 M sodium chloride in 
50 mM HEPES, pH 7.5 assisted the elution and refolding of adsorbed denatured 
lysozyme from a strong cation exchange resin. 
7.3.3 Packed Bed refolding of denatured lysozyme  
Protein load is an important operational variable in the ion exchange refolding of 
denatured lysozyme because it directly affects the fractional mass recovery and 
volumetric productivity of the process. Varying concentrations of denatured lysozyme 
were loaded onto the pre-packed column, and fractions collected were analyzed to assess 
the influence of protein load. The experimental protocol has been discussed in materials 
and methods. Figure 7.3, elucidates a typical elution chromatogram of the cation-
exchange protein refolding experiment when 5 mg of denatured lysozyme was loaded on 
to the column. 
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Figure 7.3 Chromatogram illustrating the elution of refolded lysozyme.  
The blue line represents the change in UV absorption at 280nm, the brown line represents 
the change in conductivity and the green line represents the change in concentration of 
elution buffer. Load: 5mg of denatured lysozyme. The sharp blue peak represents the 
elution peak.  
As discussed earlier  (in Chapter 4), the nature of the protein load affected the adsorption, 
desorption and thereby refolding yield of the protein, and consequently efficiency of the 
process.  Therefore, native and denatured lysozyme, at similar protein concentrations, 
was applied to the ion-exchange system. Experimental results from the series of 
experiments are represented in Figure 7.4 and Table 7.1. It was observed that, 
irrespective of the nature of the load, approximately 85 to 92% of the load, bound to the 
equilibrated ion-exchange resin. 
 Native lysozyme 2mg with EMIM Cl elution001:1_UV  Native lysozyme 2mg with EMIM Cl elution001:1_Cond  Native lysozyme 2mg with EMIM Cl elution001:1_Conc
 Native lysozyme 2mg with EMIM Cl elution001:1_Inject  Native lysozyme 2mg with EMIM Cl elution001:1_UV@01,BASEM  Native lysozyme 2mg with EMIM Cl elution001:1_Logbook
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Figure 7.4 Effect of protein load and feeding state (native or denatured) on the 
fractional mass recovery.  
Different concentrations o
on to HiTrap SPFF 5ml column.  
Figure 7.4 illustrates the effect of protein load (mg) and the feeding state (native or 
denatured) on the fractional mass recovery on a pre-packed HiTrap SP FF (5 ml) column. 
The results show that the natures of the protein load and the concentration both strongly 
affect the fractional mass recovery. As opposed to a native protein, the hydrophobic core 
of the denatured protein is exposed making it susceptible to protein-protein interactions 
and aggregations. Increase in protein concentration, thereby, increases the probability of 
aggregation affecting the fractional mass recovery adversely. Similar result is reported by 
Freydell et al., (2010). They examined the effect of feeding state (native or denatured or 
denatured-reduced) lysozyme on various cation exchange resins, including Sepharose fast 
flow beads (Freydell, Van Der Wielen, Eppink, & Ottens, 2010). A major drawback of 
their process and operation conditions was the inefficient elution of denatured lysozyme 
from Sepharose beads with sodium chloride. It is noteworthy that, the elution buffer they 
used did not contain any ionic liquid.  
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Table 7.1 represents the experimental results obtained by loading varying concentrations 
of denatured lysozyme on 5 ml HiTrap SP FF column and its corresponding effect on the 
refolding yield and fractional mass recovery of the protein. 
Table 7.1 Effect of load on refolding yield and fractional mass recovery of lysozyme 
in a packed bed ion exchanger 
Ion Exchanger Load : denatured 
lysozyme (mg) 
% Refolding 
Yield 
Fractional mass 
recovery 
HiTrap Sepharose 
Fast Flow (5ml) 
 
 
2.5 84.34 0.79 
5 85.39 0.76 
10 84.29 0.71 
25 54.29 0.53 
Fractional mass recovery of the protein is the ratio of concentration of eluted protein (mg) 
to the concentration of protein load (mg). It is evident that increase in the protein load, up 
to 25 mg, had an adverse effect on the fractional mass recovery of the protein; however 
up to 10 mg of load the refolding yield was considerably high, 85%. A plausible 
justification for this could be loading under denatured state of protein. The probability of 
aggregation in a solution of denatured protein increases with increase in concentration of 
protein, by virtue of its exposed hydrophobic patches. This claim is further supported by 
similar trends reported by (Freydell et al., 2010; Langenhof, Leong, Pattenden, & 
Middelberg, 2005).  
In order to meet the economies of scale there is a strong demand in the industry for 
systems that can support high concentration of protein solutions. Packed bed refolding of 
lysozyme has already presented its limitation with regards to protein concentration. 
Whether this changes favorably or not, in a fluidized bed system was investigated in the 
following section. 
  
138 
7.3.4 Protein refolding in a fluidized-bed ion-exchange 
chromatographic system 
Previously optimized concentrations of refolding additives and buffer compositions were 
employed in the batch- refolding of denatured lysozyme in the fluidized bed ion-
exchange system developed in-house and described earlier.  
Similar to packed bed studies, series of experiments were conducted to assess the 
efficiency of the fluidized bed ion-exchange refolding system.  Samples from each step of 
the ion exchange process (adsorption, wash, elution) was collected and analyzed for both 
protein concentration and enzyme activity. Process performance indicators, discussed in 
analytical methods, Chapter 3, were used to assess the efficiency of the system in 
comparison to the packed-bed refolding of denatured lysozyme and use of conventional 
refolding buffer containing a redox couple. 
One of the main limitations in the use of a packed-bed system has consistently been its 
inability to handle higher protein concentration loads, and viscous solutions. Poor mass-
transfer, resin fouling and saturation of the resin are commonly encountered issues. After 
a fixed period of cycles, the ion-exchange resin is often rendered unusable. On the other 
hand, in the fluidized mode of operation, resin particles are lifted inside the column by an 
upward liquid and/or air stream generated by buffers, sample solutions or air-inlet. As a 
result of increased inter-particle porosity, fluidized beads allow for treatment of solution 
with considerably higher viscosity without generation of any significant backpressure. It 
was therefore our hypothesis that increased mass transfer and inter-particle porosity 
would permit a denatured adsorbed protein to elute into an environment conducive for 
protein refolding. In order to test this hypothesis, experiments were executed at similar 
conditions as a packed bed, only in a fluidized bed system. It is shown here for the first 
time that ionic liquid aided adsorptive protein refolding is noticeably better in a fluidized 
bed with an efficiency ca. 90% versus 55% for packed-bed a system, for a protein load of 
25mg. 
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 Table 7.2 illustrates the experimental results obtained by varying the concentration of the 
denatured lysozyme loaded onto the ion-exchange resin. In comparison to the results 
presented in table 7.1, the fractional mass recovery of the eluted protein and the refolding 
yield was substantially higher, thereby indicating the superior efficiency of the fluidized 
bed. 
It is interesting to note, that with increase in the protein load (mg), the refolding yield did 
not decrease substantially. Even at high protein load (25 mg), the refolding yield obtained 
was 35% higher than that obtained with a packed bed system. Also the fractional mass 
recovery was almost consistent through the range of protein load concentrations 
examined. 
Table 7.2 Effect of load on the refolding yield and fractional mass recovery of 
lysozyme in a fluidized bed ion exchanger 
Ion 
Exchanger 
Load: denatured 
lysozyme (mg) 
Refolding Yield 
(%) 
Fractional Mass 
Recovery 
Sepharose 
Fast Flow 
(5ml) 
2.5 97.71 0.82 
5 93.38 0.80 
10 92.04 0.81 
25 89.54 0.81 
Comparing the protein elution (%), refolding yield (%) and fractional mass recovery (%) 
of two different adsorptive processes – packed bed and fluidized, Figure 7.5, elucidates 
the enhanced efficiency of ion-exchange system in a fluidized bed vis-à-vis a packed bed 
system. At lower protein concentration range, i.e., 2.5mg, percentage elution and percent 
mass recovery in packed bed and fluidized bed was almost similar; indicating the mass 
transfer limitations did not vary much. However, the refolding yield in fluidized bed was 
greater than packed bed by 14%. Increasing the protein load (mg) ten fold adversely 
affected the output in a packed bed system. The refolding yield in packed bed was only 
54.29%, while in fluidized bed it was 89.54%. At both higher and lower concentrations of 
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protein load, fractional mass recovery in the fluidized bed was substantially higher than 
that in a packed bed system. Thereby, exemplifying the tolerance of a fluidized bed to 
higher concentrations of protein and its augmented efficiency in refolding denatured 
lysozyme. 
 
Figure 7.5  Effect of mode of operation and protein load (mg) on the refolding yield, 
elution and fractional mass recovery of lysozyme.  
Percentage elution (black bar), refolding yield (white bar) and fractional mass recovery 
(grey bar) are plotted against the load (mg) and mode of operation (packed bed, fluidized 
bed).  
7.3.5 Comparing the efficiency of [EMIM]Cl as an elution/refolding 
buffer   
Figure 7.7 describes the experimental results of similar refolding process in a fluidized 
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mg and 25 mg. It was evident from the previous study that [EMIM]Cl enhances refolding 
yield of denatured of lysozyme. How it compared with the conventional buffer containing 
the redox couple, cysteine/cystine was evaluated in this study.  
Additional elution buffers, Buffer F and G were incorporated to test the efficiency of 
[EMIM]Cl in comparison to other imidazolium based ionic liquids, as a refolding 
additive. It was interesting to note that with regards to the fractional mass recovery, 
Buffer G containing BMIM Cl was almost similar (difference of less than 3%) to that of 
Buffer F. However, the refolding yield with the buffer containing the less hydrophobic 
ionic liquid, 1-methyl-3-methylimidaozlium chloride (MIM Cl) was at least 25% higher 
than that with the buffer containing 1-butyl-3-methylimidazolium chloride (BMIM Cl); at 
either concentration of protein load. This could be explained by the increase in 
hydrophobicity and chaotropicity of the ionic liquid. 
 
Figure 7.6 Effect of load (mg) and buffer composition on the refolding yield and 
fractional mass recovery of lysozyme in a fluidized bed ion-exchanger 
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Experimental results of four different buffers are graphically represented in the Figure 
7.6. Composition of the buffers is as follows; Buffer D: 50mM HEPES, pH 7.5 
containing 75mM [EMIM] Cl and 1M sodium chloride and buffer E: 50mM HEPES, pH 
8.1 containing 2M urea, 0.03mM cysteine, 0.3mM cystine and 1M sodium chloride 
Buffer F: 50mM HEPES, pH 7.5 containing 75mM [MIM] Cl and 1M sodium chloride, 
Buffer G: 50mM HEPES, pH 7.5 containing 75mM [BMIM] Cl and 1M sodium chloride, 
Studies have shown that a kosmotropic anion has low affinity for the amide group of the 
protein and instead competes for the water associated with the protein, thereby driving 
the protein to its native state. While, a chaotropic cation penetrates the micro aqueous 
environment of the protein and forms a protective, stabilizing layer around it (Bae et al., 
2012; Lange et al., 2005a; Zhao, 2006). Thus, in order to achieve better refolding yields it 
is often advised that the ionic liquid be designed with a kosmotropic anion and chaotropic 
cation. In comparison to [MIM] and [EMIM], [BMIM] interacts poorly with water and 
has a destabilizing effect. It is therefore, no surprise that maximum refolding yield was 
obtained with Buffer D, containing [EMIM] Cl.  
7.4 Conclusions 
Proactive debottlenecking the downstream process of proteins is scrupulously dependent 
on the development of efficient, cost-effective refolding processes. In order to achieve 
this, it is important that the protein is provided with an environment, which promotes 
refolding and suppresses aggregation. This is commonly achieved by addition of 
refolding additives (L-arginine, 2 M urea, redox couples (cysteine/cystine) and 
GSH/GSSG etc) and employing strategies such as dilution, dialysis, or a combination of 
the two. Dilution and dialysis, albeit easy to adapt and execute, are plagued with 
limitations during scale up. The requirement of large volumes of refolding buffer, holding 
tanks, temperature and pH control, mixing and low concentration of denatured protein 
(less than 0.5mg/ml), make it inefficient and expensive. On-column adsorptive refolding 
of proteins, on the other hand, enhances refolding yield by reversibly binding the protein 
to the solid matrix, gradually removing the denaturants from the solution and providing 
the protein with sample space to refold to its natural state. The first report of on-column 
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protein refolding was by Creighton et al., in 1986 for horse cytochrome c  and bovine 
pancreatic trypsin inhibitor. Since then, several methods have been developed to increase 
refolding yield of denatured-lysozyme for ion exchange refolding matrices, including but 
not limiting to, two and three buffer systems and dual gradient chromatography. 
Langenhoff et al., (2005) report a maximum refolding yield of 60% with bovine serum 
albumin (BSA) at protein load of 2 mg on an anion-exchange system using the redox 
couple GSH/GSSG (Langenhof et al., 2005). Li et al (2002), using redox couples 
GSH/GSSG and cation exchange system with lysozyme as target protein, demonstrated 
that avoiding high salt concentrations for elution, and thus avoiding stronger hydrophobic 
interactions, could lead to suppression of aggregation of the folding intermediates and 
thereby enhance refolding yield (Li & Su, 2002). 
Ionic liquids, is an emerging class of refolding additives, that are gaining popularity due 
to their malleable nature and ‘green’ chemistry. Ionic liquids consist of organic cations 
such as N-alkyl-N-methylimidaozlium, N-substituted pyridinium, tetraalkylated 
ammonium and tetraalkylated phosphonium, and either organic or inorganic anions. They 
represent a rather diverse class of organic solvents and co-solvents with a 
correspondingly assorted range of physico-chemical properties, which may be readily, 
engineered by changes in anion and cation substitution patterns (Austen Angell, Ansari, 
& Zhao, 2011).  There are several publications that discuss the efficacy of ionic liquids as 
protein refolding additives in dilution refolding (Attri & Venkatesu, 2012; Lange et al., 
2005; Summers & Flowers, 2000). However, to the best of our knowledge, none of the 
studies published so far, have incorporated ionic liquids as refolding additives for on-
column adsorptive refolding of proteins.  
The work presented in this study demonstrates, the efficacy of [EMIM] Cl as a refolding 
additive. When incorporated in the elution buffer, it increased the ionic strength of the 
buffer and assisted in the elution and subsequent refolding of the denatured protein. The 
presence of a chaotropic cation ([EMIM]) and kosmotropic anion (Cl) in the ionic liquid 
suppressed aggregation and enhanced refolding of denatured lysozyme. Further, two 
different modes of operation were compared, packed bed and fluidized bed. In 
comparison to a packed bed mode of operation, at denatured lysozyme concentration of 
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25 mg with the aid of 75mM [EMIM] Cl in the elution buffer, fluidized bed delivered 
refolding yield ca. 92%. This could be explained by the increase in the mass transfer and 
inter-particle porosity, offered by fluidized mode of operation, which directly translates 
into improved efficiency for the system. Where this improves at concentration higher 
than 25 mg of denatured lysozyme, is adaptable to different proteins and ionic liquids, 
remains to be examined. At present, these results pave the way for incorporation of ionic 
liquids as refolding additives in adsorptive refolding of denatured lysozyme, and for the 
development of economic, efficient refolding processes at an industrial scale. 
7.5 Nomenclature  
Abbreviation Full form 
[BMIM] Cl 1-butyl-3-methylimidazolium chloride 
BSA Bovine serum albumin 
DTT Dithiothrietol 
[EMIM] Cl 1-ethyl-3-methylimidazolium chloride 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
[MIM]Cl Methylimidazolium chloride 
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Chapter 8  
8 Concluding remarks and recommendations 
Based on the experimental results acquired in this thesis, final concluding remarks and 
recommendations are provided.  
8.1 Summary 
Protein refolding is one of the most severe rate limiting steps in the downstream 
processing of proteins. The efficient conditions required for refolding proteins generally 
have to meet the following requirements; a) concentration of denaturants should be 
reduced to a level where intramolecular non-covalent interactions are retained, b) the 
refolding process should be performed under an appropriate environment to form the 
disulfide bridges and c) the concentration of the denatured protein should be maintained 
at a low level (usually less than 100μg/ml) to avoid intermolecular aggregation. 
Low protein concentration, is traditionally accomplished by diluting the solubilized 
protein in the refolding buffer. This also results in dilution of the denaturants. A rapid 
change in concentration of denaturants, however, may result in the formation of 
misfolded protein or aggregates. Due to the ease of automation and ability to handle high 
protein concentrations with integrated purification steps, the use of on-column refolding 
has gained momentum. However, irrespective of the methodology employed, dilution or 
on-column refolding, refolding additives play a significant role in the overall 
development of the process. These can be broadly classified into categories based on their 
mechanism of action, aggregation inhibitors or stabilizers of native protein structure.  
Ionic liquids, are gaining popularity in the biotechnology and pharmaceutical industry, 
primarily due to their characteristic low vapor pressure that renders them valuable as 
‘green solvents’ in comparison to the other molecular solvents. They have been 
successfully applied in biocatalysis, synthesis of active pharmaceutical ingredients and to 
enhance protein stability (Austen Angell, Ansari, & Zhao, 2011; Hough & Rogers, 2007; 
van Rantwijk & Sheldon, 2007). The effect of ionic liquids on protein structure, at a 
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molecular level has been examined, which exposed their role as protein aggregation 
suppressors and native structure stabilizers; both ideal characteristics required of a 
refolding additive (Endres et al., 2010; Kohno & Ohno, 2012; Mann, McLuskey, & 
Atkin, 2009; H. Zhao, 2010). 
A thorough, yet comprehensive, review of research findings (with respect to ionic 
liquids) has been provided in the literature review section of this thesis. It is apparent 
that, although there are numerous papers that discuss the role of ionic liquids as refolding 
additives, none so far have examined their worth in adsorptive, on-column refolding of 
denatured proteins. Hence the main objective of this thesis was to identify the potential of 
ionic liquids as refolding additives for on-column refolding of proteins, specifically 
denatured lysozyme. Each ion (cation and anion) of the ionic liquid has a significant 
impact on the protein. Dependent on their behavior, they are often classified as 
kosmotrope – order makers- or as chaotropes –order breakers. Ideally, for an ionic liquid 
to be effective protein refolding additive, the most desirable combination is that of a 
kosmotropic anion and a chaotropic cation. We reviewed this theory by using six 
different ionic liquids, encompassing a range of kosmotropic and chaotropic ions, for the 
refolding studies of denatured lysozyme. The ionic liquids that were investigated as 
refolding additives were all imidazolium based ionic liquids with varying alkyl chain 
lengths of the cation and varying anions.   
It is an established fact that protein-refolding yield is dependent on the type- and -
concentration -of- protein and refolding additive, duration of incubation, pH and 
refolding strategy employed. Successful dilution refolding demands low concentration of 
protein. Hence, by maintaining the concentration of denatured lysozyme, the refolding 
yield was assessed as a function of change in concentration of ionic liquid and incubation 
duration for each of the chosen six ionic liquids. The results showed maximum refolding 
yield close to 90% (within an hour of incubation) in the presence of [EMIM] Cl. Next, by 
using response surface methodology and central composite design optimized refolding 
conditions, for [EMIM] Cl and denatured lysozyme were identified and an empirical 
model was developed. The conditions for refolding denatured lysozyme that yield 
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optimal results are; 75 mM [EMIM]Cl in 50 mM HEPES, pH 7.5 at denatured lysozyme 
concentration 0.18 mg/ml. The model was validated by experimental results. 
Ionic liquids dissociate into individual anion and cation when dissolved in water. It was 
therefore critical and pertinent to the development of on-column refolding process to test 
if [EMIM] Cl in buffer adsorbed to the cation exchange resin, Sepharose Fast Flow. At 
the tested concentration of [EMIM] Cl (up to 150 mM in 50 mM HEPES, pH 7.5), there 
was no evidence of binding to the resin. Therefore, it was safe to use the ionic liquid in 
the elution buffer for the on-column refolding of denatured lysozyme.  
Protein load has a significant impact on the fractional mass recovery and refolding yield. 
Hence, by varying the concentration of denatured lysozyme load (mg), on the packed bed 
and fluidized bed resin, the efficiency of [EMIM] Cl in the elution buffer as a refolding 
additive was assessed. Elution buffer containing 75 mM [EMIM] Cl, 1 M NaCl in 50 mM 
HEPES, pH 7.5 not only enhanced the elution of the adsorbed protein but also increased 
the refolding yield in comparison to conventional refolding buffer tested in Chapter 4. 
This was found to be independent of the mode of operation, packed bed vis-a-vis 
fluidized bed.  
Further, the efficiency of on-column adsorptive refolding of denatured lysozyme in 
packed bed was compared to that of that in a fluidized bed.  At low protein load (2.5 mg) 
the refolding yield and recovery was comparable in both modes of operation. However, 
as the protein load increased, the enhanced mass transfer and inter-particle porosity in the 
fluidized-bed mode of operation enhanced the elution protein and refolding yield of the 
protein. In comparison to fluidized bed, the reduction in the number of available sites for 
protein adsorption, especially at the top of the column in the packed bed system resulted 
in poor recovery and refolding yield. 
In summary, based solely on the experimental results presented in this thesis, it is safe to 
that ionic liquids, particularly [EMIM] Cl is an effective refolding additives for refolding 
denatured lysozyme. On-column adsorptive refolding of denatured lysozyme is enhanced 
in the fluidized bed and by incorporation of [EMIM] Cl in the elution-refolding buffer. 
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8.2 Recommendations 
Purity, toxicity and economic feasibility of the application of ionic liquids at industrial 
scale need to be rigorously evaluated. The reusability of the ionic liquids by suitably 
modifying the fluidized bed to a circulating fluidized bed is a proposed plan to combat 
the economical and ecological aspects of ionic liquids. The efficacy of the ionic liquid as 
a refolding additive in on-column refolding process was demonstrated by inclusion in the 
elution buffer. However, the separation of the refolded protein from the ionic liquid 
elution pool, remains to be evaluated. Summers and Flowers (2000) did successfully 
separate refolded lysozyme from ethylammonium nitrate [EAN] by use of advanced 
centrifugal filters (Summers and Flowers, 2000). Whether this is applicable to other ionic 
liquids, based on imidazolium, pyrrolidinium or pyridinium etc., is yet to the examined. 
Also, how this would translate into economies of scale at the industrial level.  
Thus, in summary, while the use of fluidized bed ion exchange refolding system is an 
effective means to refold high concentrations of denatured lysozyme, an organized, 
systematic assessment of its applicability to other proteins, in the presence of other 
refolding additives including different types of ionic liquids, could in the long run help 
over come the biggest obstacle in downstream processing today – protein refolding 
8.3 Nomenclature  
Abbreviation Full form 
[EAN]  Ethyl ammonium nitrate 
[EMIM] Cl 1-ethyl-3-methylimidazolium chloride 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid ) 
NaCl Sodium chloride 
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Appendices  
Appendix  A Specification of the UV-Star 96 well microplate 
1 Description/Specification  
1.1 Description UV-Star® Microplate, 96 well, clear film F-bottom 
(flat), alphanumeric well 
coding, chimney well 
1.2 Plate Length Plate: length: 127,76 mm (± 0,2 mm) 
width: 85,48 mm (± 0,2 mm) 
curvature: £ 200 μm 
Foil: 135 μm (± 10 μm) 
1.3 Volume Total volume: 392 μl (mathematically calculated) 
Working volume: 25 - 340 μl 
1.4 Material/ Resin Plate and foil :Cycloolefine, free of heavy metal 
1.5 Color 658801 : Clear 
1.6 Sterilisation No 
1.7 Quality Control Raw Material-Control: physical testing 
- Product-Control: testing of attributive and variable 
characteristics in 
accordance with the valid specification 
1.8 Other Information For single use only 
2 Features  
2.1 Basic Features Free of detectable DNase/RNase, human DNA and 
pyrogens 
2.2 Temperature Range -20°C to +40°C 
2.3 Autoclavability No 
2.4 Centrifugation, max. RCF 4800 x g: swinging-bucket rotor 
2.5 Chemical Resistance See homepage: www.gbo.com/bioscience ®Products 
®Literature 
®Technical Information ®Chemical Resistance of 
Resins 
2.6 Shelf Life Not applicable 
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Appendix  B Specifications of HiTrap Sepharose Fast Flow columns (1ml and 5ml) 
HiTrap SP FF 5ml Column 1ml column 
Bed Dimensions  16 × 25 mm  7 × 25 mm 
Bed Volume  5 ml  1 ml 
Flow rate  <20 ml/min1)  <4 ml/min1) 
Flow Rate  < 20 ml/min2)  < 4 ml/min2) 
Pressure Max. [Over the 
Packed Bed During Operation] 
 3 bar [0.3 MPa] (42 psi)  3 bar [0.3 MPa] (42 psi) 
Storage Conditions 
 4 to 30°C, 0.2 M Sodium 
Acetate in 20% Ethanol 
 4 to 30°C, 0.2 M Sodium 
Acetate in 20% Ethanol 
Media 
BioProcess Medium  Yes  Yes 
Ligand  Sulphopropyl  Sulphopropyl 
Average Particle Size  90 µm  90 µm 
Ion Exchanger Type  Strong cation exchanger  Strong cation exchanger 
Matrix  6% cross-linked agarose  6% cross-linked agarose 
Particle Size  45 µm-165 µm  45 µm-165 µm 
Ionic Capacity 
 0.18-0.25 mmol H+/ml 
medium 
 0.18-0.25 mmol H+/ml 
medium 
pH stability Working Range  4-13  4-13 
Pressure/Flow Specification 
 400-700 cm/h, 100 kPa, XK 
50/30 column, bed height 15 
cm 
 400-700 cm/h, 100 kPa, XK 
50/30 column, bed height 15 
cm 
Exclusion Limit [Mr] 
[Globular Proteins] 
 4 x 106  4 x 106 
Storage Conditions 
 4 to 30°C, 20% Ethanol + 0.2 
M Sodium Acetate 
 4 to 30°C, 20% Ethanol + 0.2 
M Sodium Acetate 
Chemical Stability 
 Stable to all commonly used 
aqueous buffers:1 M NaOH, 8 
M urea, 8 M guanidine 
hydrochloride, 70% ethanol1) 
 Stable to all commonly used 
aqueous buffers:1 M NaOH, 8 
M urea, 8 M guanidine 
hydrochloride, 70% ethanol1) 
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Appendix C. Clean-in-place protocol for Sepharose Fast Flow resin 
Cleaning-in-place (CIP) is a cleaning procedure that removes contaminants such as lipids, 
precipitates, or denatured proteins that may remain in the packed column after 
regeneration. Such contamination is especially likely when working with crude materials. 
Regular CIP also prevents the build-up of these contaminants in the media bed and helps 
to maintain the capacity, flow properties and general performance of the media.  
Standard CIP protocol followed: 
Step 1. Wash with 0.5 column volume of 1 M sodium hydroxide solution, contact time 15 
minutes.  
Step 2. Wash with 4 column volumes of Milli Q water, contact time 30 minutes.  
Step 3. Re-equilibrate Resin : Wash with 5 column volumes of equilibration buffer or 
until the base line is stabilized.  
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Appendix D. Sample calculation - refolding yield of lysozyme 
Preparation of denatured lysozyme solution:  
 Native Lysozyme solution (10 mg/ml) in 50 mM HEPES, pH 7.0 was prepared by 
dissolving 100 mg of lyophilized lysozyme in 10 ml of 50 mM  HEPES buffer (pH 7.0). 
Next, native lysozyme solution, 1 ml aliquot, is diluted with 9 ml of denaturation buffer 
(6 M urea, 32 mM dithiothreitol, 1 mM EDTA in 50 mM HEPES, pH 8.7) and placed in 
water bath for 2 hours at 37 °C. At the end of 2 hours, denaturation is confirmed by 
lysozyme activity assay.  
Concentration of denatured lysozyme: 1 mg/ml 
Experimental methodology  
Refolding buffer: 75 mM [EMIM] Cl in 50 mM HEPES, pH 7.5  
Technique: Fluidized bed refolding.  
Load: 2.5 mg of denatured lysozyme (i.e. 2.5 ml) 
Raw Data: Lysozyme activity assay  
Time 
(s) 
0 10 20 30 40 50 60 70 80 90 100 110 120 
Elute 0.616 0.558 0.516 0.469 0.469 0.405 0.39 0.358 0.334 0.317 0.307 0.295 0.295 
Elute 0.615 0.555 0.515 0.468 0.453 0.404 0.4 0.368 0.357 0.333 0.3 0.299 0.293 
Elute 0.615 0.557 0.515 0.468 0.433 0.404 0.395 0.363 0.345 0.325 0.304 0.297 0.294 
Average Slope (GraphPad Prism, linear regression) -0.002614 ± 0.0001046 
Using Equation 3.2, specific activity of elute = -0.105 units mg
-1
 ml
-1 
Specific activity of native lysozyme: -0.114 units mg
-1
 ml
-1 
Therefore, substitute the values in Equation 3.3, Refolding yield = 92.13 %  
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